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FUNCTIONAL ANALYSIS OF DROSOPHILA INTEGRATOR COMPLEX
IN SNRNA 3’ END PROCESSING
Publication No.________
Jiandong Chen, M.S.
Supervisory Professor: Eric J. Wagner, Ph.D.
Uridine-rich small nuclear RNAs (U snRNAs) play essential roles in eukaryotic gene
expression by facilitating the removal of introns from mRNA precursors and the processing of
the replication-dependent histone pre-mRNAs. Formation of the 3’ end of these snRNAs is
carried out by a poorly characterized, twelve-membered protein complex named Integrator
Complex.
In the effort to understand Integrator Complex function in the formation of the snRNA 3’
end, we performed a functional RNAi screen in Drosophila S2 cells to identify protein factors
required for snRNA 3’ end formation. This screen was conducted by using a fluorescencebased reporter that elicits GFP expression in response to a deficiency in snRNA processing.
Besides scoring the known Integrator subunits, we identified Asunder and CG4785 as
additional core members of the Integrator Complex. Additionally, we also found a conserved
requirement for Cyclin C and Cdk8 in both fly and human snRNA 3’ end processing. We have
further demonstrated that the kinase activity of Cdk8 is critical for snRNA 3’ end processing
and is likely to function independent of its well-documented function within the Mediator Cdk8
module. Taken together, this work functionally defines the Drosophila Integrator Complex and
demonstrates a novel function for Cyclin C/Cdk8 in snRNA 3’ end formation.
This thesis work has also characterized an important functional interaction mediated by a
microdomain within Integrator subunit 12 (IntS12) and IntS1 that is required for the activity of
the Integrator Complex in processing the snRNA 3’ end. Through the development of a
reporter-based functional RNAi-rescue assay in Drosophila S2 cells, we analyzed domains
within IntS12 required for snRNA 3’ end formation. This analysis unexpectedly revealed that
an N-terminal 30 amino acid region and not the highly conserved central PHD finger domain,
is required for snRNA 3’ end cleavage. The IntS12 microdomain (1-45) functions
autonomously, and is sufficient to interact and stabilize the putative scaffold protein IntS1.
Our findings provide more details of the Integrator Complex for understanding the
molecular mechanism of snRNA 3’ end processing. Moreover, these results lay the foundation
for future studies of the complex through the identification of a novel functional domain within
one subunit and the identification of additional subunits.
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INTRODUCTION AND BACKGROUND
Overview: Cellular functions and biogenesis of uridine-rich small nuclear RNA (U
snRNA).
U snRNAs are a population of non-coding small RNAs in eukaryotic cells that are highly
expressed, non-polyadenylated, and function in the nucleoplasm. Based on consensus
sequence features and bound protein cofactors, U snRNAs are grouped into two different
classes. The Sm-class contains a tri-methylguanosine cap at the 5’ end, a stem-loop structure
at the 3’ end, and a central consensus protein binding site that serves as a binding platform for
the heteroheptameric Sm ring (Sm site) (Figure 1.1A). The Lsm-class, in contrast, have a 5’
mono-methylphosphate cap, a 3′ stem-loop, and a stretch of uridines at the 3’ end that serves
as a binding site for a distinct heptameric ring of Lsm proteins (Figure 1.1B).
The Sm-class snRNAs are transcribed by RNA polymerase II (RNAPII) and include U1,
U2, U4, U5, U7, U11, U12, and U4atac. In contrast, the Lsm-class snRNAs are RNA
polymerase III (RNAPIII) transcripts and include U6 and U6atac. U snRNAs are best known for
their function in forming the RNA core of the spliceosome to facilitate the removal of introns
from mRNA precursors (pre-mRNA). During the splicing reaction, specific and dynamic
complementary interactions between the substrate and snRNA take place in the context of
over a hundred of accessory proteins (Figure 1.2A). Accurate removal of intronic sequences is
achieved by sequential synergistic actions of distinct small nuclear ribonucleoproteins
(snRNPs). The early interactions in the splicing reaction include the U1 snRNP recognition of
the 5’-splice sites of the pre-mRNA by base pairing, the U2 snRNP recognition of the branch
point sequences, and identification of the 3’ splice site by the U2 auxiliary factors. Once these
recognition events have been established, the U4/U6/U5 tri-snRNP enters the complex to
ultimately form the catalytic spliceosome (Will and Luhrmann 2011). The aforementioned
snRNAs are the components of the cellular major spliceosome, whereas the U11, U12, U4atac
and U6atac are found in the minor spliceosome and catalyze the removal of the non-canonical
“atac” introns (Will and Luhrmann 2005). One exception within this snRNA group is the U7
snRNA, which is required for histone pre-mRNA 3′ processing and plays no role in pre-mRNA
splicing. The U7 snRNP can basepair with the histone downstream element (HDE) that is
located downstream of the cleavage site, and facilitates the 3’ end endonucleolytic cleavage of
the histone pre-mRNA (Figure 1.2B) (Marzluff et al. 2008).
Recent studies of the U1 snRNP reveal that it also functions beyond pre-mRNA splicing.
The U1 snRNP is shown to activate gene transcription through a combination of interactions
with the pre-mRNA transcript and with the transcription initiation machinery (Kwek et al. 2002).
It is also found to repress the levels of viral transcripts by suppression of RNA
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Figure 1.1 Anatomical features of Sm- and Lsm-class small nuclear RNAs.
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Adapted from Nature Reviews Molecular Cell Biology Matera et al. Non-coding RNAs: lessons from the small nuclear and small nucleolar
RNAs. 8, 209–220 (March 2007).
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Figure 1.1 Anatomical features of Sm- and Lsm-class small nuclear RNAs. (A). Sm-class
small nuclear RNAs are transcribed by RNAPII, and have a 5’ trimethylguanosine (TMG) cap,
a 3’ stem loop and a Sm protein binding site in the middle. The U7 snRNA has a noncanonical
Sm site that is bound by a U7 Sm core. (B). Lsm-class snRNAs are transcribed by RNAPIII
and have a 5’ monomethylphosphate (MMP) cap, a 3′ stem loop, and a stretch of uridines at
the very 3’ end that serve as a binding site for a distinct heptameric ring of Lsm proteins.
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A. snRNPs function in pre-mRNA splicing

Figure 1.2 Cellular functions of spliceosomal snRNP and U7 snRNP.

!

5

Figure 1.2 Cellular functions of spliceosomal snRNP and U7 snRNP. (A). Schematic
representation of the spliceosome assembly pathway during pre-mRNA splicing. Introns are
excised from pre-mRNA by the spliceosome that is assembled by stepwise integration of U1,
U2, and U4/U6.U5 snRNPs. (B). Schematic representation of U7 snRNP involved in histone
mRNA 3’ end formation. The U7 snRNP binds histone downstream element (HDE) through
basepairing between 5’ U7 snRNA and HDE sequence, and the stem loop binding protein
(SLBP) binds the 3’ stem-loop, together with ZFP100 and FLASH to stabilize the U7 snRNP
and help recruiting the endonuclease to cleave the histone pre-mRNA.
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polyadenylation (West 2012), and in human cells, it has been shown to protect the widespread
premature cleavage and polyadenylation of pre-mRNA transcripts through U1 snRNA binding
to the 5’-splice site-like sequences present in primary transcripts (Kaida et al. 2010). These
studies are all consistent with the fact that the U1 snRNA is expressed at significantly higher
levels than other snRNAs.
The Lifecycle of the snRNP.
Introduction.

The biogenesis of snRNPs is an extensively studied research topic. The

primary focus of these investigations has been to determine how snRNPs are assembled as
well as how the mature snRNPs function in pre-mRNA splicing. In contrast, less is known
about the events that precede snRNP incorporation into the spliceosome. The biogenesis of
the functional Sm-class snRNPs includes a sophisticated nuclear-cytoplasmic life cycle (Figure
1.3A), while the Lsm-class snRNPs are only subject to a nuclear maturation process (Figure
1.3B).
snRNA Transcription.

Transcription of the RNAPII transcribed snRNA genes is related in

several ways to other transcription reactions but also possesses several important distinctions
from mRNA-encoding genes (for more comprehensive reviews, see (Hernandez 2001; Egloff
et al. 2008)). The RNAPII-transcribed snRNA genes have a TATA-less promoter that is
featured by the presence of a well-conserved DNA element called the proximal sequence
element (PSE). Transcription initiation at snRNA genes is mediated by a group of snRNA
gene-specific proteins that have been referred to differently in the literature: the snRNA
activating protein complex (SNAPc), the PSE-binding transcription factor (PTF), PSE-binding
protein (PBP) (Hung and Stumph 2011). The SNAPc complex is thought to recruit RNAPII to
the snRNA promoter by binding to the PSE element, similar to how general transcription
factors recruit RNAPII, but the events that follow are snRNA-specific. For protein-encoding
genes, transcription initiates from the recruitment of RNAPII by transcription factors, and is
followed by phosphorylation of Ser5 within C-terminal domain of the heptad repeat
(YSPTS5PS) of the RNAPII large subunit (Rpb1) by the cyclin-dependent kinase 7 (Cdk7) of
transcription factor IIH (TFIIH), which is critical for promoter clearance (reviewed in (Phatnani
and Greenleaf 2006; Buratowski 2009)). Subsequent to promoter clearance there is an
increase in the phosphorylation of Ser2 within the CTD heptad repeat by CDK9 of the positive
transcription elongation factor-b complex (P-TEFb) that is concomitant with a reduction in the
levels of pSer5. This change in phosphorylation status is thought to increase elongation
efficiency and facilitate the loading of RNA-processing factors onto the RNAPII
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A.

B.

Figure 1.3 Sm-class and Lsm-class snRNP biogenesis pathways.
Adapted from Nucleic Acids Research, Patel S and Bellini M, The assembly of a spliceosomal
small nuclear ribonucleoprotein particle. 2008, Vol. 36, No. 20, 6482–6493.
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Figure 1.3 Sm-class and Lsm-class snRNP biogenesis pathways. (A). The biogenesis of
Sm-class snRNPs occurs both in the nucleus and the cytoplasm. The snRNA primary
transcripts are generated by RNAPII, cleaved by the Integrator complex and then exported to
the cytoplasm by the PHAX-containing snRNA export complex. In the cytoplasm, the SMN
complex recruits the heteroheptameric Sm proteins ring and tethers it to snRNA to form the
Sm-core RNP. Following assembly of the Sm core, the 7-methylguanosine (m7G) cap is
hypermethylated and the 3' end is trimmed. The newly formed TMG cap serves as a signal for
assembling the import complex containing the import adaptor Snurportin-1 (SPN) and the
import receptor Importin-β (Imp-β). Once returned to the nucleus, the Sm-class snRNPs are
targeted to Cajal bodies for snRNA-based modification, which is requisite for spliceosomal
function. The matured snRNPs then leave the Cajal bodies and either are stored in the splicing
factor compartments (SFCs) or participate in transcription-coupled pre-mRNA splicing at
perichromatin fibrils (PFs). (B). The biogenesis of Lsm-class snRNP (U6 snRNP) is an
exclusively nuclear process. The U6 snRNA are transcribed by RNAPIII and the 3’ end is
formed by transcription termination with stretch of uridines. The newly transcribed U6 snRNA
is bound by the La antigen at both 5’ and 3’ ends and then is targeted to nucleoli, where its 5’
cap and 3’ end are modified. The modification discharges La protein binding and enables Lsm
protein binding. Once the Lsm core is assembled onto U6 snRNA, the U6 snRNP is targeted
to Cajal bodies for further maturation. The mature U6 snRNP either are stored in the splicing
factor compartments (SFCs) or participate in transcription-coupled pre-mRNA splicing
process.
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CTD in order to catalyze downstream RNA processing reactions (Zhang et al. 2005; Zhang
and Gilmour 2006). Unlike its role in protein-encoding genes, P-TEFb is found to be
dispensable for efficient elongation of snRNA genes, which is not unexpected given the
relative short length and lack of polyadenylate tails in snRNAs (Medlin et al. 2005).
Surprisingly, however, phosphorylation of Ser2 in the heptad repeat of the RNAPII CTD has
been reported to be required for proper snRNA 3′ end formation, thereby implicating a distinct
requirement for P-TEFb in snRNA 3’ end formation (Medlin et al. 2005). Recently, an
additional phosphorylation at Ser7 of the RNAPII CTD has been reported by the Murphy
laboratory to be essential for snRNA processing (Chapman et al. 2007; Egloff et al. 2007),
and, surprisingly, TFIIH has been found to phosphorylate Ser7 of the CTD, expanding its
established substrate specificity beyond Ser5 (Akhtar et al. 2009).
snRNA nuclear export.

The primary snRNA transcript is cleaved at the 3’ end to facilitate

RNAPII termination and recycling. This cleavage event is governed by a poorly conserved cisregulatory element called the 3′-box, which is located several nucleotides downstream the
cleavage site (Hernandez 1985). The 3′ box is likely to serve as a recognition site for the
Integrator Complex (described in more detail below) that is responsible for the nascent snRNA
cleavage from the elongating polymerase. Once the snRNA is cleaved from the DNA template,
it is exported to the cytoplasm by an snRNA-specific export complex for maturation.
The cytoplasmic export of snRNA is carried out by a protein complex that is comprised of
the snRNA-specific phosphorylated adaptor for RNA export (PHAX), the cap-binding complex
(CBC), the chromosome region maintenance-1 (CRM1/Xpo1), and RanGTP (Ohno et al.
2000). The 5′ mono-methylguanosine cap structure and length of the snRNA are key
determinants in snRNA nuclear export while the compartmentalized phosphorylation status of
PHAX controls the directionality of export (Ohno et al. 2000). Phosphorylated PHAX is
localized in the nucleus and together with CBC complex bridges the snRNA to CRM1/Xpo1 for
export. Once PHAX enters into the cytoplasm it is dephosphorylated causing export complex
disassembly and PHAX is then recycled to the nucleus through the import receptor importin-β
(Segref et al. 2001). The nuclear kinase and cytoplasmic phosphatase that regulate this
process have been identified to be Casein Kinase 2 (CK2) and protein phosphatase 2A,
respectively (Kitao et al. 2008). There have been no PHAX orthologues found in fungal
genomes suggesting that either the fungal snRNAs are not exported to cytoplasm or they use
a different system for snRNA export.
SMN and snRNP assembly. Once exported to the cytoplasm, the snRNAs are loaded onto
the Sm-core particles under the facilitation of the Survival of Motor Neuron (SMN) protein
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complex. Proper function of SMN is critical, as loss or mutation of SMN1 gene is known to
cause selective dysfunction of motor neurons leading to Spinal Muscular Atrophy (SMA)
(Burghes and Beattie 2009; Coady and Lorson 2011; Workman et al. 2012). Given the
importance of SMN in snRNP biogenesis, one explanation is that mutation of SMN results in
splicing alterations of specific genes that are required for neuromuscular junction function. The
SMN complex (SMN, Germin2-8 and UNR-interacting protein) bridges the heptameric Sm
protein ring and the newly exported snRNA precursors to form the snRNPs. The binding
specificity of SMN complex to snRNAs is mediated through the interaction between the
Germin5 WD repeat and Sm site of snRNA (Lau et al. 2009; Yong et al. 2010). It is noteworthy
that the U7 snRNA has a nonconsensus Sm site, which determines the inclusion of two
alternative Sm-like proteins (Lsm10 and Lsm11) in the U7 core (Figure 1.1A). It is still not
known how the SMN complex facilitates loading the alternative heptameric Sm core onto the
U7 snRNA.
Once the Sm core/SMN complex are assembled on the Sm sites, the cap structure of
snRNA is hypermethylated by the tri-methylguanosine synthase-1 (TGS1) to form a 2,2,7trimethylguanosine (TMG) cap (Mouaikel et al. 2002). The snRNA 3’ end is then further
trimmed several nucleotides by a yet-to-be identified cytoplasmic exonuclease. The newly
formed TMG cap serves as a nuclear import signal that is recognized by the adaptor protein
Snurportin-1, and together with the SMN complex, the snRNP is re-imported into the nucleus
through the import receptor importin-β (Imp-β), which directly interacts both Snurportin-1 and
SMN complex (Segref et al. 2001).
Once imported back into the nucleus, the Sm-class snRNPs are sorted into Cajal bodies
for further maturation through site-specific modification and assembly of snRNP-specific
proteins (Matera et al. 2007; Patel and Bellini 2008). A recent study also indicates that the
production of snRNAs is a critical event for maintaining the integrity of the nuclear Cajal bodies
in human cells (Takata et al. 2012). This suggests that there is an interplay between the
formation of the Cajal Body and the levels of snRNAs that transit through the Cajal Body.
Functional snRNPs then leave the Cajal bodies and function in splicing at perichromatin fibrils
(PFs) or are stored in splicing factor compartments (SFCs) for later use.
The RNAPIII-transcribed U snRNAs (U6 and U6atac) use a unique extragenic RNAPIII
type III promoter for transcription (Schramm and Hernandez 2002) and their 3’ ends terminate
with a run of uridines that serves as the Lsm-binding site (Figure 1.1B) as well as the Pol III
transcription terminator. These snRNAs remain in the nucleus for maturation (Figure 1.3B)
(detailed review, see (Patel and Bellini 2008)).
3’ end formation of RNAPII transcripts
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Introduction. In eukaryotes, RNA polymerase II transcribes a variety of RNA transcripts that
serve distinct functions within the cell. The three major types of RNAPII-transcribed RNA are:
the polyadenylated mRNAs, the nonpolyadenylated histone mRNAs, and the small nuclear
RNAs. The presence of a poly(A) tail at the 3’ end is a prominent feature of the eukaryotic
mRNAs, which is important for mRNA export, stability and translation. However, the metazoan
replication-dependent histone mRNAs and the ubiquitously expressed snRNAs have a stemloop structure at their 3’ end. These non-polyadenylated RNAs utilize mechanisms to form
their 3’ ends that are distinct from poly(A)+ mRNA but they also share certain similarities for
the 3’ end formation that include the arrangement of cis-regulatory sequence elements and the
chemistry of the cleavage event itself (Reviewed in (Chen and Wagner 2010)).
The polyadenylated messenger RNA.

The 3’ end formation of polyadenylated mRNAs is

carried out by the cleavage/polyadenylation machinery and initially requires recognition of the
two cis-regulatory 3’ end processing signals and then cleavage of the pre-mRNA (Figure 1.4).
The initial binding of the highly conserved AAUAAA polyadenylation signal (PAS) is carried out
by the 160 kDa subunit of the five membered Cleavage and Polyadenylation Specificity Factor
(CPSF) complex (Murthy and Manley 1995). This occurs in parallel or in concert with the
recognition of the downstream G/U-rich sequence element (DSE) through the 64 kDa subunit
of the trimeric Cleavage Stimulation Factor (CstF) complex (MacDonald et al. 1994).
Recognition of these two conserved sequence elements by the CPSF and CstF complexes
facilitates the recruitment of a cleavage factor that then cleaves the pre-mRNA at the cleavage
site, which is preferably a CA dinucleotide located between the PAS and DSE. The cleavage
factor for polyadenylated mRNA comprises of the endonuclease CPSF73, the catalytically
inactivated CPSF100, and a large scaffold protein called Symplekin (Mandel et al. 2006). The
crystal structure of CPSF73 demonstrates that it belongs to the metallo-β-lactamase (MBL)
and metallo-β-lactamase-associated CPSF, Artemis, SNM1/PSO2 (β-CASP) subfamily
chelating zinc ions, and cleavage assay further revealed that it is a hydrolase capable of
cleaving single stranded RNA substrates in vitro (Mandel et al. 2006). Interestingly, the crystal
structure of CPSF100 clearly demonstrates that it adopts the same fold as CPSF73, but it
does not coordinate zinc ions in its active site and cleavage analysis shows that it has no
endonuclease activity to RNA tested in vitro, consistent with the observation that it lacks
critical amino acids thought to be required for catalytic activity. Symplekin is an ARM/HEAT
repeats containing protein and data from its crystal structure indicates that its HEAT domain is
likely to function as a scaffold for protein-protein interactions essential to the mRNA maturation
process in mammalian cells (Andrade et al. 2001). Besides the factors mentioned above,

!

12

Poly(A)+ mRNA 3’ end processing machinery

Poly(A)- histone mRNA 3’ end
processing machinery

snRNA 3’ end processing machinery

Figure 1.4 Comparison of the three 3’ end processing complexes for RNA polymerase II transcripts. The molecular machineries

governing 3’ end processing for polyadenylated mRNA (A), nonpolyadenylated histone mRNA (B) and small nuclear RNA (C) are

presented. The three ‘cleavage factor’ proteins are denoted in pink for all three systems with the Integrator cleavage factor having one of

its unknown subunits labeled with a question mark. The dark-grey proteins represent factors involved in either CTD recognition or

downstream cis element (DSE, HDE or 3’ box) binding, and the green proteins represent factors for upstream 3’ end sequence element

13

(DES, stem-loop) recognition. CstF, cleavage stimulation factor; HDE, histone downstream element; RNA Pol II, RNA polymerase II.
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cleavage factor I (CFIm) and cleavage factor II (CFIIm) complexes have also been implicated
in the cleavage reaction of pre-mRNAs lacking the canonical PAS signal by stimulating binding
of the CPSF complex to the pre-mRNA through a functional interaction with Fip1 (Brown and
Gilmartin 2003; Venkataraman et al. 2005). Finally, the C-terminal domain (CTD) of the largest
subunit of RNA polymerase II (Rpb1) is required for the pre-mRNA cleavage step likely
through its ability to recruit cleavage factors to sites of transcription. Tightly coupled to the
cleavage step is the addition of a poly(A) tail to the newly formed mRNA 3’ end by the poly(A)
polymerase (PAP) to form the mature mRNA with a 200-250 nucleotide poly(A) tail.
The replication-dependent histone mRNA.

The mature replication-dependent metazoan

histone mRNAs terminate with a 3’ end stem-loop structure that is generated by single
endonucleolytic cleavage but it is distinctly not followed by polyadenylation. Histone genes are
intronless, thus this single cleavage reaction is the only RNA processing event required to
form mature histone mRNAs. The 3’ end of histone mRNA is formed by a distinct processing
machinery that recognizes two conserved sequence elements present in histone pre-mRNAs:
the 3’ end stem-loop and a purine-rich histone downstream element (HDE) (Dominski and
Marzluff 2007) (Figure 1.4). The stem-loop sequence is highly conserved throughout evolution
and consists of a 6-base pair stem and a 4-nucleotide loop. In contrast, the HDE sequence of
vertebrate histone pre-mRNAs is less conserved but all contains a purine-rich core, which has
a typical sequence of PuAAAGAGCTG (Pu, purine) located 15-20 nucleotides downstream of
the 3’ end stem-loop. The conserved stem-loop structure in histone pre-mRNA is recognized
by the stem-loop binding protein (SLBP) through its central RNA binding domain (RBD) (Wang
et al. 1996), and the downstream HDE sequence is a binding site for the U7 snRNP where the
5’ end of U7 snRNA basepairs with HDE sequence (Mowry and Steitz 1987; Dominski et al.
2003). Recognition of these two elements by SLBP and U7 snRNP recruits other protein
factors, including the cleavage factor CPSF73/CPSF100 and Symplekin, to cleave the histone
pre-mRNA at the cleavage site, typically an adenosine between the stem-loop and the HDE
sequences. Thus the unique histone mRNA 3’ end processing machinery includes at least the
U7 snRNP, SLBP, a 100-kDa zinc-finger protein (ZFP100) and a same large complex
consisting of CPSF and CstF complexes as the effector of RNA cleavage.
The U7 snRNA has an unstructured 5’ terminus that is involved in formation of a duplex
with the histone HDE sequence, and thus is essential for histone pre-mRNA 3’ end formation.
In contrast, the 3’ end of U7 snRNA folds into a stem-loop structure, which has been shown to
be resistant to alterations at the sequence level suggesting that the structure itself is important
rather than the content. The central region of the U7 snRNA contains its noncanonical Sm
protein-binding site that guides inclusion of a different Sm core called the U7 core. Instead of
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the classical Sm core consisting of seven Sm proteins: B, D1, D2, D3, E, F and G, the U7 core
forms a heptameric ring by replacing the SmD1, D2 proteins with Lsm10 and Lsm11,
respectively (Pillai et al. 2001; Pillai et al. 2003). Lsm10 resembles other Sm proteins in size
and structure and shares the highest sequence homology to SmD1 but is not observed to be
included in spliceosomal snRNPs and is required for U7 snRNP function. Interestingly, Lsm11
has an unusual large size with a long N-terminus, and it has been shown to directly participate
in recruiting an essential processing factor for histone pre-mRNA 3’ end formation (Yang et al.
2012). The U7 snRNP that contains either N-terminal truncated Lsm11 or N-terminal mutated
Lsm11 is defective in histone pre-mRNA 3’ end processing (Pillai et al. 2003). Recognition of
the HDE sequence by the U7 snRNP is an essential event for histone pre-mRNA 3’ end
processing and has been proposed to serve as a molecular ruler that specifies the site of
cleavage. Mutations introduced into the HDE sequence that compromise U7 snRNA
complimentary base paring consistently lead to complete inhibition of the 3’ end cleavage
reaction and alteration of the distance between the stem-loop and the HDE sequence shifts
the location of the cleavage site (Mowry et al. 1989; Scharl and Steitz 1994).
Mutation of the stem-loop (SL) sequence or genetic loss of SLBP leads to misprocessing of
histone pre-mRNA underscoring the essential nature of this element and its RNA binding
protein (Wang et al. 1996). However, mutations introduced into the stem-loop sequence in the
context of an HDE that has very high complementarity with the U7 snRNA does not
significantly affect the efficiency of 3’ end processing tested in vitro (Dominski et al. 1999).
This suggests that the recognition of the stem-loop by SLBP is used to stabilize binding of U7
snRNP to the HDE, especially in histone pre-mRNAs with relatively weak complementarity of
the HDE sequence to U7 snRNA 5’ end. This notion is further supported by the evidence that
ZFP100 interacts with the SL/SLBP complex and Lsm11 thus bridging both factors (Dominski
et al. 2002; Azzouz et al. 2005). Additional interactions have been identified with the recent
finding that binding between a 220 kDa proapoptotic protein FLASH and Lsm11 in the U7
snRNP is essential for histone pre-mRNA 3’ end processing (Yang et al. 2009). The N-terminal
regions of these two proteins interact and form a platform for a unique combination of
polyadenylation factors including all CPSF subunits, Symplekin and CstF subunits, providing a
molecular mechanism for recruitment the similar cleavage factor containing the endonuclease
CPSF73 to histone pre-mRNAs (Burch et al. 2011; Yang et al. 2012). Finally, in stark contrast
to its role in protein-encoding genes, the CTD of Rpb1 is likely not required for coupling
transcription and 3’ end processing of histone pre-mRNA. Evidence shows that inhibition of the
CTD Ser2 kinase Cdk9 affects neither transcription of histone genes nor 3’ end processing of
histone pre-mRNAs (Medlin et al. 2005).
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The uridine-rich small nuclear RNAs.

U snRNA primary transcripts made by RNAPII are

very similar to their histone pre-mRNA counterparts in that both transcripts are short,
intronless, and contain a stem-loop structure at their 3’ end. For snRNA, however, the size and
content of this 3’ stem-loop is not well conserved, and the 3’ end processing signal
downstream of the cleavage site is an AU-rich cis-regulatory sequence element termed “3’
box” (Hernandez 1985). The 3’ box is located 9-19 nucleotides downstream of the 3’ end of
mature snRNA and has a typical sequence of GTTTN0-3AAAPuN2AGA (N, any nucleotide; Pu,
purine). Unlike the rigid requirement for the HDE element in 3’ end processing of the histone
pre-mRNAs, the snRNA 3’ box is required but more tolerant to mutation in that no single point
mutation significantly compromises efficient snRNA 3’ end processing (Ach and Weiner 1987;
Ezzeddine et al. 2011). This suggests that other mechanisms are likely to contribute to the
cleavage specificity. Indeed, mutagenesis analysis of Drosophila U7 snRNA reveals that its 3’
end stem-loop structure is also required for efficient 3’ end formation, which is analogous to
the role of the 3’ end stem-loop in histone pre-mRNA 3’ end formation (Ezzeddine et al. 2011).
Accurate 3’ end formation of pre-snRNA in metazoan cells also requires that transcription
initiates from the unique TATA-less snRNA promoters. Replacing the snRNA promoter with
other RNAPII promoters completely abolishes proper pre-snRNA 3’ end formation, indicating
that unique factors important for accurate 3’ end processing must load onto the snRNA
promoter early in the transcription cycle (de Vegvar et al. 1986; Hernandez and Weiner 1986;
Ezzeddine et al. 2011).
In addition to the promoter-coupled 3’ end formation is the fact that the CTD of Rpb1 is
also required for snRNA gene expression. Inhibition of Cdk9 activity by kinase inhibitors does
not affect snRNA gene transcription but abolishes their RNA 3’ end processing suggesting that
phosphorylation of serine 2 of the CTD is selectively required for snRNA 3’ end processing but
is dispensable for transcription elongation (Medlin et al. 2003; Jacobs et al. 2004). Indeed,
follow-up studies in mammalian cells demonstrate that a double phosphorylation mark on the
RNAPII CTD, pSer2 and pSer7 is required for recruitment of the snRNA specific 3’ end
processing machinery-the Integrator complex to snRNA gene promoters (Egloff et al. 2007;
Egloff et al. 2010).
The snRNA 3’ -end processing complex: Integrator Complex
The Integrator complex was serendipitously discovered by Baillat et al from the Shiekhattar
laboratory to associate with the CTD of RNAPII and serves as the 3’ end processing
machinery for metazoan RNAPII transcribed U snRNAs (Baillat et al. 2005). The name
“Integrator” refers to integrating the CTD of RNAPII largest subunit with the 3’ end processing
of small nuclear RNAs U1 and U2. The original biochemical purification and mass
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spectrometric analysis identified twelve different polypeptides that exhibited very little
homology with known proteins. A domain schematic of all 12 known human Integrator proteins
analyzed by Pfam is shown in Figure 1.5 and well-defined domains are shown in black and
regions with high sequence conservation are marked in grey. Proteins in the complex are
annotated in numerical order based on migration size on the SDS-PAGE gel, with Integrator 1
(IntS1) migrating the slowest with a molecular weight of ~ 244 kDa and IntS12 migrating as the
fastest at ~48 kDa. The majority of proteins in the Integrator complex were not studied at the
time of purification, and none of the proteins have an identifiable RNA-binding domain.
However, a close examination reveals the presence of a von Willebrand factor type A (VWA)
domain in IntS6, Armadillo repeats (ARM) in IntS4 and IntS7, and a plant homeodomain (PHD)
finger in IntS12. IntS11/RC-68 and IntS9/RC-74 both contain the MBL/β-CASP domains and
display high sequence similarity to the cleavage and polyadenylation specificity factor CPSF73
and CPSF100, which are known to function in the cleavage reaction of other RNAPII
transcripts (Dominski et al. 2005a; Dominski et al. 2005b). Interestingly, IntS11 is predicted to
be the catalytically active endonuclease analogous to CPSF73 that enables to cleave single
strand RNA, and IntS9 analogous to CPSF100 has critical residues required for the activity of
the MBL/β-CASP domain mutated, making it catalytically inactive (Mandel et al. 2006). As
predicted, IntS9 and IntS11 have been shown to form heterodimer through their C-terminal
regions using yeast two-hybrid analysis and pulldown assays and this interaction is important
for snRNA 3’ end formation in vivo (Albrecht and Wagner 2012). Based on these results,
IntS9/11 are proposed to form the core that performs the catalytic cleavage reaction of the presnRNA. An in vitro RNA cleavage assay or a co-crystallization of the snRNA substrate and the
endonuclease will provide final evidence to support this model. The details of the Integrator
Complex molecular mechanism remain to be determined. More specifically, it is not known
which Integrator subunit is responsible for recognition of the 3’ box or the 3’ stem-loop
structure and which subunit facilitates complex recruitment to the snRNA promoter to couple
transcription with 3’ end formation.
Several studies have emerged to provide cellular and biological details of the Integrator
complex in different organisms. Some of these studies are consistent with a function of snRNA
biogenesis, whereas others suggest that Integrator proteins may function beyond that.
Targeted disruption of mouse IntS1/KIAA1440 causes embryonic lethality at the blastocyst
stage, demonstrating a fundamental role of IntS1 in mouse development that is not
compensated by other genes (Hata and Nakayama 2007). The observation of accumulation of
unprocessed, primary U2 snRNA transcript but decrease of the mature U2 snRNA transcript in
IntS1 null embryos implies that the developmental role of IntS1 in mouse is likely through
controlling snRNA biogenesis pathway.
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Figure 1.5 Schematic representations of domains and motifs found in Integrator protein.
Protein domain and conserved motif search is conducted by using Pfam analysis, and protein
domains are labeled in black whereas conserved motif (>80%) over a stretch of ten amino
acids are labeled in grey. The species used for conservation analysis are human, cow,
chicken, Drosophila and zebrafish. Abbreviations: ARM, Armadillo-fold repeats; MBL, metalloβ-lactamase domain; β-CASP, metallo-β-lactamase-associated CPSF Artemis SNM1/PSO2;
DEAD, RNA helicase DEAD box; DUF, domain of unknown function; HEAT, HEAT repeat
units; PHD, plant homeodomain finger; TPR repeats, tetratricopeptide repeats; VWA, von
Willebrand factor type A domain; IntS, Integrator subunit; * represents that certain critical
residues are altered that renders the domain inactive.
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Similarly, IntS4 or IntS7/deflated null flies exhibit various developmental defects at early
stages and in both cases die at the stage of late second instar larvae. Elevated levels of
unprocessed primary U snRNAs are also observed in these Integrator null flies, suggesting
that an essential developmental role of the snRNA biogenesis controlled by the Integrator
complex (Rutkowski and Warren 2009; Ezzeddine et al. 2011). Moreover, antisense
morpholino-mediated depletion of IntS5 (or IntS9 and IntS11) in zebrafish embryos causes
specific red blood cell differentiation arrest. This is reported to be a requirement of the
Integrator complex for the bone morphogenetic protein (BMP) signaling pathway, a pathway
essential for the specification and proliferation of blood progenitors. Depletion of the Integrator
subunits affects snRNA processing, which in turn leads to aberrant splicing of smad1 and
smad5 pre-mRNAs, two downstream effectors of BMP signaling important for hematopoiesis
(Tao et al. 2009). The observed developmental defect in zebrafish is surprisingly specific and
one possible explanation is that splicing of these particular pre-mRNAs at specific
developmental stage is sensitive to the levels of functional snRNA in cells.
Recent studies from several different laboratories have identified IntS3 as DNA damage
response gene as IntS3 localizes to DNA damage foci once human cells are subject to
genotoxic stress (Huang et al. 2009; Li et al. 2009; Skaar et al. 2009). It is found to be one
component of the heterotrimeric sensor of single-stranded DNA (SOSS) complex that is likely
involved in maintenance of genome stability. IntS3 may function as a platform to form the
complex and its N-terminal region including the highly conserved DUF domain shown in Figure
1.5 is required for both interactions with other two components in the complex (Huang et al.
2009). The SOSS complex appears to be distinct from the known Integrator complex, as
SOSS subunits other than IntS3 were neither found in the original Integrator purification nor in
the recent high-throughout proteomic analysis of Integrator immunoprecipitations
(Malovannaya et al. 2010; Malovannaya et al. 2011). Recently, a DNA damage response
screen also identified IntS7 as one candidate protein that is recruited to the sites of DNA
damage (Cotta-Ramusino et al. 2011). But it is still unknown how IntS7 participates in the DNA
damage response. IntS6/DICE1 (deleted in cancer 1) is the only member in the Integrator
complex that had been functionally studied before the purification of the Integrator complex
(Wieland et al. 1999; Han et al. 2006; Filleur et al. 2009). IntS6 is a putative tumor suppressor
gene, as it is often found to be deleted or downregulated in the majority of non-small cell lung
carcinomas and prostate cancers and overexpression of IntS6 in prostate cancer cells or
human non-small cell lung carcinoma cells inhibits colony formation and causes a cell-cycle
arrest (Wieland et al. 1999; Filleur et al. 2009). No mutations in IntS6 were reported in human
non-small cell lung carcinomas and prostate cancers, and the reduced levels of expression in
prostate cancers is due to CpG hypermethylation of the IntS6 promoter (Ropke et al. 2005). It
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is unexpected that loss or downregulation of a specific Integrator protein, which would
presumably affect snRNA biosynthesis, correlates to tumorigenesis. The possible explanation
is that IntS6 may form different complexes that function in different pathways. IntS6 contains
an N-terminal well-conserved VWA (von Willebrand factor type A) domain, which is present in
both extracellular and intracellular proteins. The extracellular VWA domains are found to
mediate adhesion via metal ion-dependent adhesion sites (MIDAS), and the intracellular VWA
proteins are commonly found in multiprotein complexes, which are involved in a variety of
functions such as transcription, DNA repair and the proteasome (Whittaker and Hynes 2002).
Absence of a signal motif and association with the RNAPII CTD suggests that IntS6 plays an
intracellular function. Work on the worm orthologue of IntS6 (DIC-1) however, suggests that
DIC-1 is a mitochondrial protein located in the inner membrane of mitochondria, and is
required for formation of the normal morphology of mitochondria. DIC-1 is required for worm
development as RNAi-mediated depletion of DIC-1 leads to defective oogenesis and inviable
embryos (Han et al. 2006). This observation is unexpected, as Integrator proteins have been
shown to function in the nucleus in snRNA 3’ end formation. Finally, IntS4 (or IntS11) has
been found to be required for the Integrity of the nuclear Cajal bodies as RNAi-mediated
depletion of IntS4 significantly abolishes Cajal body formation in HeLa cells (Takata et al.
2012). Given the importance of the Integrator complex in snRNA 3’ end formation, it is very
likely that Integrator complex contributes to nuclear Cajal body formation through controlling
snRNA maturation.
Besides the known Integrator subunits, a recent high-throughput proteomic analysis of
immunoprecipitates from human cells using specific antibodies against different Integrator
subunits confirms the presence of all 12 Integrator proteins in the complex and demonstrates
the existence of additional protein factors that form an expanded complex (Malovannaya et al.
2010; Malovannaya et al. 2011). However, no functional studies have been done to determine
the importance of these factors, especially their roles in snRNA 3’ end formation, making their
importance to snRNA biogenesis unknown.
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SIGNIFICANCE OF THE STUDY
RNA processing is a major engine driving diversity within the proteome that is absent in
the comparatively simpler genome. Not surprisingly, mutations in many of the genes involved
in RNA processing can lead to human diseases manifesting in almost any tissue type. One of
the most dramatic examples of such a disease is SMA, which is caused by attenuation in the
activity of the SMN protein that is responsible for snRNP assembly (Coady and Lorson 2011;
Workman et al. 2012). SMA and a host of other splicing-related diseases underscore the need
for further understanding of snRNA biogenesis.
The combined efforts of several laboratories have created the paradigm that the 3’ end
formation of metazoan RNAPII-transcribed snRNA requires the snRNA promoter itself as well
as the 3’ box and the potential 3’ stem-loop structure (Hernandez 1985; Ezzeddine et al.
2011). It is clear that the 3’ box is not a termination site as RNAPII has been found to
transcribe much further downstream (Cuello et al. 1999). Rather, it is a cis-regulatory element
that likely binds a complex of proteins that carry out the 3’ end cleavage reaction but the
components of this complex had remained unknown until 2005.
The identification of the Integrator complex as the snRNA 3’ end processing machinery
represents a significant advancement in our knowledge of how snRNA 3’ end formation occurs
(Baillat et al. 2005). The Integrator subunits were purified due to their association with the CTD
of the large subunit RNAPII. The initial purification identified twelve polypeptides that bear little
resemblance to the 3’ processing factors known to participate in both poly(A) mRNA and
histone mRNA 3’ end formation with the exception of IntS9/11. The predicted snRNA 3’ end
processing model (Figure 1.4), which is analogous to the counterpart for poly(A) mRNA or
histone mRNA 3’ end processing, involves recognition of the 3’ box and 3’ stem-loop elements
by Integrator proteins, which subsequently recruit the endonuclease IntS11 to perform the
cleavage reaction.
Since no identifiable RNA-binding domain is present in the original purified Integrator
complex and a more expanded biochemical Integrator complex has been identified, we set out
to identify the candidate protein factors that are functionally required for snRNA 3’ end
formation by a genome-wide functional RNAi screen in Drosophila S2 cells. Chapter 3
describes the genome-wide screen data and it shows that a majority of the known Integrator
subunits (10/12) are required for reporter U7 snRNA 3’ end formation. Importantly, this screen
identified Asunder and CG4785 as two additional core Integrator subunits that are functional
required for snRNA 3’ end formation and biochemically interact with the known Integrators.
The screen also identified a conserved requirement for Cyclin C/Cdk8 in snRNA 3’ end
formation. This work is important for understanding snRNA 3’ end formation because it
provides genome-wide analysis from a functional perspective, and thus complements the
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existing biochemical data. This work also lays the foundation to further understand the
mechanism of the snRNA 3’ end machinery through the identification of additional critical
factors required for cis-regulatory sequence element recognition and cleavage complex
assembly.
The work described in Chapter 4 characterizes the role of one of the Integrator subunits,
IntS12, in snRNA 3’ end formation. IntS12 is the smallest subunit in the Integrator Complex
and contains a centrally located and well-conserved plant homeodomain (PHD) finger. Data in
Chapter 4 demonstrate the surprising finding that there is an N-terminal “microdomain” within
IntS12 that is capable of mediating its function in snRNA 3’ end formation. The IntS12
microdomain mediates its function through an interaction with IntS1, while the centrally located
conserved PHD finger is functionally dispensable. These results suggest that IntS12
contributes to snRNA 3’ end formation through a requisite binding to IntS1, which is the largest
Integrator subunit. Chapter 5 further characterizes the biochemical features of IntS12, focusing
specifically on its PHD finger and its affinity toward histones. Data in this chapter show that
though functionally not required for processing of the reporter snRNA 3’ end, the IntS12 PHD
finger avidly binds histone H3 in vitro, and enhances interaction with other Integrators in cells.
The cellular function of these biochemical interactions is not known yet, but we speculate that
the PHD finger is playing a role beyond snRNA processing.
At the beginning of my doctoral research, very little was known about the human Integrator
Complex and essential nothing was known about the fly complex. Taken together, data
presented in these studies functionally define the Drosophila Integrator complex to comprise of
fourteen core subunits (IntS 1-12, Asu/IntS13, IntS14), and of a regulatory CycC/Cdk8 kinase.
These features are likely conserved in other metazoan species. This work also provides the
first detailed structural-functional analysis of the smallest Integrator subunit and reveals an
unexpected autonomous microdomain mediating the activation of the Integrator complex in
snRNA 3’ end formation. All of the work presented here provides a foundation for future
studies to characterize the network of interactions within the Integrator Complex that are
important for snRNA 3 end formation.
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Chapter 2. Materials and Methods
(Partial contents described in this chapter have been published in RNA December 2012 18:
2148-2156, and usage permissions have been granted from the publishers.)
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Plasmids and Cell Lines Used
Plasmids and oligonucleotides (Sigma) used in these studies are described in Table 2.1
and Table 2.2, respectively. The pUB-Myc/HA/FLAG Drosophila expression vector was
generated by cloning the ubiquitin 63E promoter (ubi-p63E) and the viral OpIE2
polyadenylation signal into the bacterial plasmid pUC19 backbone. The Green Fluorescent
Protein (GFP) based snRNA readthrough reporters were constructed by cloning the snRNA
gene (including the promoter, coding sequence and 3’ flanking sequence) upstream of the
EGFP Open Reading Frame (ORF) into the promoterless pUB (Drosophila snRNA-GFP
reporter) or pcDNA6 (human U7-GFP reporter) vectors as described in detail previously
(Ezzeddine et al. 2011; Albrecht and Wagner 2012). The GFP-based histone H3 reporter and
Actin5C promoter driven H3 reporter were described in detail earlier (Wagner et al. 2007;
Yang et al. 2009). The Drosophila expression clones (pUB-Myc/HA/FLAG), the yeast two
hybrid clones (pGADT7 and pGBKT7) and bacterial recombinant protein clones (pET49) were
constructed by standard PCR cloning procedures. Site-directed mutation-containing clones
were created using the QuickChange method (Stratagene).
All cell lines and bacterial and yeast strains used in these studies are listed in Table 2.3.
D.mel-2 (S2) cells from Invitrogen (Catalog No. 10831-014) were used for most of studies
described here. S2 stable cell lines were generated by co-transfection of the plasmids
expressing FLAG-tagged protein with a Blastocidin expressing plasmid (w/w,19:1) and
selection was performed in Drosophila media (Invitrogen) containing 10%FBS and 25 ug/mL
blastocidin. Escherichia coli XL-1 blue was used for standard cloning, and E.coli BL-21 (DE3)
was used for expression of recombinant IntS12 proteins. Yeast strain AH109 (a/α) was used to
perform the yeast two-hybrid assay (Clontech, Matchmaker 3).
Cell Culture and RNA Interference
S2 cells were maintained in Sf-900 II SFM medium (Invitrogen) unless otherwise
mentioned following the manufacture’s instructions. Double-stranded RNA (dsRNA) used for
the RNA interference (RNAi) experiment in S2 cells were created by in vitro transcription of the
T7 DNA templates using T7 RNA polymerase (Fermentas). All T7 DNA templates were
created by PCR amplification of targeted genes off of genomic DNA using primers containing
T7 promoters at the 5’ end. In all cases, PCR primers were designed to amplify exons to
preclude the inclusion of intronic sequences in the dsRNA. To minimize off-target effects
(OTEs), the online dsRNA design tools “Snapdragon” (http://www.flyrnai.org/cgibin/RNAi_find_primers.pl) and “Find OTEs” (http://www.flyrnai.org/RNAi_find_frag_free.html)
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Description
pUC19 backbone, ubi-63E promoter, OpIE2 polyA site
Promoterless pIZ vector, U7 promoter, coding region, 3' UTR followed by
eGFP coding sequence (ref)
Promoterless pUB vector, U4 promoter, coding region, 3' UTR followed by
eGFP ORF
Described by Albrecht and Wagner 2012 (ref)
Described by Wagner and Marzluff 2007 (Ref)
Described by Ezzeddine and Wagner 2011 (ref)
Ubi-p63E promoter, Drosophila Cdk8 ORF
Ubi-p63E promoter, Drosophila kinase activity dead Cdk8 ORF (D173A)
Ubi-p63E promoter, Myc, Drosophila IntS12 ORF
Ubi-p63E promoter, Myc, Drosophila RNAi-resistant IntS12 ORF
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 2-251
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 2-185
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 2-130
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 184-328
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 124-328
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 46-328
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 124-185

Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp

Amp
Amp
Zeo
Zeo
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp

Zeo

Marker
Amp

Wagner lab
Wagner lab
Wagner lab
Wagner lab
CO3, CO4
WO127, WO128
CO63, CO20
CO13, CO20
CO13, CO14
CO13, CO21
CO13, CO15
CO20, CO22
CO16, CO20
CO17, CO20
CO16, CO21
CO13-CO18,
CO19-CO20,
CO13-CO20
CO41, CO20
CO23, CO20
CO13, CO24
CO25, CO26
CO27, CO28
CO29, CO30
CO31, CO32

Wagner lab

Origin
Wagner lab

Table 2.1: Plasmids used
Name
pUB

pUB-U4GFP
pcDNA-hU7GFP
pIZ-H3GFP
pIZ-ActH3GFP
pUB-Myc-Cdk8
pUB-Myc-Cdk8(DN)
pUB-Myc-IntS12
pUB-Myc-IntS12*
pUB-Myc-ΔC
pUB-Myc-NP
pUB-Myc-N
pUB-Myc-C
pUB-Myc-PC
pUB-Myc-ΔN
pUB-Myc-P

Ubi-p63E promoter, Myc, Drosophila IntS12* residues 2-130 and 184-328
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 16-328
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 31-328
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 2-45
Ubi-p63E promoter, Myc, Drosophila IntS12* (16DPVLK20->AAAAA)
Ubi-p63E promoter, Myc, Drosophila IntS12* (21KAIKL25->AAAAA)
Ubi-p63E promoter, Myc, Drosophila IntS12* (26LHSSN30->AAAAA)
Ubi-p63E promoter, Myc, Drosophila IntS12* (31PTSAA35->AAAAA)

pIZ-U7GFP

pUB-Myc-ΔP
pUB-Myc-ΔN15
pUB-Myc-ΔN30
pUB-Myc-N45
pUB-Myc-IntS12*Mt1
pUB-Myc-IntS12*Mt2
pUB-Myc-IntS12*Mt3
pUB-Myc-IntS12*Mt4
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Ubi-p63E promoter, FLAG, Drosophila IntS12 residues 1-129, mCherry
Ubi-p63E promoter, FLAG, Drosophila IntS12 residues 1-129 (T76A), mChe

Table 2.1: Plasmids used (continued)
Name
Description
pUB-Myc-IntS12*Mt5
Ubi-p63E promoter, Myc, Drosophila IntS12* (36ELRLL40->AAAAA)
pUB-Myc-IntS12*Mt6
Ubi-p63E promoter, Myc, Drosophila IntS12* (41LDEAL45->AAAAA)
pUB-Myc-IntS12*NMt1
Ubi-p63E promoter, Myc, Drosophila IntS12*N (16DPVLK20->AAAAA)
pUB-Myc-IntS12*NMt2
Ubi-p63E promoter, Myc, Drosophila IntS12*N (21KAIKL25->AAAAA)
pUB-Myc-IntS12*NMt3
Ubi-p63E promoter, Myc, Drosophila IntS12*N (26LHSSN30->AAAAA)
pUB-Myc-IntS12*NMt4
Ubi-p63E promoter, Myc, Drosophila IntS12*N (31PTSAA35->AAAAA)
pUB-Myc-IntS12*NMt5
Ubi-p63E promoter, Myc, Drosophila IntS12*N (36ELRLL40->AAAAA)
pUB-Myc-IntS12*NMt6
Ubi-p63E promoter, Myc, Drosophila IntS12*N (41LDEAL45->AAAAA)
pUB-Myc-NS2829
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 1-129 (S2829A )
pUB-Myc-NS33
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 1-129 (S33A )
pUB-Myc-NT56
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 1-129 (T56A )
pUB-Myc-NT76
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 1-129 (T76A )
pUB-Myc-NT91
Ubi-p63E promoter, Myc, Drosophila IntS12* residues 1-129 (T91A )
pUB-HA-IntS12
Ubi-p63E promoter, HA, Drosophila IntS12
pUB-FLAG-Asu
Ubi-p63E promoter, FLAG, Drosophila Asunder ORF
pUB-FLAG-CG4785
Ubi-p63E promoter, FLAG, Drosophila CG4785 ORF
pUB-FLAG-mCherry
Ubi-p63E promoter, FLAG, mCherry ORF
pUB-FLAG-Cdk8
Ubi-p63E promoter, FLAG, Drosophila Cdk8 ORF
pUB-FLAG-CycC
Ubi-p63E promoter, FLAG, Drosophila Cyclin C ORF
pUB-FLAG-IntS12*
Ubi-p63E promoter, FLAG, Drosophila IntS12*
pUB-FLAG-Mt3
Ubi-p63E promoter, FLAG, Drosophila IntS12* (26LHSSN30->AAAAA)
pUB-FLAG-Mt5
Ubi-p63E promoter, FLAG, Drosophila IntS12* (36ELRLL40->AAAAA)
pUB-FLAG-ΔN
Ubi-p63E promoter, FLAG, Drosophila IntS12* residues 46-328
pUB-FLAG-N45
Ubi-p63E promoter, FLAG, Drosophila IntS12* residues 1-45
Ubi-p63E promoter, FLAG, Drosophila IntS12* residues 1-45 fused to
mCherry
pUB-FLAG-N45Ch

pUB-FLAG-12NmCh
pUB-FLAG-12NT76mCh
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Marker
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp
Amp

Origin
CO33, CO34
CO35, CO36
CO25, CO26
CO27, CO28
CO29, CO30
CO31, CO32
CO33, CO34
CO35, CO36
CO37, CO38
CO39, CO40
CO47, CO48
CO51, CO52
CO49, CO50
CO5, CO6
CO80, CO81
CO82, CO83
CO53, CO54
CO3, CO4
CO1, CO2
CO13, CO20
CO29, CO30
CO33, CO34
CO17, CO20
CO13, CO24
CO13-CO55,
CO53-CO54
CO13-CO56,
CO53-CO54
CO61, CO62

!

ADH1 promoter, GAL4 activation domain, HA epitope tag, Drosophila IntS12
ADH1 promoter, GAL4 activation domain, HA epitope tag, Drosophila IntS12
(26LHSSN30->AAAAA)
ADH1 promoter, GAL4 activation domain, HA epitope tag, Drosophila IntS12
(36ELRLL40->AAAAA)
ADH1 promoter, GAL4 activation domain, HA epitope tag, Drosophila IntS12
residues 46-328
ADH1 promoter, GAL4 activation domain, HA epitope tag, Drosophila IntS12
residues 1-45
ADH1 promoter, GAL4 DNA binding domain, c-Myc epitope tag, Drosophila
IntS1 ORF
ADH1 promoter, GAL4 DNA binding domain, c-Myc epitope tag, Drosophila
IntS2 ORF
ADH1 promoter, GAL4 DNA binding domain, c-Myc epitope tag, Drosophila
IntS3 ORF
ADH1 promoter, GAL4 DNA binding domain, c-Myc epitope tag, Drosophila
IntS4 ORF
ADH1 promoter, GAL4 DNA binding domain, c-Myc epitope tag, Drosophila
IntS5 ORF

Ubi-p63E promoter, FLAG, mCherry, Drosophila IntS12 residues 184-328
ADH1 promoter, GAL4 activation domain, HA epitope tag, Drosophila
Asunder ORF
ADH1 promoter, GAL4 activation domain, HA epitope tag, Drosophila
CG4785 ORF

Ubi-p63E promoter, FLAG, Drosophila IntS12 residues 1-185, mCherry
Ubi-p63E promoter, FLAG, Drosophila IntS12 residues 1-185 (L145A),
mCherry
Ubi-p63E promoter, FLAG, Drosophila IntS12 residues 1-185 (E147A),
mCherry

Table 2.1: Plasmids used (continued)
Name
Description
pUB-FLAG-12NPmCh
pUB-FLAG-12NPLmCh
pUB-FLAG-12NPEmCH
pUB-FLAG-mCh12C
pGADT7-Asu
pGADT7-CG4785
pGADT7-IntS12
pGADT7-IntS12Mt3
pGADT7-IntS12Mt5
pGADT7-IntS12ΔN
pGADT7-IntS12N45
pGBKT7-IntS1
pGBKT7-IntS2
pGBKT7-IntS3
pGBKT7-IntS4
pGBKT7-IntS5
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Amp

Amp

CO74, CO75

Origin
CO13-CO57,
CO53-CO54

Marker

Amp

Warren lab

Warren lab

Warren lab

Warren lab

Warren lab

CO76, CO79

CO78, CO77

CO76, CO77

CO76, CO77

CO76, CO77

WO, WO

WO, WO

WO811, WO812
CO58-CO20,
CO59-CO60

Amp
Amp,
LEU2
Amp,
LEU2
Amp,
LEU2
Amp,
LEU2
Amp,
LEU2
Amp,
LEU2
Amp,
LEU2
Kan,
TRP1
Kan,
TRP1
Kan,
TRP1
Kan,
TRP1
Kan,
TRP1
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Description

Kan

Kan

Kan

Kan

Kan

Kan

Kan
Kan

Kan

Kan,
TRP1
Kan,
TRP1
Kan,
TRP1
Kan,
TRP1
Kan,
TRP1
Kan,
TRP1
Kan,
TRP1
Kan

Marker

WO813, WO814

WO811, WO812

CO74, CO75

WO807, WO808

WO805, WO806

WO803, WO804

CO11, CO12
CO5, CO6

CO9, CO10

Warren lab
Novagen

Origin

Warren lab

Warren lab

Warren lab

Warren lab

Warren lab

Warren lab

ADH1 promoter, GAL4 DNA binding domain, c-Myc epitope tag, Drosophila
IntS6 ORF
ADH1 promoter, GAL4 DNA binding domain, c-Myc epitope tag, Drosophila
IntS7 ORF
ADH1 promoter, GAL4 DNA binding domain, c-Myc epitope tag, Drosophila
IntS8 ORF
ADH1 promoter, GAL4 DNA binding domain, c-Myc epitope tag, Drosophila
IntS9 ORF
ADH1 promoter, GAL4 DNA binding domain, c-Myc epitope tag, Drosophila
IntS10 ORF
ADH1 promoter, GAL4 DNA binding domain, c-Myc epitope tag, Drosophila
IntS11 ORF
ADH1 promoter, GAL4 DNA binding domain, c-Myc epitope tag, Drosophila
IntS12 ORF
T7 promter,N-terminal GST-tag, His-tag
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12 PHD finger,
residues 120-193
T7 promter,N-terminal GST-tag, His-tag, human IntS12 PHD finger, residues
130-224
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12 PHD finger,
residues 120-193 (V133A)
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12 PHD finger,
residues 120-193 (M137A)
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12 PHD finger,
residues 120-193 (N143A)
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12 PHD finger,
residues 120-193 (L145A)
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12 PHD finger,
residues 120-193 (E147A)
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12 PHD finger,
residues 120-193 (Y155A)

Table 2.1: Plasmids used (continued)
Name
pGBKT7-IntS6
pGBKT7-IntS7
pGBKT7-IntS8
pGBKT7-IntS9
pGBKT7-IntS10
pGBKT7-IntS11
pGBKT7-IntS12
pET49b(+)
pET49-IntS12PHD
pET49-hIntS12PHD
pET49-IntS12
pET-12PHDV
pET-12PHDM
pET-12PHDN
pET-12PHDL
pET-12PHDE
pET-12PHDY
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Table 2.1: Plasmids used (continued)
Name
Description
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12 PHD finger,
pET-12PHDH
residues 120-193 (H160A)
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12 PHD finger,
pET-12PHDP
residues 120-193 (P162A)
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12 PHD finger,
pET-12PHDD
residues 120-193 (D171A)
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12 PHD finger,
pET-12PHDW
residues 120-193 (W177A)
T7 promter,N-terminal GST-tag, His-tag, Drosophila IntS12 PHD finger,
residues 120-193 (C148A,C151A,H156A)
pET-12PHDCCH
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Kan

Kan

Kan

Kan

Marker

CO66, CO67
CO68-CO69,
CO70-CO71

CO64, CO65

CO72, CO73

CO7, CO8

Origin

Kan

Table 2.2: Oligonucleotides used
Cloning Oligos
Sequence
CO1
GATGAATTCTGGCGGGCAATTTTTGGCAG
CO2
GATTCTAGACTAACGCTGAGGCGGTGG
CO3
GCGACTAGTCGACTACGATTTCAAGATGAAAAC
CO4
GCGTCTAGAGTTGAAGCGCTGGAAGTTC
CO5
GCGTCTAGAATGGCCGCAAATATAGCC
CO6
GCGAAGCTTTTACTGCTTGGATCTGCG
CO9
GTAGAATTCTACCGGTGACACCGGCGAC
CO10
GCGAAGCTTTTATGTTGTCCTCCCGCTGCT
CO11
GCGGAATTCTGCTGATGATTTTGCCATG
CO12
CGCAAGCTTTTACTGAGTTTTTTGAGCCAT
CO13
GCGGAATTCTGGCGGCCAACATCGCGGC
CO14
CGCTCTAGAGCTGCTACTGCTGCTGGC
CO15
GCGTCTAGACAGATCTCCGAAATCTCC
CO16
CGCGAATTCTGGGAGATTTCGGAGATCTG
CO17
GATGAATTCTGCTGAAAGCCCGCTTCGGC
CO18
CGTTGGCTTGTTCAGATCTCCGAAATCTCC
CO19
TTCGGAGATCTGAACAAGCCAACGAGCAGC
CO20
CGCTCTAGATTACTGCTTGGATCTGCG
CO21
CGCTCTAGACTTGTTGCAGCACGTGTC
CO22
GCGGAATTCTGAACAAGCCAACGAGCAGC
CO23
GATGAATTCTGCCGACGAGCGCCGCGGAG
CO24
CGCTCTAGACAGGGCTTCATCCAGCAG
CO53
CATGCGGCCGCTGTGAGCAAGGGCGAGGAG
CO54
CGCTCTAGATTACTTGTACAGCTCGTCCATG
CO55
CATGCGGCCGCCAGGGCTTCATCCAGCAG
CO56
CATGCGGCCGCCAGATCTCCGAAATCTCC
CO57
CATGCGGCCGCCTTGTTGCAGCACGTGTC
CO58
CATGCGGCCGCTAACAAGCCAACGAGCAGC
CO59
GCGGAATTCTGGTGAGCAAGGGCGAGGAG
CO60
CATGCGGCCGCCTTGTACAGCTCGTCCATG
CO63
GCGGAATTCTGATGGCCGCAAATATAGCC
CO76
GATGAATTCGCGGCCAACATCGCGGCG
CO77
GCGGGATCCTTACTGCTTGGATCTGCGC
CO78
GCGGAATTCCTGAAAGCCCGCTTCGGC
CO79
CGCGGATCCTTACAGGGCTTCATCCAGCAG
CO80
GGCCACTAGTCATGTTCGAACGCAACCAGAAG
CO81
GGCCGAATTCTTAACTACGTACGGATTCCTCC
CO82
GGCCGGATCCCATGCTGCGCCCGGTGCCGGG
CO83
GGCCGAATTCTCAATACATGTATGCAGGAGC
QuickChange Oligos
CO7
GGTGCCATGTACGCTCAGGAGTGCCAC
CO8
GTGGCACTCCTGAGCGTACATGGCACC
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CO25
CO26
CO27
CO28
CO29
CO30
CO31
CO32
CO33
CO34
CO35
CO36
CO37
CO38
CO39
CO40
CO47
CO48
CO49
CO50
CO51
CO52
CO61
CO62
CO64
CO65
CO66
CO67
CO68
CO69
CO70
CO71
CO72
CO73
CO74
CO75
WO811
WO812
WO127
WO128
WO803
WO804
WO805
WO806
WO807
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CGCGCAGGAGGTCGCCGCGGCCGCCGCAAAAGCGATTAAAC
GTTTAATCGCTTTTGCGGCGGCCGCGGCGACCTCCTGCGCG
CCGGTCCTCAAAGCAGCGGCTGCAGCGCTCCATAGCTCC
GGAGCTATGGAGCGCTGCAGCCGCTGCTTTGAGGACCGG
GCGATTAAACTGGCCGCTGCCGCCGCCCCGACGAGCGCC
GGCGCTCGTCGGGGCGGCGGCAGCGGCCAGTTTAATCGC
CATAGCTCCAACGCGGCGGCCGCCGCGGAGCTC
GAGCTCCGCGGCGGCCGCCGCGTTGGAGCTATG
CGAGCGCCGCGGCGGCCGCCGCCGCGCTGGATGAAGC
GCTTCATCCAGCGCGGCGGCGGCCGCCGCGGCGCTCG
CTCCGCCTCCTGGCGGCTGCAGCCGCGAAAGCCCGCTTC
GAAGCGGGCTTTCGCGGCTGCAGCCGCCAGGAGGCGGAG
AAGTTGCTGCACGCGGCTAATCCCACCTCG
CGAGGTGGGATTAGCCGCGTGCAGCAACTT
AGTAATCCCACCGCGGCGGCCGAACTG
CAGTTCGGCCGCCGCGGTGGGATTACT
GAGAAAAGTTTGGCCAACAACATGACG
CGTCATGTTGTTGGCCAAACTTTTCTC
ATCATCAATTTGGCCAACTCACCGGAC
GTCCGGTGAGTTGGCCAAATTGATGAT
GGACGTGCTGCCGCGCCCCCGCAGCAG
CTGCTGCGGGGGCGCGGCAGCACGTCC
GGGCCGCGCCGCGGCCCCGCCCCAACAAC
GTTGTTGGGGCGGGGCCGCGGCGCGGCCC
AAGGAGGAGGCGGCCGCTGACCAGGAGCAGAAC
GTTCTGCTCCTGGTCAGCGGCCGCCTCCTCCTT
GACCAGGAGCAGAACGCGCAGTGCGACACGTGC
GCACGTGTCGCACTGCGCGTTCTGCTCCTGGTC
ATGTACGCTCAGGAGGCCCACAAGCCGCCCATA
TATGGGCGGCTTGTGGGCCTCCTGAGCGTACAT
AATCGGCTGATTGAGGCCTCCAAGGCCGGTGCC
GGCACCGGCCTTGGAGGCCTCAATCAGCCGATT
CAGGAGTGCCACAAGGCGCCCATAACCAAGGAG
CTCCTTGGTTATGGGCGCCTTGTGGCACTCCTG
ACGGCCACCAATCGGGCGATTGAGTGCTCCAAG
CTTGGAGCACTCAATCGCCCGATTGGTGGCCGT
CCAATCGGCTGATTGCGTGCTCCAAGTGCGG
CCGCACTTGGAGCACGCAATCAGCCGATTGG
GCCGCGTAAAAATCGCCGcCATGGGTTTCGCGCGGCTC
GAGCCGCGCGAAACCCATGGCGGCGATTTTTACGCGGC
CGACCTCAATTGCTGCGCGTGCGGCGAGATGG
CCATCTCGCCGCACGCGCAGCAATTGAGGTCG
CTGCGTGTGCGGCGAGGCGGTTTTCACGGCCAC
GTGGCCGTGAAAACCGCCTCGCCGCACACGCAG
GGTTTTCACGGCCACCGCTCGGCTGATTGAGTGC
31

WO808
WO813
WO814

GCACTCAATCAGCCGAGCGGTGGCCGTGAAAACC
CAAGTGCGGTGCCATGGCCCATCAGGAGTGCCAC
GTGGCACTCCTGATGGGCCATGGCACCGCACTTG

PCR Oligos for endogenous misprocessed/unprocessed snRNA
U1-pF
GCTGAGTTGACCTCTGCGATTA
U1-pR
CTTTTAAAATTTATTGCAGATGTCGG
U2 pF
CCCGGTATTGCAGTACCGCCGGGA
U2 pR
CAAAGGACACTTTCGACATGTC
U4 pF
GGTGGCAATACCGTAACCAAT
U4 pR
GGCTAAGACAACCGTCATATTAA
U5 pF
CGCCTTTTACTAAAGATTTCCGTGG
U5 pR
CCATGTATATGACCACCAGACC
Rps17 for
CGAACCAAGACGGTGAAGAAG
Rps17 rev
CCTGCAACTTGATGGAGATACC
Realtime PCR Oligos for Integrator mRNAs
IntS2-1-f
GAGCTGAAGAAGGAGCTGCAG
IntS2-1-r
CAGATCCTCGGGATGCTTGAG
IntS3-1-f
GAGATGCATGATATGTTGTCAC
IntS3-1-r
GGCGTACAAAATCTCTTCCTAG
IntS4-1-f
CGTCAACAGGTGTCATCG
IntS4-1-2-r
GCTCGAGTCCTGCGAGTC
IntS5-2-f
CGGAAAATCGCGAGAACC
IntS5-2-r
CAGTGCGCGCAGTAGCAC
IntS6-1-f
CGCTGGGATCAGCGCTTG
IntS6-1-r
GACGGGGAAGCTGCGCAC
IntS7-1-f
CATCTGGACAAGATCCTCAAC
IntS7-1-r
GTATGCGTACTGGTGTCC
IntS8-2-f
CTGCTGGAGAAGTTCCAGC
IntS8-2-r
CTTGGAGTGACACATCCAGTC
IntS10-1-1-f
GTTGTACATGGTCAAGGAG
IntS10-1-2-r
CAGATTTGGCGAAAGTTCC
IntS13-1-f
CTCCAAGAAGGGACTGGTC
IntS13-1-2-r
GCTGGAGTTGGCGTTCTG
IntS14-2-f
CACGAACGTGATTCCCTGG
IntS14-2-r
GTAAACACAGTCTTAAAGTAAGGAC
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Description
Drosophila Schneider 2 (S2) Cells (Catalog no. R690-07)
S2 stable cell line expressing FLAG-tagged
S2 stable cell line expressing FLAG-tagged mCherry
S2 stable cell line expressing FLAG-tagged Asunder/IntS13
S2 stable cell line expressing FLAG-tagged CG4785/IntS14
S2 stable cell line expressing FLAG-tagged cycline C
S2 stable cell line expressing FLAG-tagged Cdk8
S2 stable cell line expressing FLAG-tagged RNAi-resistant full-length IntS12
S2 stable cell line expressing FLAG-tagged IntS12* mutant (Mt3)
S2 stable cell line expressing FLAG-tagged IntS12* mutant (M5)
S2 stable cell line expressing FLAG-tagged IntS12* microdomain deletion mutant
S2 stable cell line expressing FLAG-tagged IntS12* microdomain
S2 stable cell line expressing FLAG-tagged mCherry fused IntS12 microdomain
S2 stable cell line expressing FLAG-tagged mCherry fused IntS12 N-terminus
S2 stable cell line expressing FLAG-tagged mCherry fused IntS12 N-terminus
phosphorylation mutant
S2 stable cell line expressing FLAG-tagged mCherry fused IntS12 C-terminus deletion mutant
S2 stable cell line expressing FLAG-tagged mCherry fused IntS12 C-terminus deletion mutant
with point mutation in L145
S2 stable cell line expressing FLAG-tagged mCherry fused IntS12 C-terminus deletion mutant
with point mutation in E147
S2 stable cell line expressing FLAG-tagged mCherry fused IntS12 C-terminus
HeLa cells (Catalog no. CCL-2)
Genotype
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4∆, gal80∆, LYS2 : : GAL1UASGAL1TATA-HIS3, GAL2UAS-GAL2T A T A-ADE2, URA3 : : MEL1UAS-MEL1 TATA-lacZ
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F′ proAB lacIqZΔM15 Tn10 (Tetr)]

Table 2.3: Cell Lines
Cell line
D.mel-2 (S2) cell
S2 (FLAG)
S2 (FLAG-mCh)
S2 (FLAG-Asu)
S2 (FLAG-CG4785)
S2 (FLAG-CycC)
S2 (FLAG-Cdk8)
S2 (FLAG-IntS12*)
S2 (FLAG-Mt3)
S2 (FLAG-Mt5)
S2 (FLAG-ΔN)
S2 (FLAG-N45)
S2 (FLAG-N45Ch)
S2 (FLAG-12NmCh)

AH109
E.coli XL-1

E. coli B F- dcm ompT hsdS(rB- mB-) gal λ(DE3[lacI lacUV5-T7 gene 1 ind1 sam7 nin5])

S2 (FLAG-12NPEmCH)
S2 (FLAG-mCh12C)
HeLa
Strains

S2 (FLAG-12NPLmCh)

S2 (FLAG-12NT76mCh)
S2 (FLAG-12NPmCh)

E.coli BL-21
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Reference
Invitrogen
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study

This Study
This Study

This Study

This Study
This Study
ATCC
Reference
James et al.,
1996
Stratagene
New England
BioLabs

from Harvard Drosophila RNAi Screening Center (DRSC) were used. In vitro transcribed
dsRNA was purified using TRIzol reagent (Invitrogen) and the quality of dsRNA was assessed
by electrophoresis or using the Nanodrop spectrophotometer (Thermo Scientific). To perform
RNAi in S2 cells, 5x104 cells per 96 well in 100µl of Sf-900 II media or 3x105 cells per 24 well
in 300µl medium were plated in each well and supplemented with 1µg (96-well) or 3µg (24well) dsRNA. The next day, an additional 1µg or 3µg of dsRNA was added and then cells were
harvested in the fourth day for qRT-PCR or Western blot analysis. Cells were harvested for
analysis using TRIzol for total RNA extraction or radioimmunoprecipitation assay (RIPA) buffer
[50 mM Tris-HCl pH 8, 150 mM NaCl, 1% NP-40, 0.5% Na deoxycholate, 0.1% SDS] for
protein lysates.
HeLa cells were cultured in Dulbecco’s modified Eagle medium (DMEM) (Invitrogen,
Carlsbad CA) supplemented with 1% penicillin-streptomycin (pen/strep) (Invitrogen) and 10%
fetal bovine serum (FBS; Phenix Research, NC). RNAi experiments in HeLa cells were
performed by the use of the manufacturer’s instructions for Lipo-fectamine 2000 with minor
modifications. Briefly, 3µl of 20 µM siRNAs were mixed with 47µl of Opti-MEM (Invitrogen) in
tube A, and 12µl of Opti-MEM and 3µl of Lipofectamine 2000 were mixed in Tube B. Both
tubes were incubated at room temperature for 7 min, and then the contents were mixed and
incubated at room temperature (RT) for an additional 25 min. After this incubation, 38µl of
Opti-MEM was added and the mixture (100µl/tube) was pipetted dropwise into the wells. For
siRNA transfection, 8.5x104 cells per well were initially plated in 24-well plates, and in second
day after the RNAi treatment, cells were re-plated into a 6-well plate for each well containing 2
ml DMEM complete media. The next day, the same amount of siRNA and 500 ng human U7GFP reporter cells were co-transfected into each well under the conditions described above.
Two days after the second siRNA transfection, cells were harvested for Western blot analysis.
Quantitative Real Time-PCR (qRT-PCR) Analysis
Total RNA was isolated from Drosophila S2 cells using TRIzol reagent, and 2 µg of
RNA was treated with DNase I (Fermentas, Burlington, ON, Canada) in accordance
with the manufacturer’s recommendations. Reverse transcription was performed on the
2 µg of RNA using random hexamer primers and MMLV reverse transcriptase
(Invitrogen) in a total volume of 20µl at 37°C for 1 h, followed by incubation at 95°C for
5 min. In each case, 2µl of the reverse transcription product was used for real-time
PCR reaction using SYBR green master mix (Fermentas) and specific primers to each
amplicon tested (for oligonucleotides, see Table 2.2). Data were acquired using a
Stratagene Mx3000P real-time PCR machine, and were analyzed by the ΔΔCT (CT,
threshold cycle) method using the equation fold change = 2-[(CTGOI – CTnorm)control – (CTGOI –
CT
)
]
norm treated , where CTGOI is the CT for the gene of interest and CTnorm is the normalized
CT. Triplicate experiments were performed for each Integrator knockdown, and data
are plotted as fold increases in amplicon CT values normalized to the reference gene
RpS17 versus those for the control dsRNA-treated cells, which were also normalized to
RpS17. (An excerpt from: Ezzeddine, N., et al. (2011). "A subset of Drosophila
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integrator proteins is essential for efficient U7 snRNA and spliceosomal snRNA 3'-end
formation." Mol Cell Biol 31(2): 328-341.)
Immunoprecipitation
For immunoprecipitation of FLAG-tagged protein, 1 mg nuclear extracts were
incubated with 10 µl of anti-FLAG antibody-conjugated agarose beads (anti-FLAG M2
affinity gel, Sigma) with constant rotation for 2 hrs at 4 °C in buffer D [20 mM HEPES
pH7.9, 20% glycerol, 0.1 M KCl, 0.2 mM EDTA, 0.5 mM PMSF] plus 0.1% Triton X100. Beads were washed twice with 1XTris Buffered Saline [50 mM TrisHCl pH 7.4,
150 mM NaCl] and then twice with buffer D plus 0.1% Triton X-100. During last wash,
switch to new tube. For immunoprecipitation of endogenous protein, 2 µg antigen
purified antibody was pre-incubated with 20 µl Protein A/G beads (Santa Cruz
Biotechnology, Inc.) with constant rotation in buffer D at 4 °C for 1 hr, and then 400 µg
nuclear extracts were added and incubated with rotation for another 2 hrs at 4 °C.
Wash condition is same as above mentioned. Finally 50 µl of 1XSDS loading buffer
was added to the beads and boil at 95 °C for 3 minutes and resolved in 12.5% SDSPAGE gel. Western blot analysis was performed using standard procedure. (An
excerpt from: Chen, J., et al. (2012). "An RNAi screen identifies additional members of
the Drosophila Integrator complex and a requirement for cyclin C/Cdk8 in snRNA 3'end formation." RNA.)
Yeast Two-Hybrid Analysis
Full-length coding regions of the twelve Drosophila Integrator subunits were
obtained from the Drosophila Genomics Resource Center and cloned in frame into the
pGBKT7 vector (BD), Asu/Ints13 and CG4785/Ints14 were cloned into pGADT7 (AD).
IntS12 full length, first 45 amino acid microdomain (N45), N-terminal truncation (ΔN),
and functional deficient alanine-scanning mutants Mt3 and Mt5 were cloned into
pGADT7 (AD) using standard methods. Pairwise co-transformations of AD and BD
constructs into yeast strain AH109 were according to manufacturer’s instructions
(Matchmaker 3 system, Clontech). Empty vectors were co-transformed to control for
construct autoactivation. Positive interactions were analyzed using nutritional selection
by spotting four serial ten-fold dilutions on SD- plates lacking Leucine/Tryptophan
(vector control), or additionally Histidine (medium stringency) and Histidine/Adenine
(high stringency). Images were taken after three or five days incubation at 30 °C. To
determine the HA-tagged protein expression, yeast transformants were harvested at
OD600 of ~0.8 in SC-Leu liquid culture, lysed using the glass beads method and
tagged proteins were detected by western blotting using anti-HA antibody (Covance,
Princeton NJ). (An excerpt from: Chen, J., et al. (2012). "An RNAi screen identifies
additional members of the Drosophila Integrator complex and a requirement for cyclin
C/Cdk8 in snRNA 3'-end formation." RNA.)
Genome-wide RNAi Screen in S2 Cells
The dsRNA library was purchased from Open Biosystems (Thermo Scientific,
Waltham, MA) as 5 µg per well resuspended in 100 µl of water. The dsRNA was
realiquoted into 167 96-well plates (Greiner Bio-One, Monroe, NC) at 1µg per well and
allowed to dry down. Then 5x104 cells were plated into each well and allowed to
incubate for three days. On the fourth day, the 30 ng of U7-GFP reporter was
transfected into each well using Effectene according to manufacturer’s instructions
(Qiagen, Hilden, Germany). Two days following reporter transfection, cells were
imaged live using a Cellomics Array Scan V highthroughput automated microscope
(Thermo Scientific). Exposure times were calculated on a plate-to-plate basis and

!

35

fluorescence levels were calculated using pre-written algorithms incorporated into the
manufacturer’s software. The two algorithms used in the data presentation are the
standard deviation in fluorescence intensity and the mean differential intensity as these
two methods were most effective in blindly identifying positive controls in pilot assays.
(An excerpt from: Chen, J., et al. (2012). "An RNAi screen identifies additional
members of the Drosophila Integrator complex and a requirement for cyclin C/Cdk8 in
snRNA 3'-end formation." RNA.)
S2 Cell Nuclear Extracts Preparation
S2 cell nuclear extracts were prepared using previously described methods (Dignam et al.
1983) with minor modifications. In brief, harvested S2 cells were washed twice with cold
1xPBS and resuspended in 5 times packed cell volume (PCV) of ice-cold buffer A [10 mM
HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 0.5 mM PMSF] for 30 min on ice to
swell. Swollen cells were further disrupted by grinding 35 strokes using the glass dounce
tissue grinder and then cell nuclei were pelleted by centrifuging at 2000 rpm for 5 min. The
crude nuclei pellet were further resuspended in ½ pellet volume of buffer C [20 mM HEPES pH
7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF]
and incubated 1 hr at 4 °C with rotation for extraction. Extracted supernatants were collected
by centrifugation at 14000 rpm for 30 min and final nuclear extracts were dialyzed overnight in
buffer D [20 mM HEPES pH7.9, 20% glycerol, 0.1 M KCl, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM
PMSF]. Dialyzed nuclear extracts were stored at -80 °C for future use.
Site-directed Mutagenesis
Site-directed mutations of Cdk8 and IntS12 were generated using QuickChange Kit
(Stratagene) protocol. In brief, 25 ng of template plasmids were used for PCR amplification
using quickchange oligos listed in Table 2.2 in a total volume of 50 µl reaction, and 1 µl
FastDigest DpnI (Fermentas) was used to digest the methylated template DNA at 37 °C for 30
min. 1 µl of DpnI treated PCR product was used for transformation, and the right clones were
screened and confirmed by direct sequencing.
S2 Cell Immunofluorescence Microscopy
The method to prepare S2 cells for immunofluorescence microscopy was described by
Rogers & Rogers (Rogers and Rogers 2008). Briefly, 1x105 S2 cells in 100 µl Sf-900 II
medium were allowed to attach to the Concanavalin A coated round coverslips for 1hr at 28
°C, and followed by two washes with 1xPBS. Cells were fixed by treating with 10%
paraformaldehyde diluted in 1xPBS for 10 min at room temperature. Fixed cells were then
permeabilized by washing three times with 1xPBS supplemented with 0.1% Triton X-100.
Permeabilized cells were then blocked in 1xPBST containing 5% normal goat serum, and
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probed by anti-FLAG M2 antibodies (Sigma) with 1:1000 dilutions in the blocking buffer for 1hr
at room temperature. Cells were washed using 1xPBST three times for 10 min each, and
probed with light sensitive Cy3-conjugated anti-mouse secondary antibodies (1:1000) for 45
min. Cells were washed again twice in 1xPBST and the final wash was supplemented with
4',6-diamidino-2-phenylindole! (DAPI) (1:1000). Finally, washed coverslips were mounted
facing down on glass slides using fluoro-gel mounting medium (Electron Microscopy Sciences,
PA) and then imaged using fluorescence microscopy. FLAG tagged proteins were visualized
at excitation wavelength 550 nm, and the nuclear DAPI staining was observed at 350 nm.
GST Recombinant Protein Preparation
pET49 clones expressing GST, GST-tagged full-length IntS12, or various IntS12 PHD
fingers were transformed into E.coli BL-21(DE3). Bacterial culture were grown at 37 °C in 1liter
of LB medium [1% tryptone, 0.5% yeast extract, and 1% NaCl] supplemented with Kanamycin
(50 µg/ml) to OD600 of ~0.6. To induce the expression of GST-tagged recombinant protein,
isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the cultures to at a final
concentration of 1mM, and continued to culture for another 2 hrs at 37 °C. Induced cultures
were pelleted and resuspended in 30 ml of cold PBS [140 mM NaCl, 2.7 mM KCl, 10 mM
Na2PO4, 1.8 mM KH2PO4, supplemented with10 mM DTT, and 1 mM phenylmethylsulfonyl
fluoride (PMSF), 1% Triton X-100, pH 8]. Culture suspensions were lysed by using EF-C3
high-pressure homogenizer (Avestin, Germany), and crude lysates were cleared by
centrifuging 15 min at 12,000xg at 4 °C. Cleared lysates were incubated with 0.5 ml
glutathione agarose beads with rotation at 4 °C for 1 hr. Protein bound beads were pelleted
and washed three times for 15 min each with cold PBS. To elute the recombinant GST-tagged
proteins, washed beads were resuspended in 1ml Elution buffer [50 mM Tris HCl pH 8, 10 mM
reduced glutathione] and incubated at room temperature for 10 min. The supernatants were
collected after centrifugation and the concentration of recombinant proteins were determined
by Bio-rad protein assay (Bio-rad Laboratory, California). The purified recombinant proteins
were supplemented with glycerol to 50% [v/v] and stored at -80 °C for later use.
GST Pulldown Assay
The assay for GST-tagged recombinant protein pulldown of histones was carried out by
incubation of 2 µg of purified GST-tagged proteins with 10 µg of global histones (Worthington,
NJ) for 3 hrs at 4 °C in 300 µl incubation buffer [50 mM Tris-HCl pH7.5, 500 mM NaCl, 1% NP40, 0.5 mM EDTA, 1mM PMSF]. Then 20 µl glutathione beads were added and incubated for 1
hr. Beads were collected by centrifugation and washed three times for 5 min each with 1 ml
incubation buffer. Washed beads were resuspended in 50 µl 1xSDS loading buffer and boiled
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for 3 min at 95 °C. Boiled samples were centrifuged and 20 µl of supernatant were resolved in
15% SDS-PAGE. Western blot analysis was conducted using the standard procedure. AntiGST serum were generated by injection of Guinea pig with recombinant GST proteins and
anti-histone antibodies [H2A (Upstate 07-146), H2B (Upstate 07-371), H3 (Abcam ab1791)
and H4 (Activemotif 39269), H1 (Upstate 05-457)] were kindly provided by Dr. Barton’s Lab at
the University of Texas MD Anderson Cancer Center.
Biotin-labeled Histone Peptide Pulldown Assay
Biotinylated histone peptide pulldown of recombinant GST-tagged IntS12 PHD finger
proteins was carried out by incubation of 1 µg GST-tagged proteins with 1 µg of biotinylated
histone peptides for 4 hrs at 4 °C in 300 µl binding buffer [50 mM Tris-HCl pH 7.5, 150 mM
NaCl, 0.05% NP-40]. Then 15 µl Streptavidin sepharose beads (Amersham) were added to the
binding reaction and incubated for another hour. Beads were collected by centrifugation and
wash three times for 5 min each with 1 ml binding buffer. Washed beads were resuspended in
60 µl 1xSDS loading buffer and boiled for 3 min at 95 °C. Boiled samples were centrifuged and
10 µl supernatant were resolved in 12.5% SDS-PAGE gel. Biotinylated histone peptides (H3,
1-21; H3, 22-44; H3, 66-88; H4, 1-25; H3K4, K9, K27, K36, K79 and H4K20 mono-, di- or trimethylated peptide) were kindly provided by Dr. Shi’s Lab at the University of Texas MD
Anderson Cancer Center.
Chromatin Immunoprecipitation (CHIP)
Cultured S2 cells were crosslinked with 1% formaldehyde for 7 min at room temperature
and the crosslinking reaction was quenched by adding glycine to a final concentration of 125
mM for 10 min. Fixed S2 cells were collected and washed twice with ice-cold PBS and
resuspended in cold sonication buffer [0.5% SDS, 20 mM Tris-HCl pH 8, 2 mM EDTA, 0.5 mM
EGTA, 0.5 mM PMSF] in a ratio 108 cells per 1 ml buffer for 10 min on ice. Lysed cells were
further sonicated for 12 min (30 sec on/2.5 min off) using the Ultrasonic Converter C5749 and
clarified by centrifugation at 14 000 rpm for 10 min. The clarified supernatant was used
immediately for immunoprecipitation or stored at -80 °C.
75 µl sonicated chromatin was diluted in 1 ml IP buffer [0.5% Triton X-100, 2 mM EDTA,
20 mM Tris-HCl pH 8, 150 mM NaCl, 10% glycerol] and pre-cleared by incubating with 30 µl
50% Protein A/G beads slurry for 2 hrs at 4 °C on a rotator before overnight incubation with 2
µg of antigen purified IntS12 antibodies or the M2 resin. The bound materials were washed
rigorously once with Low Salt buffer [0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM TrisHCl pH 8, 150 mM NaCl], three times with High Salt buffer [0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris-HCl pH 8, 500 mM NaCl], once with LiCl buffer [2 mM EDTA, 20 mM Tris-
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HCl pH 8, 1% Sodium Deoxycholate, 1% NP-40, 250 mM LiCl], twice with Tris-EDTA buffer
[10 mM Tris-HCl pH 8, 1 mM EDTA], and eluted 15 min at room temperature with 500 µl
Elution buffer [1% SDS, 0.1% NaHCO3]. Eluted fractions were reverse crosslinked by adding
20 µl of 5 M NaCl and incubate at 65 °C in the water bath for at least 4 hrs, and then treated
with proteinase K and purified by phenol/chloroform extraction followed by ethanol
precipitation. Finally, purified DNA is resuspended in 150 µl ddH2O, and 2 µl was used for
qPCR analysis.
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Chapter 3. A Functional RNAi Screen Identifies Drosophila Genes Required for snRNA
3’ End Formation.
(Partial contents described in this chapter have been published in Mol. Cell. Biol. 31, 2011,
328-341, doi:10.1128/MCB.00943-10 and RNA December 2012 18: 2148-2156, and usage
permissions have been granted from the publishers.)
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INTRODUCTION
RNA processing is a fundamental biological process required to generate mature RNA
species. The U snRNA are non-coding transcripts that play important roles in different RNA
processing events. They form the RNA core of spliceosome to help remove introns from
mRNA precursors and the U7 snRNA is involved in the 3’ end processing of the replicationdependent histone pre-mRNA (Reviewed in (Matera et al. 2007; Marzluff et al. 2008)). Most
snRNAs are transcribed by RNA polymerase II, and their 3’ end is formed by a single
endonucleolytic cleavage at the 3’ end cleavage site from the elongating polymerase to allow
for release and subsequent export to the cytoplasm (Reviewed in (Egloff et al. 2008)).
Studies in the past decades have established the requirement of three features for snRNA
3’ end processing: an snRNA promoter, a 3’ box sequence element located 9-19 nt
downstream of the mature snRNA 3’ end, and the CTD of RNAPII largest subunit Rpb1
(Hernandez 1985; de Vegvar et al. 1986; Hernandez and Weiner 1986; Medlin et al. 2003;
Jacobs et al. 2004; Egloff et al. 2007; Egloff et al. 2010)). Promoter-swap experiments reveal
that replacement of either human or Drosophila snRNA promoters with other RNAPII
promoters significantly compromises proper snRNA 3’ end formation (de Vegvar et al. 1986;
Hernandez and Weiner 1986; Ezzeddine et al. 2011)). The 3’ end formation of viral-encoded
snRNA-like transcripts in Herpesvirus saimiri has recently been reported to be highly
dependent on the snRNA promoter as well (Cazalla et al. 2011), further supporting the
importance of the snRNA promoter for their 3’ end formation. Conserved promoter coupling
indicates that the 3’ end processing machinery is loaded onto the snRNA promoter early in the
transcription cycle. The 3’ box sequence element has been determined to be required for
proper snRNA 3’ end processing though was found to be highly tolerant to mutation (Ach and
Weiner 1987; Ezzeddine et al. 2011). It very likely serves as a binding site for the protein
complex that carries out the cleavage process for snRNA. Finally, phosphorylation of the Ser2
and Ser7 but not Ser5 in the heptad repeats of the Rpb1 CTD is reported to be important for
snRNA 3’ end formation (Egloff et al. 2007; Egloff et al. 2010).
Biochemical purification and functional identification of the Integrator complex in snRNA 3’
end formation provides new insight into the snRNA 3’ end processing events (Baillat et al.
2005; Ezzeddine et al. 2011). Twelve different members were initially identified in the complex
associated with the RNAPII CTD and two of them (IntS1 and IntS11) were shown to be
functionally required for U1 and U2 snRNA 3’ end formation. Among the twelve members,
IntS9 and IntS11 are homologous to the poly(A)+ mRNA and poly(A)- histone mRNA 3’ end
processing factors CPSF100 and CPSF73 (Mandel et al. 2006; Sullivan et al. 2009). IntS9/11
have been shown to form a heterodimer through their unique C-terminal regions and this
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interaction is required for the endonucleatytic cleavage activity of the Integrator complex
(Albrecht and Wagner 2012). Other than these two proteins, the remainder of the ten founding
members in the complex display insignificant similarity with the known factors involved in
either poly(A)+ mRNA or histone mRNA 3’ end formation, making their role in 3’ end formation
of snRNA difficult to anticipate. Recent high-throughput mass spectrometry analysis of
Integrator immunoprecipitations from mammalian cells has identified a number of additional
factors associated with the core Integrator subunits (Malovannaya et al. 2010; Malovannaya et
al. 2011), and these include additional RNAPII subunits, a group of phosphatases, OB-fold
nucleic acid binding proteins, zinc-finger proteins and many others either uncharacterized
and/or not previously known to be involved in snRNA biogenesis. Functional validation of
these factors has not been done, making their importance to snRNA 3’ end formation unclear.
In this chapter, I describe a functional RNAi screen in Drosophila S2 cells to identify genes
required for snRNA 3’ end formation by utilizing the U7-GFP readthrough reporter assay
(Ezzeddine et al. 2011). Our screen scored ten of the twelve known Integrator subunits, and
also identified four new non-Integrator subunits necessary for snRNA 3’ end formation. Followup systematic functional analysis confirmed the functional requirement for 10 of the 12 known
Integrator subunits. We also determined that the four novel factors CG4785, Asunder (Asu),
cyclin C (CycC), and Cdk8, are required for snRNA 3’ end formation. Further analysis
demonstrates that Asunder and CG4785 are additional core components of the known
Integrator complex, and the Cdk8 kinase activity is required for proper snRNA 3’ end
processing. We further discovered that CycC/Cdk8 play a conserved role in both fly and
human snRNA 3’ end formation and it is likely that this cognate CycC/Cdk8 pair exerts it
function through a novel pathway independent of the canonical Mediator Cdk8 module. Taken
together, this study redefines the Drosophila Integrator complex as comprising of fourteen core
subunits and demonstrates a novel role of CycC/Cdk8 in snRNA 3’ end formation unrelated to
its known function in the mediator complex.
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RESULTS
(Excerpts in Results section are from: Chen, J., et al. (2012). "An RNAi screen identifies
additional members of the Drosophila Integrator complex and a requirement for cyclin C/Cdk8
in snRNA 3'-end formation." RNA.)
Genome-wide RNAi screen for Drosophila snRNA 3’ end Processing Factors
We previously developed a cell-based reporter that expresses green fluorescent
protein (GFP) in response to misprocessing of U7 snRNA, allowing for non-invasive
and sensitive detection of misprocessing in vivo (Figure 3.1A; (Ezzeddine et al. 2011)).
To determine whether this reporter would be suitable for use in a genome-wide RNAi
screen, we treated S2 cells with dsRNA targeting either the Polypyrimidine Tract
Binding Protein (PTB) (negative control) or IntS12 (positive control) and in both
instances found no overt effects on growth. Three days following the dsRNA treatment,
cells were transfected with the U7-GFP reporter and fluorescence was assessed 48
hrs later. Robust GFP expression was clearly observed after IntS12 depletion, relative
to a low level of background fluorescence in cells treated with PTB dsRNA (Figure
3.1A). Western blot analysis confirmed that only after significant reduction in IntS12
expression was GFP expression observed (Figure 3.1A).
Using the U7-GFP reporter we performed a genome-wide RNAi screen in
Drosophila S2 cells using a library consisting of 15,881 unique dsRNAs targeting >90%
of the annotated fly genome. U7-GFP reporter expression in cells grown in 96 well
plates was imaged via automated high throughput microscopy and plotted as a function
of fluorescence variance. We observed that in ~7% of the wells the dsRNA targeted
essential genes, resulting in no viable cells at the time of image acquisition. The
imaging of nearly all plates of the dsRNA screen revealed a relatively homogenous
level of background fluorescence in practically all wells. Representative graphs of two
plates are shown in Figure 3.1B. A small number of wells displayed strong GFP
fluorescence, for example on plate 25, cells treated with dsRNA targeting CG5859
identified the fly orthologue of IntS8 as a ‘strong hit’. In addition, a modest number of
moderately fluorescent wells were also identified, as evidenced by the GFP signal and
cell images presented for plate 54 (Figure 3.1B). The levels of GFP expression after
knockdown of either CG10572 or CG10583 were clearly above plate background, yet
were below the signal of the positive control dsRNA (targeting Drosophila IntS9).
In total, our RNAi screen identified 89 genes that, when subjected to RNAi
knockdown, resulted in detectable levels of GFP expression from the U7-GFP reporter
(Figure 3.1C and Table 3.1). The screen identified ten of the twelve annotated
Drosophila Integrator subunits, as well as genes involved in RNA binding,
chromatin/DNA function, and UTP biosynthesis. To determine the reproducibility of the
data, we regenerated dsRNAs corresponding to each of the 89 target genes identified
in the initial screen and performed iterative RNAi followed by transfection of the U7GFP reporter. From this, the initial list of 89 genes was reduced down to 21 that either
scored as high or modest with regards to their GFP expression (Figure 3.1D). Ten of
these were Integrator genes that encode proteins previously found in the twelvemembered Integrator complex. Since only IntS1 and IntS11 were functionally validated
in the initial study that is required for U1 and U2 snRNA 3’ end processing, here we
comprehensively investigated the importance of each Integrator subunit in U7 and
spliceosomal snRNAs 3’ end formation. Importantly, eleven genes scored in our
functional screen were not previously known to be involved in snRNA biogenesis. As
depletion of four of these genes (CG4785, Asu, cyclin C, and Cdk8) produced high
levels of GFP expression comparable to that observed after depletion of known
Integrator subunits, we then focused the remainder of our analysis on these genes.
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Figure 3.1 Using the U7-GFP reporter to conduct a genome-wide RNAi screen. (A).
Schematic of U7-GFP reporter and the results from transient transfection of the reporter into
S2 cells treated with dsRNA targeting PTB (-control) or IntS12 (+control). Fluorescence and
brightfield images are on the left and Western blot analysis on the right. (B). Bar graph
representing quantification of screen results for plate 25 and 54. The figure insets are taken
from the acquired image collection. (C). Pie graph representing results of RNAi screen
categorically. (D). Trimmed down list of non-Integrator genes that reproducibly scored as
strong or modest by secondary screening.
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Table 3.1 Genes required for snRNA 3’ end processing identified from functional RNAi screen
Human
Gene number
Fly gene name
orthologue
Function/domains
CG3173
Integrator 1
Integrator 1
snRNA 3'-end processing
CG8211

Integrator 2

Integrator 2

snRNA 3'-end processing

CG12113

Integrator 4

Integrator 4

snRNA 3'-end processing

CG9591

Integrator 5

Integrator 5

snRNA 3'-end processing

CG3125

Integrator 6

Integrator 6

snRNA 3'-end processing

CG18176

Integrator 7

Integrator 7

snRNA 3'-end processing

CG5859

Integrator 8

Integrator 8

snRNA 3'-end processing

CG5222

Integrator 9

Integrator 9

snRNA 3'-end processing

CG1972

Integrator 11

Integrator 11

snRNA 3'-end processing

CG5491

Integrator 12

Integrator 12

snRNA 3'-end processing

CG6233

UFD1-like

UFD1L

ubiquitin-specific protease activity

CG3593

Rudimentary like

UMPS

UMP biosynthetic process

CG1743

Gs2

GLUL

Novel

HECW1

glutamine synthesis
(HECT, C2 and WW domain) protein
ubiquitination

CG3307

pr-Set7

SETD8

chromatin modification

CG3931

Rrp4

EXOSC2

deadenylation-dependent decay

CG4482

mol

DUOXA1

protein transport

CG4467

Novel

TRHDE

metallopeptidase

CG6437

GLcT-1

UGCG

Glycosyl transferase

CG6721

Gap1

RASA2

Ras GTPase activator

CG7281

CycC

CCNC

Cyclin

CG34401

novel

KIAA0913

zinc finger protein

CG7610

ATPsyn-gamma

ATP5C1

ATP biosynthetic process

CG7487

RecQ4

NA

ATP-dependent DNA helicase

CG7940

Arp5

ACTR5

DNA repair

CG8114

pebble

ECT2

guanyl-nucleotide exchange factor

CG8274

Megator

TPR

protein import into nucleus

CG8344

RpIII128

POLR3B

RNA polymerase III

CG34389
CG9428

crossveinless c

STARD13

GTPase activator

ZIP1
Cyclin-dependent kinase
8

SLC39A1

metal ion transport

CDK8

cyclin-dependent protein kinase

CG10583

Separase

ESPL1

peptidase activity

CG13345

tumbleweed
Serine protease inhibitor
5

RACGAP1

Rac GTPase activator

SERPINC1

erine-type endopeptidase inhibitor

α-Adaptin

AP2A2

Adaptor protein complex AP-2

CG10911

Novel

NA

NA

CG30184

Novel
Ecdysone-induced gene
71Ec

NA

phospholipase A2 activity

NA

defense response to bacterium

CG3181

thymidylate synthase

TYMS

dTMP biosynthetic process

CG42670
CG10134

pasilla

NOVA1

RNA splicing

beat-Va
Novel (LisH dimerisation
motif)

NA

NA

NA

NA

Novel (MADF domain)

NA

NA

CG42797

CG10572

CG18525
CG4260

CG7608

CG5614
CG11504

!

45

Table 3.1 (continued)
Gene number

Fly gene name

Human
orthologue

CG43374

Cht6

CHI3L2

Sex combs reduced

HOXB5

Chitinase II
sequence-specific DNA binding
transcription factor

CG1258

pavarotti

KIF23

microtubule motor

CG3924

Chip

LDB2

Novel

KHDRBS

LIM domain binding 2
KH domain containing, RNA binding
protein

TBP-associated factor 11
Minichromosome
maintenance 5

TAF11

transcription coactivator

MCM5

DNA helicase

CG4567

iconoclast

GFM1

Translation elongation factor

CG4785

Novel

C15orf44

NA

CG4798

lethal (2) k01209

UCKL1

uridine kinase

CG34420
CG5941

Novel

DPEP2

peptidase activity

Novel

MCTS1

RNA binding

CG6147

Tsc1

TSC1

kinase binding

CG6196

novel

TRAPPC6B

vesicle-mediated transport

CG6814

asunder
SET domain binding
factor

ASUN

spermatogenesis regulator

SBF2

SET binding factor

CG7108

DNA polymerase α 50kD

PRIM1

DNA primase

CG7109

microtubule star
Minichromosome
maintenance 2

PPP2CB

protein serine/threonine phosphatase

MCM2

DNA replication

CG8372

Novel

TMEM222

transmembrane protein

CG8388

novel

NA

DNA binding

CG9504

Ecdysone oxidase

CHDH

choline dehydrogenase activity

CG9667

ISY like splicing factor
Dihydroorotate
dehydrogenase

ISY1

RNA splicing

DHODH

UMP biosynthetic process

pumilio

PUM2

RNA binding

CG9945

Novel (WD40 repeat)

DCAF11

protein ubiquitination

CG9943

Surfeit 1

SURF1

cytochrome-c oxidase activity

CG9951

novel

CCDC22

coiled-coil domain containing 22

CG10399

novel

HMGCL

leucine metabolic process

CG10463

novel

DUS3L

tRNA-dihydrouridine synthase

CG11352

jim

NA

regulation of chromatin silencing

CG11207

fascetto

PRC1

cytokinesis

CG11247

novel

NA

Zinc finger protein

CG11291

Novel

PGP

4-nitrophenylphosphatase activity

CG42568

novel
Guanine nucleotide
exchange factor GEF64C

NA

NA

NET1

guanyl-nucleotide exchange factor

novel (SH3 domain)
novel (Leucine-rich
repeat)
Novel (Tetratricopeptide
repeat)

UBASH3

NA

TCTE1

carboxy-lyase activity

TTC36

NA

CG10395

Novel

INO80B

DNA repair

CG32845

Novel

PIN1

isomerase activity

CG1030

CG4021
CG4079
CG4082

CG6939

CG7538

CG9741
CG9755

CG32239
CG13604
CG14325
CG14105
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Table 3.1 (continued)
Gene number
CG14339

Fly gene name
Novel (Tetratricopeptide
repeat)

Human
orthologue

Function/domains

NA

NA

CG32198

Novel

NA

NA

CG14024

Novel

CHST

carbohydrate biosynthetic process

CG10342

neuropeptide F
Novel (Armadillo and
BTB domain)

NA

neuropeptide hormone

ARMC5

ATP hydrolysis coupled proton transport

CG7837

Table 3.1 Positive hits from RNAi screen. Color coding describes relative intensity of GFP
signal to background within the plate. Red font denotes the strongest scoring hits, blue are
medium, and purple are the weakest scoring hits. Column one denotes the CG number
present in flybase (www.flybase.net). Column two gives the fly gene name while column three
is the putative human orthologue according to ensemble (www.ensembl.org). The fourth
column is a short description of known function or putative domains in the absence of known
function. Novel means that no characterization of the gene has been found and “NA” means
that no orthologue or function is known at this time.
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Knockdown of different Integrator components results in differential 3’ end processing
defects of U7 reporter and endogenous spliceosomal snRNAs.
To systematically assess the importance of individual Integrator subunit for the
requirement in snRNA biosynthesis, we measured snRNA misprocessing by using the U7GFP readthrough reporter in S2 cells depleted of each corresponding Integrator subunit. To
accomplish this, we generated dsRNAs targeting all of the known Drosophila Integrator
subunits using the method described in detail in Chapter 2 (Cell culture and RNAi Section).
The dsRNA targeting PTB was used as a negative control. S2 cells were treated with dsRNA
for two days before transfection with the U7-GFP reporter, and we observed no overt effect on
cell growth in response to the dsRNAs treatment. To assess the knockdown efficiency of
endogenous Integrator proteins in S2 cells, antibodies to Drosophila Integrator subunits IntS1,
IntS9, IntS11 and IntS12 were successfully generated by injection of Guinea pigs with
recombinant GST-fusion proteins. Western blot analysis demonstrated that dsRNA targeting
each endogenous Integrator mRNA tested significantly reduced the corresponding Integrator
protein levels in cells (Figure 3.2A). U7-GFP reporter expression was measured in these cells
depleted of each Integrator subunit by both fluorescence microscopy (Figure 3.2B, D) and
Western blot analysis (Figure 3.2C, E). Only background GFP fluorescence was observed in
control dsRNA (PTB) treated cells while knockdown of nearly every Drosophila Integrator
subunit gave rise to increased levels of GFP expression from the U7-GFP reporter with the
highest level of GFP expression observed from IntS9 depleted cells. However, knockdown of
IntS3 and IntS10 only gave rise to low levels of GFP expression equivalent to that observed in
control dsRNA treated cells.
To further determine the effect of knockdown of each Integrator subunit on the 3’ end
processing of endogenous spliceosomal snRNAs, a sensitive quantitative real-time PCR
method was developed to measure the accumulation of endogenous premature snRNA
species in Integrator knockdown cells. To accomplish this, each snRNA amplicon was
designed with a forward primer priming to sequences within the snRNA coding region and
reverse primer recognizing ~50 nucleotides downstream of the 3’ cleavage site. Therefore, by
design, only premature or misprocessed snRNA transcripts would be specifically amplified and
detected. PCR primer quality was verified by agarose gel electrophoresis followed by ethidium
staining as well as an analysis of the dissociation curves. All amplicons identities were
confirmed by sequencing. S2 cells were treated with dsRNA targeting each Integrator subunit
or PTB (negative control) for two days, and on the fourth day, total RNA was isolated and
subject to reverse transcription (RT). The levels of premature snRNAs were then determined
by qRT-PCR analysis using primers specific for premature snRNAs, and data analysis was
carried out by using the ΔΔCt method using Rps17 as the reference gene and PTB dsRNA
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Figure 3.2 Knockdown of the Drosophila Integrator subunits causes misprocessing of
the U7-GFP reporter.
(Figure reprinted from Ezzeddine N, Chen J et al. Mol. Cell. Biol. 2011; 31:328-341)
(A) Western blot analysis of lysates from Drosophila S2 cells treated with either control dsRNA
targeting PTB or a specific dsRNA targeting Integrator 1, 11, or 12. RNAPII (center) or a crossreacting band (*) serves as a loading control. (B) Fluorescence images of cells treated with a
specific dsRNA (labeled in white), then transfected with the U7-GFP reporter. (C) Western blot
analysis of cell lysates from the cells shown in panel B. Lysates were probed with either antiGFP antibodies or with anti-Symplekin (αSym.) antibodies as a control. (D) Fluorescence
images of cells treated with dsRNA targeting IntS5, 9 and 12 followed by transfection with the
U7-GFP reporter. In this case the control dsRNA targeted LacZ and not PTB. (E) Western blot
analysis of cell lysates from panel D.
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treated cells as a control. Results (Figure 3.3A) were plotted as fold changes in the level of
premature snRNA in Integrator knockdown cells versus control treated cells and the average
presented was from three independent RNAi experiments. With the exception of Integrator 3
dsRNA treatment, all knockdowns led to increase in the levels of premature spliceosomal
snRNAs (Figure 3.3A). Notably, knockdown of Integrator 10 gave rise to the smallest increase,
consistent with our observations from the U7-GFP reporter assay (Fig. 3.2B). For each
knockdown, data garnered from our qPCR analysis were very consistent with those from our
reporter assay where knockdown of Integrators 1, 4, and 9 led to a over 50-fold increase in the
levels of premature snRNAs, and knockdowns of Integrators 11 and 7 resulted in a ~10 fold
increase. Except for IntS3 and IntS10, knockdown of the remainder of the Integrator subunits
led to a 2-10 fold increase in the levels of premature snRNAs. We measured Integrator protein
knockdown efficiency in these cells by using antibodies for IntS1, 9, 11 and 12, and measured
IntS3 and IntS10 mRNA levels in knockdown cells by qRT-PCR analysis using PTB and IntS9
dsRNAs treated cells as negative and positive controls respectively (Figure 3.3B). We
observed a 65%, 75% and ~90% reduction in the levels of IntS3, IntS9 and IntS10 mRNAs
respectively, and these results suggest that dsRNAs targeting IntS3 or IntS10 was effective in
depleting endogenous Integrator mRNA levels and it is likely that IntS3 and IntS10 are not
required for efficient snRNA 3’ end formation. Taken together, functional analysis indicates
that with the exception of IntS3 and IntS10, all known Integrators are functionally required for
snRNA 3’ end processing.
Asunder and CG4785 are specifically required for snRNA 3’ end formation.
In addition to the known Integrator proteins, our genome-wide RNAi screen also identified
four non-Integrator proteins: Asunder, CG4785, cyclin C, and Cdk8.
To confirm that the observed snRNA misprocessing occurs as a consequence of
knockdown of CG4785 and Asu, we designed a second set of dsRNA targeting a
distinct region of each open reading frame. S2 cells were then treated with dsRNA
targeting LacZ or the Stem Loop Binding Protein (SLBP) as negative controls, IntS9
and IntS12 as positive controls, and either dsRNA targeting Asu or CG4785. We
observed only background levels of GFP expression in negative control dsRNA treated
cells while both dsRNA targeting Asu and CG4785 gave rise to robust and nearly
identical levels of GFP expression comparable to those observed after depletion of
IntS9 or IntS12 (Figure 3.4A and B). To determine the specificity of the misprocessing
phenotype, we utilized two related GFP reporters that we developed previously to
determine defects in histone pre-mRNA processing (Wagner et al. 2007; Yang et al.
2009; Ezzeddine et al. 2011). The H3-GFP report is almost identical to the U7-GFP
construct, except the histone H3 gene is used. In addition, the Act-H3-GFP reporter
replaces the H3 promoter with the actin promoter, which was found to sensitize it to
additional factors whose depletion normally extinguishes the histone promoter (Yang et
al. 2009). We treated cells with the same series of positive control, negative control,
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Figure 3.3 Knockdown of Integrator subunits causes various degrees of misprocessing
of endogenous spliceosomal snRNAs.
(Figure reprinted from Ezzeddine N, Chen J et al. Mol. Cell. Biol. 2011; 31:328-341)
(A) Histogram of real-time PCR experimental data generated using primer pairs designed to
detect the presence of misprocessed (mis.) spliceosomal U1, U2, U4, or U5 snRNAs. Results
are plotted as fold increases relative to control-treated cells and reflect expression normalized
to an internal control gene (RpS17). All results are derived from biological triplicates, with error
bars indicative of the standard deviations of the triplicate quantification. (B) Histogram of qRTPCR quantitation of IntS3, IntS9, and IntS10 mRNA following dsRNA treatment. Levels
represented are the averages of triplicate experiments normalized to an internal control
(RpS17) and then normalized to control-treated cells.
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and test dsRNA as described above followed by the transfection with either H3-GFP or
Act-H3-GFP reporter. Using these other two constructs, we only observed GFP
expression after depletion of SLBP, confirming that both Asu andCG4785 are
specifically required for snRNA 3’ end processing. To characterize the role of Asunder
and CG4785 in the processing of endogenous snRNA, we used a sensitive qRT-PCR
assay designed to measure misprocessed U1 and U5 snRNA following RNAi depletion.
Total cell RNA was isolated following several days of incubation with dsRNA targeting
LacZ (negative control), IntS9 or IntS12 (positive controls) or dsRNAs targeting Asu
and CG4785 (two separate dsRNAs each gene). We subjected total RNA to reverse
transcription followed by real-time PCR analysis using primers specific for the
misprocessed U1 and U5 snRNA (Ezzeddine et al. 2011). Relative to control treated
cells, we observed a 5-10 fold increase in the level of misprocessed snRNA (Figure
3.4C). The levels of misprocessed snRNA were consistent between the two individual
dsRNAs for each target and comparable to that observed after depletion of IntS12.
Taken together, these results demonstrate that Asu and CG4785 are required for both
reporter and endogenous snRNA 3’ end formation.
Cyclin C and Cdk8 are required for snRNA 3’ end formation.
The observation that both Cdk8 and CycC were independently isolated in our
screen strongly suggests that they are involved in snRNA 3’ end formation, as they
form a cognate cyclin/cdk pair (Leclerc et al. 1996).To address the possibility of any
potential off-target effects and characterize their specificity towards snRNA 3’ end
formation we created a second set of dsRNA targeting distinct regions of each ORF.
Treatment of S2 cells with dsRNAs targeting Cdk8 or targeting CycC resulted in robust
expression of GFP from the U7-GFP reporter (Figure 3.4D). We also tested the effect
of CycC or Cdk8 depletion on both the histone H3-GFP and Actin-H3-GFP reporters.
Neither the H3 nor Actin H3 reporters were found to produce GFP in response to Cdk8
or CycC knockdown. In contrast, we observed robust expression of GFP from both
reporters in response to treating cells with dsRNA targeting SLBP. These data
implicate that CycC and Cdk8 are specifically involved in the process of snRNA 3’ end
formation.
To test whether the kinase activity of Cdk8 is required for snRNA 3’ end formation,
we cloned wild-type Drosophila Cdk8 and generated a kinase-dead (D173A) form
analogous to a mutant human CDK8 shown previously to behave as a dominantnegative (DN) (Akoulitchev et al. 2000). Both wild-type and DN cDNAs were expressed
as N-terminal myc-tagged proteins in S2 cells co-transfected with the U7-GFP reporter.
Despite the reduced accumulation of the catalytically inactive Cdk8 relative to the wildtype protein, we observed potent misprocessing of U7-GFP reporter (Figure 3.4E).
These data demonstrate that the kinase activity of the CycC/Cdk8 complex is essential
for correct snRNA 3’ end processing.
One possible explanation for the observed phenotype is that CycC/Cdk8 fulfills a
general requirement in the expression of one or more Integrator subunits and therefore
CycC/Cdk8 plays an indirect role in snRNA 3’ end formation. To test this, we analyzed
the expression of all twelve Integrator subunits as well as Asunder and CG4785 after
depletion of CycC or Cdk8 using both Western blot analysis (Figure 3.5A) and qRTPCR (Figure 3.5B/C). We found no observable differences in the levels of Integrator
subunit expression following CycC or Cdk8 knockdown. Therefore, we conclude that
these two proteins are likely functioning directly in the 3’ end formation of Drosophila
snRNA.
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Figure 3.4 Validation of Asunder, CG4785, CycC, and Cdk8 as required for snRNA 3’ end
formation. (Figure reprinted from Chen J et al. RNA. 2012. doi:10.1261/rna.035725.112)
(A). Images from S2 cells transfected with U7-GFP reporter after dsRNA treatment targeting
Asu or CG4785. (B). Western blot analysis of cell lysates from Panel A. (C). qRT-PCR
analysis specific for misprocessed endogenous snRNA from knockdown cells. (D). Western
blot analysis of S2 cells treated with dsRNA targeting CycC or Cdk8 followed by transient
transfection with reporters measuring snRNA or histone mRNA 3’ end formation. (E). Western
blot analysis of cells cotransfected withU7-GFP reporter and myc-tagged Cdk8 that is wild type
or catalytically inactive.
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Figure 3.5 Functional involvement of Cyclin C and Cdk8 in snRNA 3’ end formation is
not through regulation of Integrator expression.
(Figure reprinted from Chen J et al. RNA. 2012. doi:10.1261/rna.035725.112)
(A). Western blot analysis of protein levels of Integrator subunits after treating cells with
dsRNA targeting LacZ, CycC, or Cdk8. Cells were also transfected with the U7-GFP reporter
to monitor snRNA misprocessing as a functional readout of knockdown of CycC/Cdk8. (B).
Quantitative RT-PCR analysis using SYBR green staining of PCR products. RNA was isolated
from S2 cells, treated with the three dsRNAs described in panel A and subjected to real-time
PCR analysis using amplicons specific to Integrator subunits not tested by Western blot
analysis in panel A. All measurements were normalized to RpS17 signals as a housekeeping
internal control. (C). Ethidium bromide staining of agarose gel electrophoresis of the amplicons
amplified in panel B.
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Asunder and CG4785 associate with Integrator Subunits.
To determine if either CG4785 or Asunder biochemically associate with the other
Integrator subunits, we cloned full-length cDNAs and generated stable S2 cell lines
expressing either FLAG-tagged Asunder or FLAG-tagged CG4785. Western blot
analysis of lysates from these cell lines using anti-FLAG antibodies demonstrates the
expression of specific bands of the predicted molecular weight for both proteins (Figure
3.6A). We analyzed the subcellular localization of both of the tagged proteins and
observed a nuclear localization of CG4785 and a bimodal localization of Asu in both
the nucleus and the cytoplasm (Figure 3.6B). Nuclear extracts were prepared from
both stable cell lines from which epitope tagged proteins were immunoprecipitated
using anti-FLAG agarose. A large majority of FLAG-tagged protein was recovered in
each precipitate from both cell lines and we determined the levels of interacting
endogenous Integrator subunits using antibodies to Drosophila IntS1, IntS9, IntS11,
and IntS12 proteins (Figure 3.6C). A large proportion of all four Integrator subunits
were detected specifically associating with Asu and CG4785, relative to control pull
downs (Figure 3.6C). We did not detect SLBP in either immunoprecipitate, consistent
with the observation that depletion of these two proteins does not affect histone mRNA
3’ end formation. To confirm potential direct interactions with Drosophila Integrator
subunits, we performed binary interaction tests using pairwise, directed yeast twohybrid analysis. This is an ideal assay to perform this analysis given the lack of
endogenous yeast Integrator subunits. Under low and high stringency conditions, we
did not observe any interaction between Asu and the known Integrator subunits (not
shown). In contrast, we did observe a robust interaction between CG4785 and IntS10
by Y2H (Figure 3.6D). Collectively, these data demonstrate that, in addition to their
functional requirement in snRNA 3’ end formation, both Asu and CG4785 biochemically
associate with the previously described members of the Drosophila Integrator complex
(Baillat et al. 2005). While the interaction of CG4785 is most likely mediated through
IntS10, the binding partner(s) of Asunder remain to be identified.
Requirement for Cyclin C and Cdk8 in snRNA 3’ end formation is conserved and
independent of its function in Mediator.
There has been extensive previous characterization of CycC and CDK8 as
members of the Mediator CDK8 module in conjunction with Mediator 12 and 13
(reviewed in (Galbraith et al. 2010)). Knockdown of these two Mediator subunits did not
produce GFP expression in our screen, suggesting that either they are not required for
snRNA processing or were not depleted effectively. To address the latter possibility, we
created independent dsRNAs specific to Med12 and Med13 and observed that they
elicited significant reduction in the levels of endogenous Med12 and Med13 yet failed
to trigger misprocessing in the U7-GFP reporter (Figure 3.7A). These results imply that
CycC and Cdk8 are required for snRNA 3’ end formation independent of Med12 and
Med13. To determine if CycC or CDK8 play a conserved role in the 3’ end formation of
human snRNA, we treated HeLa cells with two siRNAs targeting both transcripts and
then transfected the human version of the U7-GFP reporter that we showed previously
to express GFP in response to Integrator activity disruption (Albrecht and Wagner
2012). We observed that both siRNAs resulted in efficient reduction of the levels of
endogenous CycC and siRNA #2 resulted in significant depletion of CDK8 and gave
rise to GFP expression comparable to those after depletion of IntS12 (Figure 3.7B). We
noted that CDK8 siRNA#1 did not give rise to as much GFP expression as siRNA#2
but the knockdown was not as effective and also not as effective as co-depleting CycC.
These results demonstrate the requirement for CycC and CDK8 in snRNA 3’ end
formation in metazoans.

!

55

Figure 3.6 Asunder and CG4785 biochemically associate with the fly Integrator
Complex.
(Figure reprinted from Chen J et al. RNA. 2012. doi:10.1261/rna.035725.112)
(A). Western blot analysis of FLAG-tagged Asunder and CG4785 expression in S2 stable
cells. (B). IF analysis of stable S2 cell lines expressing FLAG- tagged Asunder or CG4785.
(C). Western blot analysis of FLAG immunoprecipitates from cell lines described in panel A.
Input lanes represent 5% of input and IP represents 50% of the immunoprecipitate. (D).
Directed yeast two-hybrid using fly Integrator subunits and CG4785 demonstrating an
interaction with IntS10.
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The functional requirement for CycC/Cdk8 in fly snRNA 3’ end formation generates
the question of whether these two proteins are associated with Integrator subunits. To
test this possibility, we generated stable S2 cell lines expressing FLAG-mcherry
(negative control), FLAG-Cdk8, or FLAG-CycC and performed immunoprecipitations
from nuclear extracts prepared from these cell lines. We observed substantial amounts
of endogenous Med12 and Med13 associating with both FLAG-CycC and FLAG-Cdk8
as predicted, yet we also observed a reproducible interaction with the Integrator
subunits (Figure 3.7C). The reduced levels of Integrator proteins in the co-IP suggest
that the interaction is relatively weak or transient and that only a small pool of
CycC/Cdk8 not associated with Med12 and Med13 binds to the Integrator subunits. To
test these predictions, we used IntS12 antibodies to immunoprecipitate the Integrator
complex from nuclear extract derived from S2 cells stably expressing FLAG-Cdk8. We
observed significant amount of IntS11 and a portion of FLAG-Cdk8 associating with
IntS12 (Figure 3.7D). Importantly, we did not detect Med13 interacting with IntS12. This
reciprocal pulldown confirms the presence of a small amount of Cdk8 associating with
the fly Integrator complex in the absence of Mediator.
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Figure 3.7 CycC/Cdk8 function in snRNA 3’ end formation independent of Mediators
12/13 and are associated with Integrator subunits.
(Figure reprinted from Chen J et al. RNA. 2012. doi:10.1261/rna.035725.112)
(A). Western blot analysis of lysates from S2 cells treated with dsRNA targeting members of
the Drosophila Mediator Cdk8 module and transfected with the U7-GFP reporter. (B). Western
blot analysis of lysates from HeLa cells treated with siRNA to CycC or CDK8 followed by
transfection with a human version of the U7-GFP reporter. (C). Immunoprecipitations using
αFLAG-agarose to detect interactions between CycC/Cdk8 and Integrator 1 and 9. Input lanes
represent 2% of input and IP lanes represent 50% of immunoprecipitate. (D). Western blot
analysis of immunoprecipitations using anti-IntS12 antibodies.
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DISCUSSION
The functional genome-wide RNAi screen presented here has defined the Drosophila
Integrator complex to comprise of fourteen core subunits. It is likely that the core members of
the Integrator complex are conserved as the human orthologues of Asu and CG4785 were
reported to be present in the human Integrator immunoprecipitations with the levels
comparable to the known twelve Integrator members (Malovannaya et al. 2010). The
conserved requirement for CycC/Cdk8 in the formation of both fly and human snRNA 3’ end
suggests that besides the conserved core complex, the regulation of snRNA 3’ end formation
is likely retained in metazoan species.
U7-GFP reporter as a sensor for snRNA misprocessing
The snRNA-GFP reporter allows us to visually monitor snRNA 3’ end formation with great
sensitivity. However, one limitation of the U7-GFP reporter is that for an RNAi-knockdown to
be scored as a positive “hit”, the protein depleted must only disrupt snRNA 3’ end formation
but not snRNA gene transcription. In this case, any factor that extinguishes snRNA
transcription will be eliminated. This likely explains why members of the snRNA Activating
Protein Complex (SNAPc) and the recently defined Little Elongation Complex were not scored
in our RNAi screen (Hung and Stumph 2011; Smith et al. 2011). Depletion of any of these
factors would compromise U7-GFP transcription and lead to no GFP expression. Developing
an snRNA reporter that is able to visualize both snRNA transcription and 3’ end formation will
significantly improve our understanding to the screen results by discriminating the effect
resulted from transcription from 3’ end formation. Recently, RNA aptamers have been reported
to lighten up modified RNAs in cells by forming the RNA aptamer/fluorophore complex, which
produce a wide spectrum of fluorescence(Paige et al. 2011). A modified snRNA reporter that
fuses these newly developed RNA aptamers to the snRNA genes will enable us to monitor
snRNA transcription and 3’ end formation simultaneously by measuring the different spectrum
of fluorescence, such as GFP and mCherry. Interestingly, the fly orthologue of RPAP2
(CG34183), a protein factor recently proposed to mediate the interaction between Integrator
complex and the RNAPII CTD (Egloff et al. 2012), was not scored in our screen either. One
possible explanation of this is that RPAP2 may be required for snRNA gene transcription as
well as 3’ end processing. Alternatively it may not be required in Drosophila. Considering the
markedly distinct structure of fly RNAP II CTD (very few Ser7 within the heptad repeat), and
the significantly smaller fly RPAP2 (143a.a.) versus its human counterpart (612a.a.), it is
possible that RPAP2 may not be involved in Drosophila snRNA 3’ end formation.
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Novel components identified to be required for snRNA 3’ end processing
Our functional screen identified Asu and CG4785 as two additional core components of the
Integrator complex. Asu was initially named Mat89b, due to its maternal deposition in the
Drosophila embryo (Stebbings et al. 1998). Later, it was characterized to be a substrate for
PanGu kinase, and the reduction of Asu expression in the spermatocytes was reported to
cause aberrant centrosome and spindle assembly (Anderson et al. 2009). Asu has a predicted
molecular weight of 76kDa with a conserved yet uncharacterized DUF2151 domain. The
CG4785 gene encodes a 65kDa protein with a less conserved (Pfam: E-value 0.022) von
Willebrand Factor (vWF) type A (VWA) domain, which was observed in IntS6 as well. Previous
studies show that the VWA domains in extracellular eukaryotic proteins are involved in cell
surface adhesion via metal ion-dependent adhesion sites (MIDAS), and intracellular VWA
domains containing proteins have been found to be involved in various functions such as
transcription, DNA repair, ribosomal and membrane transport and the proteasome(Whittaker
and Hynes 2002). The human orthologues of Asu and CG4785 have been found to be present
in the human Integrator protein immunoprecipitations by large-scale mass spectrometry at the
levels comparable to known Integrator proteins, suggesting that these two proteins are likely to
play conserved roles in snRNA biogenesis (Malovannaya et al. 2010; Malovannaya et al.
2011). Based on the existing evidence and our results, we suggest that Asu be known as
Asu/IntS13 and CG4785 as IntS14.
This study also identified the functional requirement of CycC/Cdk8 in snRNA 3’ end
formation, and suggests that CycC/Cdk8 are likely to function in a pathway independent of
Mediator 12 and 13. Our results are consistent with previous observations that sex comb
phenotypes of CycC– and Cdk8– clones are indistinguishable from each other but clearly
distinct from the phenotypes of Med12– and Med13– clones (Loncle et al. 2007). Here we
propose two potential functions for Cyclin C/Cdk8 in snRNA 3’ end formation: phosphorylation
of the RNAPII CTD, or as an Integrator subunit kinase. Phosphorylation of Ser2 and Ser7 in
the RNAPII CTD is reported to be specifically required for Integrator complex recruitment and
activation of snRNA 3’ end processing, but the kinase responsible for Ser7 phosphorylation is
not known yet. Cdk8 has been shown to phosphorylate the CTD of Rpb1 in vitro (Rickert et al.
1999), so it is possible that Cdk8 may act as a RNAPII CTD Ser7 kinase to mediate snRNA 3’
end processing. Alternatively, CycC/Cdk8 may regulate an Integrator subunit through direct
phosphorylation similar to the role it plays in the mediator complex where CycC/CDK8
phosphorylates Mediator 13 (Knuesel et al. 2009).
In conclusion, the most remarkable feature of the Integrator complex is that an essential
network of interactions is present making it intolerant to perturbation. In most cases, depletion
of even a single subunit leads to inefficient snRNA 3’ end processing. Thus, characterization of
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the functional interactions and identification of the role of each Integrator subunit in snRNA 3’
end formation represent the most compelling challenges in the field.
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Chapter 4. Functional Analysis Identifies an Autonomous IntS12 microdomain
Mediating Activation of the Drosophila Integrator Complex.
!
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INTRODUCTION!
!
The accurate production of snRNAs is an important bioprocess needed for efficient
downstream RNA processing events including intron removal and histone mRNA 3’ end
formation (reviewed in (Matera et al. 2007; Egloff et al. 2008)). With the exception of the U6
snRNA, spliceosomal snRNAs are transcribed by RNA Polymerase II (RNAPII) and their 3’
ends are processed by the Integrator complex. Both the snRNA promoter and the 3’ box
sequence element located downstream of the cleavage site have been established as features
required for snRNA 3’ end formation in metazoans (Hernandez 1985; de Vegvar et al. 1986;
Hernandez and Weiner 1986). Unlike the rigid requirements of the poly(A) signal (PAS) in
protein coding genes or the histone downstream element (HDE) in histone mRNA processing,
the snRNA 3’ box can be removed with only minor perturbation to snRNA biosynthesis (Ach
and Weiner 1987; Ezzeddine et al. 2011). This demonstrates that the snRNA processing
machinery is moderately tolerant to mutations within demarcating cis elements and that
specificity of the RNA cleavage event is in part brought about through additional means.
Precise snRNA 3’ end cleavage is predicated on transcription being initiated from an
snRNA promoter, with distinct RNAPII C-terminal domain (CTD) protein modifications found on
transcription complexes active at snRNA loci. Phosphorylations within the CTD heptad repeat
at serines 2 and 7 have been shown to be essential for Integrator recruitment and subsequent
snRNA 3’ end formation (Egloff et al. 2007; Egloff et al. 2010). Replacement of native snRNA
promoters with RNAPII promoters from protein-coding genes prevents snRNA 3’ end
formation, consistent with Integrator being assembled onto the RNAPII complex early in the
transcription cycle (de Vegvar et al. 1986; Hernandez and Weiner 1986; Ezzeddine et al.
2011).
The initial biochemical identification of the Integrator complex, subsequent analyses of
immunoprecipitates, and a recent genome-wide RNAi screen have identified fourteen
members of the complex to date (IntS1 through IntS12, Asu/IntS13 and IntS14) (Baillat et al.
2005; Malovannaya et al. 2010; Malovannaya et al. 2011; Chen et al. 2012). Each member of
the human Integrator complex is conserved in Drosophila and RNAi-mediated depletion of
nearly any Integrator subunit in S2 cells causes snRNA misprocessing (Ezzeddine et al.
2011). This latter result suggests the existence of a network of interactions within the
Integrator complex that is highly sensitive to disruption.
The only well-established protein-protein interaction among Integrator subunits is between
IntS9 and IntS11 (Dominski et al. 2005b; Albrecht and Wagner 2012). These two proteins
contain highly conserved metallo-β-lactamase and β-CASP domains and likely represent the
catalytic core of the complex (reviewed in (Dominski 2007)). They form a highly stable
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heterodimer in vivo and their association is mediated through conserved C-terminal domains
on both proteins. Formation of this heterodimer is required for snRNA 3’ end formation and
likely is important to activate the endonuclease activity of IntS11 (Albrecht and Wagner 2012).
The role of the remaining subunits in snRNA 3’ end formation has yet to be determined and
functional domains within other subunits have yet to be experimentally identified.
There are several evolutionarily conserved motifs identifiable within Integrator subunits in
addition to the conserved β-CASP/β-lactamase domains of IntS9/11 (reviewed in (Chen and
Wagner 2010)). These include the HEAT repeats within IntS4, a von-Willebrand factor type A
(VWA) motif within IntS6, and a Plant Homeodomain (PHD) finger in IntS12. PHD fingers are
typically ~60 amino acid motifs comprising a C4HC3 signature that coordinate two zinc ions
(reviewed in (Bienz 2006; Musselman and Kutateladze 2011)). Proteins containing PHD
fingers are almost exclusively found in the nucleus and are commonly present in protein
complexes that govern transcriptional regulation. The PHD finger itself robustly interacts with
N-terminal tails of histones, most commonly histone H3. Typically, PHD fingers exhibit
preference toward unique chemical modifications of amino acids in histone H3 with a particular
preference toward lysine methylation. These attributes make analysis of the role of the IntS12
PHD finger in snRNA 3’ end formation an attractive entry point to further our understanding of
Integrator subunit function.
Here, we investigate the role of Drosophila IntS12 in snRNA 3’ end formation using
snRNA-specific GFP reporters to assess Integrator complex activity. To identify regions of
IntS12 required for Integrator activity, we devised an RNAi-rescue strategy to re-express
RNAi-resistant forms of IntS12 mRNA in cells depleted for endogenous IntS12 protein.
Unexpectedly, we determined the PHD finger to be dispensable for IntS12 activity and instead
identified a small microdomain at the N-terminus of IntS12 that is essential for activity.
Surprisingly, the IntS12 microdomain by itself is sufficient to rescue the snRNA misprocessing
defected from our reporters as well as endogenous snRNAs observed in IntS12 depleted cells.
Moreover, the microdomain is sufficient to mediate interaction between Integrator subunits and
a heterologous protein. We also show that the IntS12 microdomain interacts with IntS1 in the
absence of other Integrator subunits and the stability of these two subunits requires their
interaction. Collectively, these results suggest a critical regulatory function for IntS1 and
IntS12 required for Integrator activity in snRNA 3’ end formation.
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RESULTS
Development of an RNAi-rescue assay to study IntS12 function.
Previously, we developed a GFP-based reporter system for in vivo monitoring of U7snRNA
3’ end formation in Drosophila cells (Ezzeddine et al. 2011; Chen et al. 2012). The advantage
of the U7-GFP reporter as a method of monitoring Integrator complex activity is that loss of
activity can be readily detected in vivo with high sensitivity via GFP fluorescence. A potential
limitation of this reporter is that it uses the U7 snRNA gene, which is somewhat atypical from
the spliceosomal snRNA genes due to unique variations within its core promoter elements
(Dominski et al. 2003; Hernandez et al. 2007). To control for potential experimental bias, we
created a second analogous spliceosomal snRNA reporter based instead upon the Drosophila
U4:39B snRNA gene. To test the functionality of this new reporter (U4-GFP), we treated S2
cells with separate non-overlapping dsRNAs (IntS12#1 or IntS12#2) to induce RNAi-mediated
depletion of IntS12. Cells were then transfected with either the U7-GFP or U4-GFP reporter to
assess Integrator complex functionality (Figure 4.1A). Depletion of IntS12 resulted in robust
levels of GFP expression from both reporters relative to control dsRNA (LacZ) treated cells.
Western blot analysis of lysates prepared from treated cells confirmed both the loss of
endogenous IntS12 expression and a consequential increase in GFP production from both
reporters (Figure 4.1B). While the overall sensitivity of the U4-GFP reporter is similar to that of
the U7-GFP reporter, the U4-GFP reporter displayed greater specificity, as seen by the lower
background GFP fluorescence in the control treated cells. Finally, to confirm that dsRNAmediated depletion of IntS12 led to misprocessing of endogenous snRNAs, we isolated total
RNA and performed qRT-PCR analysis using primers that specifically detect the misprocessed
forms of the U1, U2, U4 and U5 snRNAs (Figure 4.1C). Both dsRNAs directed against IntS12
were found to increase the levels of misprocessed snRNA 2-4 fold, consistent with our
previous observations (Ezzeddine et al. 2011).
To validate that the misprocessing of the U7 and U4-GFP reporters we observed is
induced by depletion of the endogenous IntS12 protein, we set to rescue the phenotype by
introducing back an IntS12 plasmid refractory to RNAi. As initial attempts to target the
endogenous IntS12 mRNA 5′ or 3′ UTRs using dsRNA failed to generate adequate depletion,
we developed a RNAi-resistant IntS12 expression construct containing 188 silent mutations
within the region targeted by the IntS12#2 dsRNA (cDNA bases 1-418) (Figure 4.2A).
Expression of this RNAi-resistant IntS12 cDNA (IntS12*) from a ubiquitin promoter yielded ~50
kDa doublet of IntS12 protein, albeit at slightly reduced levels relative to the wild-type IntS12
cDNA expressed under the same conditions. Next we tested the ability of IntS12* to restore
snRNA 3’ end processing in cells when endogenous IntS12 has been depleted.
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Figure 4.1 Dual GFP reporters reveal snRNA misprocessing following IntS12
knockdown in Drosophila S2 cells. S2 cells treated with dsRNA corresponding to bases
418-719 (IntS12#1) and 1-418 (IntS12#2) of IntS12 mRNA, or control dsRNA (lacZ) were
subsequently transiently transfected with either U7-GFP or U4-GFP 3’ cleavage reporter
constructs. (A) Fluorescence and brightfield images of treated S2 cells and. (B) Western blot
analysis of cell lysates using anti-GFP or anti-IntS12 antibodies. A nonspecific band that
cross-reacts with the IntS12 antibody is shown as a loading control (C) Graphical
representation of qRT-PCR quantification of snRNA misprocessing. Amplicons specific for
non-processed snRNAs isolated from S2 cells treated with either IntS12#1 or IntS12#2
dsRNAs. Data represent the average of triplicate independent experiments normalized to
Rps17 mRNA and plotted as fold increase relative to LacZ-treated control cells.
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Figure 4.2 RNAi-resistant IntS12* Rescues dsRNA-induced U4 and U7 snRNA
Misprocessing. (A) Schematic of the features encoded in the Drosophila (CG5491) IntS12
gene, showing the relative location of dsRNA#2 and the 188 silent site changes used to
generate the IntS12* cDNA. (B) Western blot analysis of lysates from cells transfected with
myc-tagged IntS12 (wild-type) cDNA or IntS12* cDNA using anti-myc antibodies. (C) Western
blot

analysis

demonstrating

dose-dependent

rescue

of

the

U7-GFP

and

U4-GFP

misprocessing phenotype using the IntS12* cDNA following RNAi-mediated depletion. Lanes
2-7 are from S2 cells treated with IntS12 dsRNA#2 subsequently cotransfected with reporter
plasmid and rescue plasmid DNAs. Doses of rescue plasmid (Res. P) are indicated in
nanograms. (D) Representative fluorescence images of S2 cells treated as described in panel
(C). In all cases “VA” is the abbreviation for transfecting cells with vector alone.
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To this end, we cotransfected either the U4-GFP or U7-GFP reporters with decreasing
amounts of plasmid DNA encoding IntS12* into S2 cells depleted of endogenous IntS12 by
treatment with dsRNA#2. Both fluorescence microscopy and Western blot analysis of lysates
from transfected cells revealed a clear dose-dependent response between the amount of
transfected IntS12* and the level of snRNA 3’ end processing as measured by both reporters
(Figure 4.2C/D). As 10 ng. of transfected IntS12* cDNA per 96-well was found to be the
minimal amount required to achieve full rescue of IntS12 knockdown, this amount was used in
all further experiments. Collectively, these results demonstrate that depletion of endogenous
IntS12 leads to measureable and reproducible GFP expression from both U4-GFP and U7GFP reporters and that dsRNA mediated knockdown of endogenous IntS12 can be fully
rescued through the expression of an RNAi resistant IntS12* cDNA.
The N-terminus is both Necessary and Sufficient for IntS12 Function.
Alignment of IntS12 protein sequences from multiple species identified two regions with
significant homology (Figure 4.3). The largest region includes the amino acids within the PHD
finger known to be important for zinc coordination as well as several other residues known to
be essential for maintaining PHD structure (Bienz 2006). A smaller conserved region within
the first 50 amino acids of the N-terminus bears no resemblance to any known motifs. Lastly,
the C-terminal region consists of a poorly conserved serine rich region. To investigate the
functional contribution of these conserved features to snRNA 3’ end formation, we utilized the
dual U7 or U4-GFP reporter together with the RNAi-rescue strategy we developed. To do this,
we generated a series of RNAi-resistant deletion constructs derived from the IntS12* cDNA
and tested their ability to rescue snRNA misprocessing in cells depleted of endogenous IntS12
(Figure 4.4A). Constructs lacking various combinations of the N-terminus, centrally located
PHD finger domain, or serine-rich C-terminus were myc-tagged and transfected into S2 cells.
Western blot analysis using anti-myc antibodies confirmed protein expression from all
constructs while some variability was observed (Figure 4.4B). To determine the relative ability
of these deletion mutants to restore snRNA processing after knockdown of endogenous
IntS12, we co-transfected each mutant construct with either the U7-GFP or the U4-GFP
reporter into cells pre-treated with IntS12 dsRNA#2. Data obtained using GFP fluorescence
imaging (Figure 4.4C) and Western blot analysis using anti-GFP antibodies were congruent
(Figure 4.4D). The results gathered using both GFP reporters were remarkably consistent
and, to our surprise, demonstrated that the conserved PHD finger is not required for IntS12 to
mediate snRNA 3’ end processing. We found that constructs containing N-terminal amino
acids (ΔC, NP, N, and ΔP) were as active as full-length (FL) protein in restoring reporter 3’ end
processing after endogenous IntS12 knockdown.
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Figure 4.3 Protein sequence alignment of IntS12 from four metazoan species. Vector NTI
Advance (Invitrogen) is used to generate the sequence alignment graph. Four different
species are selected: human (H.sapiens), chicken (G.gallus), zebrafish (D.rerio) and fly
(D.melanogaster). Blue highlighted residues represent similar amino acids and yellow
highlights represent identical residues. The highlighted red boxes denote the identified
functional microdomain and the defined PHD finger.
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Figure 4.4 The N-terminus of Drosophila IntS12 is required for snRNA 3’ end formation.
(A) Schematic of IntS12* truncation and deletion constructs, which were designed based upon
predicted domains. Relevant amino acid sequences are numbered. (B) Western blot analysis
of cell lysates isolated from S2 cells transiently transfected with plasmids encoding myctagged IntS12* proteins. (C) Representative fluorescence images of S2 cells treated with
either control dsRNA or IntS12 dsRNA#2 followed by cotransfection of either the U4-GFP or
U7-GFP reporters with the myc-tagged IntS12* cDNAs. (D) Western blot analysis of cell
lysates from panel (C). (E) Schematic and Western blot analysis of three additional IntS12*
deletion mutants cotransfected with the U4-GFP reporter. In all panels “VA” stands for empty
vector transfection as a control.
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Conversely, all mutants lacking the N-terminus (C, PC, ΔN, and P) were incapable of restoring
Integrator activity. These results indicate that the N-terminal 45 amino acids are required for 3’
end processing activity while the first 129 amino acids are sufficient, whereas the PHD domain
was dispensable.
Mutations within an N-terminal microdomain disrupt IntS12 Activity.
To further characterize the N-terminus of IntS12, we generated three more IntS12
constructs derived from IntS12*. Two encode proteins harboring deletions of either the first 15
or first 30 amino acids, whereas a third generated a truncated protein consisting of only the
first 45 amino acids (Figure 4.4E, upper panel). The ΔN15 mutant was observed to function as
well as full-length IntS12; however, deletion of the first 30 amino acids (ΔN30) abolished
IntS12’s ability to rescue misprocessing of the U4-GFP reporter (Figure 4.4E, blot) despite
being expressed at levels comparable to the FL protein. In addition, expression of the first 45
amino acids of IntS12 (N45) was sufficient to restore snRNA processing as effectively as the
FL expression construct. These data demonstrate that amino acids 16-45 are required for
IntS12 activity and that the first 45 amino acids are sufficient to restore snRNA 3’ end
processing after endogenous IntS12 knockdown.
Detailed examination of the evolutionary similarities within the N-terminal region of IntS12
(Figure 4.5A) shows high conservation of the residues located within the region identified as
required for IntS12 function. The combination of evolutionary conservation and requirement in
snRNA 3’ end processing implicates this region as forming a functional microdomain critical for
IntS12 activity. To achieve better resolution of the relative contribution of amino acids within
this microdomain, we created a series of 6 mutant constructs (Mt1 through Mt6) spanning
amino acids 16-45, each comprising 5 contiguous alanine substitutions in the context of the
full-length IntS12* (Figure 4.5A). In instances where alanine was encoded in the wild-type
protein at a specific residue, no change was introduced. Therefore two of the mutants
contained 4 amino acid changes (Mt2 and Mt6) and one (Mt4) contained only three
substitutions. Western analysis confirmed each of these mutants to be expressed to similar
levels at the wild-type IntS12 protein (Figure 4.5B), yet they displayed strikingly different
abilities to promote snRNA 3’ end processing. Mt1, Mt2, Mt4, and Mt6 were as capable as the
wild-type IntS12 in restoring snRNA processing; however, both Mt3 and Mt5 were completely
ineffective in abrogating GFP reporter gene expression (Figure 4.5B). When this same
mutation series was retested in the context of the “N” construct (Figure 4.3A) comprising the
first 129 amino acids only, virtually identical results were obtained (data not shown). These
data define a highly conserved ~15 amino acid ‘core’ of a microdomain within the N-terminus
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Figure 4.5 Mapping critical residues within the N-terminal IntS12 microdomain required
for snRNA 3’ end formation. (A) Upper panel, alignment of several species’ IntS12 N-termini.
Blue highlighted residues represent similar amino acids and yellow highlights represent
identical residues. The highlighted red box denotes the identified functional microdomain; the
labeled amino acids are the subject of six different alanine-scanning mutants. (B) Western blot
analysis of cell lysates treated with either control dsRNA or IntS12 dsRNA#2 that were then
cotransfected with U4-GFP reporter and IntS12* plasmids containing mutations as described
in panel (A).
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of IntS12 that is required for restoring snRNA 3’ end processing after endogenous IntS12
knockdown.
The IntS12 Microdomain is Necessary and Sufficient for Incorporation of IntS12 into the
Integrator Complex.
Given the discrete and conserved nature of the IntS12 microdomain, we hypothesize that it
may function as a protein-protein interaction motif required for association with other
member(s) of the Integrator complex. To test this possibility, we cloned full-length RNAiresistant IntS12* cDNAs encoding either full-length (FL), Mt3 or Mt5 proteins in frame with an
N-terminal FLAG to facilitate immunoprecipitation studies. Analogous constructs comprising a
deletion of the first 45 amino acids of IntS12* (ΔN) or only the first 45 amino acids at the Nterminus (N45) were also generated. We observed that different FLAG-tagged proteins
restored 3’ end processing of both the U7-GFP and U4-GFP reporters in an identical fashion
to the myc-tagged proteins described above (Figure 4.6 v.s. Figures 4.4 and 4.5). We further
determined the effect of these FLAG-tagged proteins on endogenous snRNA processing. We
generated stable cell lines expressing FLAG-tagged IntS12* constructs, treated them with
dsRNA targeting either control LacZ or IntS12 and measured snRNA misprocessing using the
qRT-PCR assay described in Figure 4.1C. We observed that in the control stable line
expressing the FLAG only, depletion of IntS12 led to a 4-5 folds increase in the levels of
misprocessed endogenous U2 or U5 snRNA. Consistent with the reporter observations, stably
expressing FLAG-IntS12* or FLAG-N45 in IntS12 depleted cells rescued the misprocessed
endogenous U2 and U5 snRNAs to similar basal levels. In contrast, depletion of IntS12 in
stable lines expressing FLAG-tagged Mt3, Mt5 or ΔN led to a 3-5 folds increase in
misprocessed levels of endogenous U2 or U5 snRNA (Figure 4.7A). These data demonstrate
that functionally the IntS12 microdomain is necessary and sufficient to mediate the 3’ end
formation of both reporter and endogenous snRNAs.
To test interactions of other Integrator subunits with the IntS12 microdomain, we generated
nuclear extracts from these same stable cells lines and immunoprecipitated IntS12-associated
proteins using anti-FLAG agarose beads (Figure 4.7B). While we observed rescue of snRNA
processing using the N45 Int12 cDNA, levels of this protein were markedly reduced relative to
the other stably expressed Int12 proteins obscuring the ability to directly compare IP
efficiencies. Therefore, we initially compared the binding of endogenous Integrator subunits to
the full length IntS12, Mt3, Mt5, and the ΔN. We observed robust and significant levels of
endogenous IntS1 and IntS9 associating with FLAG-tagged full length (FL) IntS12 relative to
control pulldowns (Figure 4.7B. lane 4 vs. 2). IntS12 protein expressed from Mt3- or Mt5containing constructs poorly associated with endogenous IntS1 or IntS9 and this association
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Figure 4.6 FLAG-tagged IntS12 microdomain restores processing of U4 and U7 snRNAGFP reporters. Western blot analysis of cell lysates from S2 cells treated with either control
dsRNA or IntS12 dsRNA#2 followed by cotransfection of FLAG-tagged rescue plasmids and
either the U4- GFP or U7-GFP reporter.
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was completely absent in cells expressing the ΔN IntS12 protein truncation (Figure 4.7B. lanes
6, 8, & 10 versus lane 4). These data demonstrate that mutations introduced into the IntS12
N-terminal microdomain compromise Integrator activity in snRNA 3’ end processing by
reducing the ability of IntS12 to interact with other Integrator subunits.
As the data presented in Figure 4.7A shows expression of only the first 45 amino acids of
IntS12 is sufficient to rescue depletion of the endogenous protein, we next asked if the IntS12
microdomain alone (N45) is sufficient to mediate interaction with endogenous Integrator
subunits. To circumvent the issue of low expression of the N45 peptide we generated stable
cell lines expressing either FLAG-mCherry or FLAG-N45mCherry, where the first 45 amino
acids of IntS12 was fused to the N-terminus of mCherry. To confirm that fusion to mCherry did
not generate any unintended effects, we transfected FLAG-mCherry, FLAG-N45mCherry, or
full-length FLAG-IntS12* into cells pretreated with IntS12 dsRNA#2. Western blot analysis
determined that both FLAG-mCherry and FLAG-N45mCherry were expressed at comparable
levels, however, only the FLAG-N45mCherry was capable of rescuing the snRNA processing
defects associated with depletion of endogenous IntS12 (Figure 4.7C, lane 2 vs. 3). FLAGtagged proteins from cell lines stably expressing these constructs were then
immunoprecipitated utilizing anti-FLAG agarose and probed for their ability to pull-down
endogenous IntS1 and IntS9. We found robust levels of both these subunits interacting with
the FLAG-N45mCherry relative to FLAG-mCherry control (Figure 4.7D, lane 2 vs. 4). We also
noticed that the FLAG-N45mCherry was not as efficient as FLAG-tagged full-length IntS12 in
interacting with either the IntS1 or IntS9 subunit suggesting that residues beyond the first 45
amino acids are likely to contribute to the interactions between IntS12 and other members of
the complex as well. Nevertheless, the N-terminal 45 amino acid IntS12 microdomain is
sufficient for binding to IntS1 and IntS9 and to restore snRNA 3’ end cleavage, either as a
peptide (FLAG-N45) or in the context of a heterologous protein (FLAG-N45mCherry).
IntS1 Binding to the IntS12 Microdomain is Essential for Maintaining IntS1 levels.
As co-depletion is commonly observed between interacting proteins and has been found to
occur between several members of the histone pre-mRNA processing complex, including
Symplekin and CPSF73 (Sullivan et al. 2009), we next asked whether expression of
endogenous IntS12 is dependent on any other Integrator subunit. To do that, S2 cells were
treated in duplicate with non-overlapping dsRNAs for each of the Integrator genes for which
we had antibodies (IntS1, IntS9, IntS11, IntS12), or with a control dsRNA (LacZ). Depletion of
Integrator subunits was equally effective with either dsRNAs relative to control dsRNA treated
cells (Figure 4.8A). In addition, both dsRNAs targeting IntS12 were as effective in depleting
IntS1 protein level as were dsRNAs directly targeted IntS1,
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Figure 4.7 Mutations in the IntS12 Microdomain causing loss of function disrupt IntS12
interaction with endogenous Integrator subunits. (A) Quantitative real-time PCR
measuring levels of misprocessed endogenous U2 or U5 snRNA in cells treated with dsRNA
targeting IntS12. Control represents S2 cells expressing FLAG only while the cell lines treated
with IntS12 dsRNA that are also stably expressing FLAG-tagged IntS12 proteins are labeled
on the x-axis. All results are plotted as fold increase relative to LacZ dsRNA treatment and
normalized to RpS17 mRNA levels. (B) Western blot analysis of immunoprecipitations using
anti-FLAG agarose from nuclear extracts prepared from cell lines stably expressing FLAGtagged IntS12* proteins. (C) Western blot analysis of cell lysates from S2 cells treated with
either control dsRNA or IntS12 dsRNA#2 followed by cotransfection with U4-GFP and FLAGmCherry plasmids with or without the N-terminal 45 amino acids of IntS12. (D) Western blot
analysis of immunoprecipitations using anti-FLAG agarose from nuclear extracts purified from
cell lines stably expressing FLAG-tagged IntS12* proteins and FLAG-mCherry proteins with
and without the IntS12 Microdomain (N45). The upper panels are probed for endogenous
IntS1/9 and the bottom panel is probed with anti-FLAG antibody to confirm pull down.
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and reciprocally, dsRNAs targeting IntS1 were capable of co-depleting IntS12. In contrast,
IntS9 and IntS11 levels were unaffected by depletion of IntS1 or IntS12 and targeting either
IntS9 or IntS11 did not impact on the levels of IntS1 or IntS12. We repeated these experiments
in the cell lines stably expressing RNAi-resistant full-length IntS12*, Mt3-containing or Mt5containing full-length IntS12*, or the FLAG-N45mCherry proteins. We observed that
expression of the resistant full-length IntS12* blocked the codepletion of IntS1 in response to
treatment of cells with IntS12#2 dsRNA whereas neither Mt3- or Mt5-containing constructs
were effective in maintaining IntS1 stability (Figure 4.8B, lane 2 vs lanes 6, 7). Consistent with
the microdomain binding studies (Figure 4.7), stable expression of the first 45 amino acids of
IntS12 was sufficient to stabilize IntS1 in cells when endogenous IntS12 had been depleted.
Collectively, these data demonstrate that there is an interdependency of protein stability
between IntS1 and IntS12 mediated by the IntS12 N-terminal microdomain and that amino
acid substitutions in this microdomain that disrupt IntS12 activity and its association with
endogenous Integrator subunits are also required to maintain endogenous IntS1 protein
stability.
Finally, to examine the role of direct protein-protein interactions in Integrator complex
composition and stability we utilized a directed yeast two-hybrid assay, since Saccharomyces
cerevisiae does not encode any orthologous Integrator proteins. We expressed full-length
Drosophila IntS12 fused to the Gal4 transcriptional activation domain (AD-IntS12) and all other
members of the fly Integrator complex as individual fusions to the Gal4 DNA binding domain
(BD-IntS1 through -IntS12). When individual BD fusions were coexpressed in cells along with
AD-IntS12, only those expressing IntS1 and IntS10 supported growth on nutritional selection
plates lacking histidine (Figure 4.9A). However, in this system we were unable to conclusively
determine the existence of an IntS10/12 association, as expression of the BD-IntS10 alone
supported growth on media lacking histidine. To determine if the yeast two-hybrid interaction
between IntS1 and IntS12 was sensitive to mutations within the N-terminal microdomain of
IntS12, we expressed AD-fusions of full-length, ΔN, N45, Mt3- or Mt5-containing full length
IntS12 in the presence of BD-Ints1. We observed a total absence of growth on selective
media lacking histidine for all IntS12 protein fusions that lacked or contained inactivating
mutations within the N-terminus previously identified as unable to complement the effects of
endogenous IntS12 knockdown (Figure 4.9B). Importantly, Western blotting confirmed loss of
growth was indicative of loss of interaction rather than loss of expression (Figure 4.9C).
Lastly, we examined the binding of Gal4 fused to the N-terminal 45 amino acids of IntS12 and
found that this small peptide, when fused to Gal4 was nearly as capable as the full-length
protein in supporting growth on selective media. These results demonstrate that the IntS12
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Figure 4.8 Expression of Drosophila IntS1 and IntS12 is interdependent and stability of
IntS1 requires an intact IntS12 Microdomain. (A) Western blot analysis of endogenous
Integrator subunit expression from S2 cells treated with various dsRNA targeting IntSs. (B)
Western blot analysis of endogenous IntS1 expression in S2 cells stably expressing FLAGtagged IntS12* proteins containing mutations within the IntS12 microdomain.
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Figure 4.9 The IntS12 microdomain is required and sufficient to mediate interaction with
IntS1 in the absence of other Integrator subunits. (A) S. cerevisiae (AH109) were
cotransformed with plasmids encoding hybrid proteins containing IntS12 fused to the Gal4
activation domain (AD-IntS12) and each of the other Integrator subunits fused to the Gal4
DNA binding domain (BD-IntSs). A dilution series of overnight cultures was spotted on either
SD/-Leu/-Trp plates or the same media without histidine to test interaction. All BD constructs
were tested for auto-activation. (B) Similar to panel A, except AH109 yeast were transformed
with full-length IntS12 containing mutations 3, 5, or a deletion of the 45 N-terminal amino acids
(DN), or the first 45 amino acids of IntS12 (N45). (C) Western Blot analysis confirming the
expression of HA-tagged IntS12 constructs in yeast strain AH109.
(The work for yeast-two-hybrid assay shown here is collaborating with Dr. Bill Warren’s group
at James Cook University Australia, and I performed Western blot analysis to determine the
expression of HA-tagged IntS12 constructs in yeast AH109.)

!

79

microdomain binds to IntS1 in the absence of other Integrators and that the first 45 amino
acids are sufficient to support a stable and autonomous interaction with IntS1.
DISCUSSION
Here we present a detailed functional analysis of the Drosophila IntS12 protein through
characterizing its role in snRNA 3’ end formation. Unexpectedly, our investigations determined
that the highly conserved PHD finger is dispensable for IntS12 to promote nascent snRNA
processing (Figure 4.4). Rather, we identified a small highly conserved ~30 amino acid
microdomain near the N-terminus that is both necessary and sufficient for the restoration of
Integrator function in IntS12 depleted cells (Figures 4.4-4.6). Residues within the IntS12
microdomain are also required for interaction with other endogenous Integrator complex
subunits, and when mutated disrupt their stable interaction (Figures 4.7-4.9). These data
establish a critical role for IntS12 in regulating the activity of the Integrator complex, mediated
through binding to and stabilization of IntS1, the largest Integrator subunit. Additionally, our
approach using dual snRNA GFP reporters in combination with functional rescue through
expression of RNAi-resistant cDNAs represents a powerful tool going forward to elucidate
function of the other Integrator subunits.
Functions of IntS12 microdomain.
Our results demonstrate a strong correlation between IntS12 microdomain binding to IntS1
and its ability to promote snRNA 3’ end formation. This argues that this small interaction motif
is critical for Integrator complex function. Moreover, results shown in Figures 4.7A and 4.7C
reveal that the microdomain is nearly as effective as full-length IntS12 in restoring the
processing of the reporter and endogenous snRNAs, thereby excluding a simple localization
sequence function. However, as the FLAG-N45mCherry protein was not as effective at pulling
down endogenous Integrator subunits as the full-length protein, other residues of IntS12 may
play a minor role in achieving maximal stability of the IntS1/IntS12 complex (Figure 4.7D).
PSIPRED secondary structure prediction posits the IntS12 microdomain may form a helixcoil-helix structure (Jones 1999; McGuffin et al. 2000; Buchan et al. 2010) similar to the
hepatocyte nuclear factor 1-alpha dimerization domain and the dimerization domain required
for the heterodimeric association of the SinR-SinI anti-repressor complex (Johnen and
Kaufman 1997; Colledge et al. 2011). In both of these cases, small helix-coil-helix domains
act as crucial protein-protein interaction motifs that elicit dimerization. Based upon these
examples, we propose that the microdomain of IntS12 binds to an as-yet unidentified
complementary domain within IntS1. This IntS1/IntS12 interaction is not only essential for
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IntS1 function but also is required for the stability of both IntS1 and IntS12 (Figure 4.8). In this
respect, the IntS12 microdomain is behaving similar to the RNAse E microdomain that
interacts with the glycolytic enzyme Enolase (Py et al. 1996; Chandran and Luisi 2006;
Nurmohamed et al. 2010). RNAse E is the essential component of the Escherichia coli RNA
degradosome and contains a N-terminal catalytic domain as well as a long C-terminal
scaffolding domain (reviewed in (Carpousis 2007)). The scaffold domain binds to the RhlB
helicase, the phosphorolytic exoribonuclease polynucleotide phosphorylase, and Enolase.
The RNAse E microdomain resides within the scaffolding section and consists of a ~28 amino
acid conserved region that binds to a dimeric interface between two Enolase proteins to
promote the decay of specific mRNAs in E. coli (Bernstein et al. 2002; Bernstein et al. 2004;
Chandran and Luisi 2006; Nurmohamed et al. 2010). Given the large size of IntS1, it may
simultaneously interact with multiple other members of the Integrator complex in an analogous
way to the scaffolding domain of RNAse E. Our data support a model where binding of IntS12
to IntS1 alters IntS1 confirmation allows further interaction(s) with other proteins and activation
of the complex.
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Chapter 5. Biochemical Analysis Identifies IntS12 as a Phosphoprotein and
its Conserved PHD Finger Plays Roles in Histone H3 Interaction in vitro
and Integrator Subunits Interaction in vivo
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INTRODUCTION
The serendipitous biochemical purification of the twelve-member Integrator complex and
the establishment of its role in snRNA 3’ end processing has expanded the existing repertoire
of the 3’ end processing machinery for RNAPII transcripts (Baillat et al. 2005). The
polyadenylated mRNA and poly(A)- histone mRNA use the same endonuclease CPSF73 for
their 3’ end endonucleolytic cleavage (Reviewed in (Dominski 2007; Dominski 2010)). Unlike
these two classes of RNAPII transcripts, a distinct endonuclease called IntS11 catalyzes the 3’
end processing of snRNA. IntS11 is homologous to CPSF73, and both proteins belong to the
metallo-β-lactamase superfamily with a signature β-lactamase/ β-CASP domain (Weiner 2005)
(See Figure 1.5 for a schematic representation of protein domain). In the Integrator complex,
another Integrator subunit, IntS9, also has the MBL/β-CASP domain but with alterations in
critical residues rendering it catalytically inactive. IntS9 shows significant homology with the
mRNA 3’ -end processing factor CPSF100. Recent work from our lab shows that IntS9 and
IntS11 form a heterodimer through a unique C-terminal domain and that the interaction
between these two subunits is required for the cleavage activity of the Integrator complex
(Albrecht and Wagner 2012). Besides these two subunits, no significant homology has been
identified between subunits of the complex and other known proteins, making it difficult to
predict their roles in snRNA 3’ end processing.
Most of Integrator subunits are conserved in metazoans and plants but absent in
Saccharomyces cerevisiae (Baillat et al. 2005), which is consistent with the observation that
yeast use a distinct Nrd1/Nab3/Sen1 complex to carry out the 3’ end processing of snRNAs. A
careful protein domain analysis of the remaining ten Integrator subunits reveals the presence
of HEAT repeats in IntS4, ARM repeats in IntS4 and IntS7, a von Willebrand factor type A
(VWA) domain in IntS6 and a plant homeodomain (PHD) finger in IntS12. The HEAT and ARM
repeats are from a common phylogenetic origin and both mediate protein-protein interactions
(Andrade et al. 2001). The VWA domain is found in both intracellular and extracellular proteins
and in both cases likely functions in protein-protein interactions (Whittaker and Hynes 2002).
The PHD finger domain is a reader domain of chromatin modifications (Bienz 2006;
Musselman and Kutateladze 2011), and the IntS12 PHD finger is the second most conserved
domain after the MBL/β-CASP domain of IntS9/11.
Drosophila IntS12 is a 328-amino acid protein, consisting of a well-conserved central PHD
finger, a conserved N-terminal motif and a less conserved C-terminal serine-rich region (See
Figure 4.3). The PHD finger is a well-defined signature chromatin-associated motif that uses
the Cys4–His–Cys3 motif to coordinate two zinc ions to form an intertwined topology (Sanchez
and Zhou 2011). At the secondary structure level, it consists of a two-strand anti-parallel β-
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sheet and a C terminal α-helix (present in many PHDs). PHD fingers are commonly found in
proteins that either possess catalytic activities or act as scaffolding proteins bridging
multisubunit enzymatic complexes to specific genomic loci (Musselman and Kutateladze 2011;
Sanchez and Zhou 2011). The biological outcome of an interaction for a particular PHD finger
is usually determined by the function of the complex in which the PHD finger resides. It is
widely accepted that PHD fingers are epigenetic effectors that recognize unique histone
modifications present in the histone N -terminal tail, preferably the tail of histone H3 (Reviewed
in (Musselman and Kutateladze 2011)). Recently, PHD fingers are also implicated in
recognition of non-histone proteins where PHD finger acts as a protein-protein interaction motif
to bind cofactors and further facilitate histone recognition (Hom et al. 2010; Miller et al. 2010).
The Drosophila IntS12 PHD finger contains ~55 amino acids and is phylogenetically
conserved cross metazoan species. Its mouse homologue has been experimentally
determined to adopt a typical PHD topology in solution (Figure 5.1A). Moreover, sequence
alignment of IntS12 PHD finger to other known PHD fingers indicates that it is most closely
related to a subgroup of PHD fingers that recognize unmodified histone H3 tail (Figure
5.2A/B). Based on these evidence and the complex context that IntS12 PHD finger resides in,
it is possible that IntS12 acts as an adaptor to bring the Integrator complex to snRNA genomic
loci by recognition of unique chromatin modifications through its conserved PHD finger
domain. Alternatively, given the emerging evidence that some PHD fingers have the ability to
bind protein co-factors, it is also possible that IntS12 PHD finger works as a protein interacting
motif to mediate Integrator complex assembly.
In this study, to test these possibilities mentioned above, we characterized several
biochemical properties of IntS12 PHD finger and investigated their functional involvement in
snRNA 3’ end processing. We also mapped a residue threonine 76 important for IntS12
phosphorylation, and investigated the biochemical and cellular roles of this phosphorylation in
Integrator interaction and snRNA 3’ end processing. Our data reveal that IntS12 PHD is able
to bind histone H3 in vitro and enhance association with other Integrator subunits in vivo.
However, functional analysis indicated that association with histone H3 or enhanced
interaction with other Integrator subunits through the PHD finger is not essential for reporter
snRNA 3’ end processing. We also demonstrate that IntS12 phosphorylation through T76 is
functionally not required for snRNA 3’ end processing but may play a negative role in
mediating protein-protein interaction between IntS12 and the other Integrator subunits.
Collectively, these data characterized several features of IntS12 protein and demonstrate their
function in Integrator protein interaction. We envision that a yet-to-be identified
cellular/biological function for the Integrator complex besides snRNA biosynthesis may involve
in the biochemical properties of IntS12 that we described here.
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RESULTS
The PHD finger of Integrator subunit 12 binds histone H3 in vitro
Recent studies show that PHD fingers have a general preference toward recognizing
unmodified or modified N-terminal tail of histone H3 thereby involving them in fundamental
cellular processes such as transcriptional regulation, nucleosome remodeling, and DNA
recombination (Reviewed in (Musselman and Kutateladze 2011; Sanchez and Zhou 2011)).
IntS12 has a central PHD finger that is conserved across different metazoan species (Figure
5.1A, left panel). The Nuclear Magnetic Resonance (NMR) structure of the mouse IntS12 PHD
finger (PDB id: 1wev) shows that this PHD finger adopts a typical PHD zinc finger structure
consisting of an antiparallel beta-sheet and a α-helix in the C-terminus (Figure 5.1A, right
panel). To determine whether the conserved IntS12 PHD finger is able to recognize specific
histones, an in vitro glutathione S-transferase (GST) pull-down assay was performed by
incubation of recombinant GST-tagged human IntS12 PHD finger, Drosophila IntS12 full
length protein, or Drosophila IntS12 PHD finger with a purified mixture of histones
(Worthington, NJ). Bound histones were co-precipitated with GST-tagged proteins by the
glutathione agarose beads, and detected by Western blot analysis using histone antibodies.
Both fly and human IntS12 PHD fingers as well as the full-length fly IntS12 protein were found
to specifically bind histones even in the presence of 500mM NaCl in the incubation buffer
(Figure 5.1B, left panel). Further analysis of the co-precipitates using individual histone
antibodies revealed that histone H3 is specifically co-precipitated with IntS12 PHD finger
(Figure 5.1B, right panel).
To further confirm the binding specificity of IntS12 PHD finger toward histone H3, ten
IntS12 PHD finger point mutants were generated and used for the GST pull-down assay.
These mutants were constructed by substituting highly conserved residues in IntS12 PHD
fingers (Figure 5.1A, left panel) to alanine using site-directed mutagenesis. Two of these
IntS12 PHD mutations (L145 and E147) were found to significantly reduce the levels of coprecipitated histone H3 (Figure 5.1C), indicating their important roles in histone H3 interaction.
Both residues were found to reside in the first β-strand of IntS12 PHD finger, which has been
shown to play essential roles in recognition of histone H3 tails (Pena et al. 2006; Shi et al.
2006). These results are highly similar to two previously well-characterized cases of
recognition of tri-methyl Lysine 4 of histone H3 by the Inhibitor of Growth protein 2 (ING2) PHD
finger and recognition of unmodified lysine 4 of histone H3 by the autoimmune regulator
(AIRE) PHD finger (Pena et al. 2006; Org et al. 2008). In these instances, the first β-strand of
PHD finger pairs with another β-strand from the histone H3 tail to form an antiparallel β-sheet
to facilitate histone H3 tail binding (Figure 5.1D). Superimposition of the mIntS12 PHD finger
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Figure 5.1 The plant homeodomain (PHD) finger of Integrator subunit 12 binds histone
H3 in vitro.
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Figure 5.1 The plant homeodomain (PHD) finger of Integrator subunit 12 binds histone
H3 in vitro.
(A)(left). Amino acid sequence alignment of IntS12 PHD finger across several different
metazoan species. Green highlighted residues represent similar amino acids and yellow
highlights represent identical residues. Blue stars on the bottom highlight the eight residues
coordinating zinc atoms, and the dashed lines and solid arrows indicate residues forming the
loops and β-strands secondary structures. (A)(right). NMR structure of the mouse IntS12 PHD
finger. Two zinc atoms are shown as balls, and zinc chelating cysteines and histidine are
highlighted in yellow with side chain shown. (B)(left). GST pull-down assay was carried out
using recombinant fly or human IntS12 PHD co-incubating with purified histone mixture.
Glutathione beads bound GST-tagged proteins were visualized by Coomassie staining, and
histones were detected by western blot analysis using a mixture of histone antibodies. (right).
Co-precipitated histone proteins were detected by western blot using individual histone
antibodies. (C). GST pull-down assay was performed using recombinant IntS12 PHD finger
point mutants. Co-precipitated histone H3 were shown as two different exposures. (D). 3Dstructures of ING2 PHD finger recognition of H3K4me3 or AIRE PHD finger recognition of
H3K4 (left, middle), Pymol 3D-superimposition of AIRE PHD finger with mIntS12 PHD finger
(right).

!

87

on mING2 PHD finger or human AIRE PHD finger by using the molecular graphics tool PyMOL
demonstrates that IntS12 PHD finger adopts a very similar tertiary structure to the PHD fingers
tested with minor difference where mIntS12 PHD finger contains a significantly longer loop2
region (Figure 5.1D). Collectively, all data indicate that the IntS12 PHD finger is structurally
similar to those for histone H3 recognition, and is able to bind histone H3 in vitro.
IntS12 PHD finger does not recognize canonical histone modifications
To further determine the specificity of IntS12 PHD finger toward unique histone
modifications, the amino acid sequence of IntS12 PHD finger was first aligned to various
subgroups of known PHD fingers using the homology-extended alignment and a predicted
secondary structure algorithm. IntS12 PHD finger is most homologous and structurally similar
to PHD fingers (AIRE-PHD1, CHD4-PHD2, TRIM24) that bind to unmodified histone H3 lysine
4 (H3K4me0) rather than those (DPF3-PHD1) that bind acetylated histone H3 lysine
(H3K14ac) or those that bind (Pygo1, MLL1-PHD3, BPTF, ING2) tri-methylated histone H3
lysine 4 (H3K4me3) as shown by both sequence alignment (Figure 5.2A) and tree
representation (Figure 5.2B). However, a distinct characteristic of IntS12 PHD finger compared
to the H3K4me0-recognition PHD fingers is the presence of two much longer loop regions, a
feature that is also observed in two PHD fingers (Pygo1, MLL1-PHD3) capable of binding nonhistone proteins (Figure 5.2A). Overall, in silico data analysis indicates that IntS12 PHD finger
is likely to recognize either an unmodified histone H3K4me0 marker or bind to a non-histone
protein.
To experimentally determine the potential unique histone modification recognized by the
IntS12 PHD finger, a biotinylated histone peptide pull-down assay was performed. In brief,
GST-tagged IntS12 PHD finger recombinant proteins were incubated with an array of biotinlabeled, 21-23 amino acid-long peptide corresponding to different regions of the N-terminal
histone tails with each containing a unique lysine methylation (H3, 1-21; H3, 22-44; H3, 66-88;
H4, 1-25; H3K4, K9, K27, K36, K79 and H4K20 mono-, di- or tri- methylated peptide). Bound
IntS12 PHD finger proteins were co-precipitated with biotin-labeled histone peptides by using
streptavidin agarose beads, and were detected by Western blot analysis using anti-GST
antibodies. The PHD finger of lysine demethylase PHF2 was used as a positive control in this
study, which recognizes di- and tri-methylated histone H3K4. As a proof-of-principle, PHF2
PHD finger was shown to specifically bind di-methylated H3K4 under both salt conditions
tested in our biotinylated pull-down assay (Figure 5.2C, top panel). We followed this with
systematic biotinylated pull-down analysis, however, this revealed that neither the human nor
Drosophila IntS12 PHD finger was able to be co-precipitated with any of the biotin-labeled
histone peptide used for this study (Figure 5.2C, bottom panel), suggesting that either IntS12
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Figure 5.2 IntS12 PHD finger does not recognize canonical histone H3 modifications.
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Figure 5.2 IntS12 PHD finger does not recognize canonical histone H3 modifications.
(A). Representation of conserved amino acids from structure-based alignments of PHD finger
sequences using PRALINE. The absolutely conserved Zinc-coordinating residues are shown
in red, and the two core β-strands are shown in gray. Residues are colored according to
sequence conservation. The residue numbers corresponding to the PHD finger in the fulllength protein are shown in parentheses on the right. (B). Tree representation of structurebased alignments of representative PHD finger sequences using PRALINE. The score
indicates the similarity between two close PHD fingers (the higher, the more similar), and the
distance from the branch (+) to the right side indicates similarity as well. Two PHD fingers in
the same branch indicate a similar structure, and the closer the branch on the right, the more
similarity present in the two groups of PHD fingers within the same branch. (C). Biotinylated
histone peptides were unable to pulldown GST-tagged recombinant IntS12 PHD finger. Biotinlabeled histone peptides each containing a single unique modification were incubated with
recombinant IntS12 PHD finger or PHF2 PHD finger (positive control), and were precipitated
by streptavidin agarose beads. Co-precipitated recombinant PHD fingers were detected by
western blot analysis using anti-GST antibodies. PHF2 input and pulldown are separated on
two blots.
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PHD finger recognizes a histone modification marker that is not tested here or it may require
other co-factors for histone recognition similar to the property observed in Pygo1 and MLL1.
IntS12 is a phosphoprotein and Threonine 76 residue is responsible for IntS12
phosphorylated.
IntS12 migrates as a doublet in SDS-PAGE gel detected by Western blot analysis,
suggesting that this protein may be phosphorylated (Figure 5.3A, left panel). To formally test
that hypothesis, phosphatase treatment and site-directed mutagenesis analysis of IntS12 were
performed. Briefly, cell lysates from untransfected S2 cells or cells transfected with Myctagged IntS12 were treated with alkaline phosphatase (AP) or lambda protein phosphatase
(λPP), and the migration shift of IntS12 proteins was detected by Western blot analysis using
anti-IntS12 or anti-myc antibodies. Both endogenous and myc-tagged exogenous IntS12 were
found to migrate faster (lower band) after phosphatase treatment (Figure 5.3A, Middle and
right panels), indicating that IntS12 is a phosphoprotein. To narrow down the phosphorylated
region, six myc-tagged IntS12 deletion mutants (N, NP, C, ΔP, PC, P) were generated and
tested for migration profile after phosphatase treatment. IntS12 N-terminal containing deletion
mutants (N, NP, ΔP) were found to both migrate as doublets and faster after phosphatase
treatment (Figure 5.3B, lane 2, 4), indicating that the phosphorylation is present in the Nterminus. To further map the position of the phosphorylated residue, potential phosphorylation
sites within IntS12 N-terminus were predicted using the Kinase-specific Phosphorylation Sites
Prediction Tool GPS 2.0 (Xue et al. 2008). Eight potential phosphorylation sites (S2829, S33,
T56, T60, T76, T91, S93) were predicted, and substituting of these sites with alanine did not
affect myc-tagged IntS12 N-terminus migration with the exception of the Threonine 76 (Figure
5.3 C). The T76A mutation lost its doublet migration pattern and instead ran as a clear single
faster migration (Figure 5.3C, let panel lane 5).The single band was completely inert to
phosphatase treatment (Figure 5.3C, right panel lane 5, 6), strongly indicating that the T76 is
an important residue responsible for IntS12 phosphorylation. A close examination of the amino
acid sequence context of the phosphorylation shows the presence of a consensus cyclinbinding motif (RXL) and a distinct threonine-proline (TP) phosphorylation motif for mitogenactivated protein kinase (MAPK) or CDK, suggesting that it is a potential substrate either of
these two protein kinases. Our previous genome-wide RNAi screen identified CycC/Cdk8 as
an important factor required for snRNA 3’ end formation. It is possible that Cdk8 is involved in
snRNA 3’ end formation through post-translational modification of IntS12 activity. However,
mutation of the potential consensus cyclin-binding motif or depletion of CycC or Cdk8 protein
in cells did not affect IntS12 phosphorylation pattern (data not shown), suggesting other Cdk
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Figure 5.3 IntS12 is a phosphoprotein and the residue threonine 76 is important for
IntS12 phosphorylation.
(A)(left). IntS12 is observed to migrate as doublets by Western blot detection. (Middle, right).
Alkaline phosphatase or lambda protein phosphatase treatment of IntS12 resulted in a
downshift for both endogenous and myc-tagged exogenous IntS12 as detected by Western
blot. (B)(left top). Schematic representation of IntS12 deletion constructs for mapping
phosphorylation region. (Left bottom, right top). Myc-tagged IntS12 deletion mutants
expressed in S2 cells were detected by Western blot before and after alkaline phosphatase
treatment. The star labeled band represents cross-reactant from the alkaline phosphatase to
the anti-myc antibodies. (C)(top). Representation of potential phosphorylation sites in IntS12
N-terminus predicted by GPS 2.0. (bottom). Western blot analysis of cell lysates from cells
transfected with potential phosphorylation site point mutants before and after alkaline
phosphatase treatment.
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kinases may be responsible for IntS12 phosphorylation. Taken together, the data presented
here show the threonine 76 is responsible for Drosophila IntS12 phosphorylation in cells.
IntS12 PHD finger enhances interaction between IntS12 microdomain and other
Integrator subunits.
We described in last chapter that the 45 amino acid IntS12 microdomain is fully functional
for reporter snRNA 3’ end formation, however, the interactions between IntS12 microdomain
and IntS1, IntS9 were not as strong as that observed for full-length Integrator IntS12. This
prompted us to test whether other parts of IntS12, especially the conserved PHD finger, is
involved in biochemical association between IntS12 and other Integrator subunits. To test that
possibility, S2 stable cell lines expressing FLAG-tagged mCherry (Ch, negative control), fulllength IntS12 (IntS12), C-terminal fused mCherry of IntS12 N-terminal 1-130 a.a. (12NCh), Cterminal fused mCherry of IntS12 NP 1-185 a.a. (12NPCh) and N-terminal fused mCherry of
IntS12 C-terminus 185-328 a.a. (Ch12C) were generated (Figure 5.4A). Then, anti-FLAG
immunoprecipitation assays using nuclear extracts prepared from these stable cells were
conducted. Consistent with previous pull-down results (Figure 4.7B/D), significant amount of
endogenous IntS1 and IntS9 were found to be co-precipitated with full-length IntS12 (Figure
5.4B, lane 4 v.s. lane 2). We surprisingly found that the IntS12 C-terminal truncation mutant
(12NPCh) was able to pulldown the endogenous IntS1 and IntS9 at the levels equivalent to
full-length IntS12 (Figure 5.4B, lane 10 v.s. lane 4), and significantly better than N-terminus
only (12NCh) or C-terminus only (Ch12C) (Figure 5.4B, lane 10 v.s. lane 6,14). These results
suggest that IntS12 PHD finger plays an important role in biochemical interaction between
IntS12 and other Integrator subunits, though it was found dispensable for snRNA 3’ end
formation in our snRNA-GFP reporter assay.
Since we characterized an important residue T76 for the IntS12 phosphorylation and
specific interaction of IntS12 and histone H3 in vitro, here we wanted to biochemically test the
involvement of these features of IntS12 with other Integrators. To accomplish this, two S2
stable cell lines expressing FLAG-tagged C-terminal fused mCherry of IntS12 N-terminal
phosphorylation mutant 1-130 a.a. (12NT76ACh) and a C-terminal fused mCherry of IntS12
NP histone binding-deficient mutant 1-185 a.a. (12NPLACh) were generated, and were tested
for interactions by anti-FLAG immunoprecipitation assays. I found that the N-terminal
phospho-mutant (12NT76ACh) was able to significantly increase the co-precipitated
endogenous IntS1 and IntS9 to the levels similar to full-length IntS12 compared to the deletion
mutant containing IntS12 N-terminus (Figure 5.4B, lane 8 v.s. lane 4, 6), suggesting that the
T76-mediated phosphorylation is likely to negatively regulate IntS12 association with other
Integrators. In contrast, the L145 mutation in the IntS12 C-terminal deletion mutant
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Figure 5.4 IntS12 PHD finger enhances association between IntS12 microdomian and
other Integrator subunits.
(A). Schematic representation of IntS12 mCherry fusion constructs for study of IntS12
domains important for Integrator interaction. The star within two of the constructs represents a
point mutation being introduced. (B). Western blot analysis of immunoprecipitates using antiFLAG agarose from nuclear extracts purified from cell lines stably expressing FLAG-tagged
mCherry-fused IntS12* proteins. The upper panels are probed for endogenous IntS1/9 and
the bottom panel is probed with anti-FLAG antibody to confirm pull down. Two different
exposures were presented.
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(12NPLACh) was found to significantly reduce the pull-down levels of IntS1 and IntS9
compared to that observed for IntS12 C-terminal deletion mutant (12NPCh) (Figure 5.4B, lane
12 v.s. lane 10), indicating that the L145 residue, which has been determined to be important
for in vitro histone H3 binding, is important for in vivo Integrator interaction as well. Taken
together, these data presented here suggest that besides interacting with histone H3 in vitro,
the IntS12 PHD finger is also likely to play an important role in enhancing interaction between
IntS12 microdomain and other Integrators in vivo and that this interaction might be modulated
by the T76-related phosphorylation.
IntS12 PHD finger and T76-related phosphorylation are not required for reporter snRNA
3’ end processing.
To further test the functional requirement of the IntS12 T76-related phosphorylation and
histone or Integrator interaction mediated through the PHD finger in snRNA 3’ end formation, a
functional RNAi rescue assay was performed as described previously (See Chapter 2 RNAirescue/snRNAGFP reporter for details). S2 cells were treated with either control dsRNA
(LacZ) or IntS12 dsRNA and co-transfected with U4-GFP reporter (See Chapter 2 Materials
and Methods section for details) and IntS12 constructs described in the pulldown assay. Cells
were imaged and subsequently lysed for Western blot analysis for GFP expression. In IntS12
depleted cells, the mCherry vector (mChe) and mCherry fused IntS12 C-terminus only
(mChe12C) completely failed to restore proper 3’ end processing of U4-GFP reporter as
significant GFP fluorescence was observed (Figure 5.5A/B). For the remaining constructs, we
observed reduced GFP fluorescence to background level in IntS12 depleted cells (Figure
5.5A/B), indicating that all of these constructs were fully functional in restoring proper reporter
snRNA 3’ end processing. The phosphorylation mutant (12NT76AmChe) and the histone H3
binding mutants (12NP(EA)mChe, 12NP(LA)mChe) fully restored reporter snRNA 3’ end
formation, implying that IntS12 T76-mediated phosphorylation and binding to histone H3 are
dispensable events for processing of the reporter snRNA 3’ end.
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Figure 5.5 IntS12 PHD finger and a phosphorylation are not required for reporter snRNA
3’ end processing.
(A). Representative fluorescence images of S2 cells treated with either control dsRNA (LacZ)
or IntS12 dsRNA#2 followed by cotransfection of the U4-GFP reporter with the FLAG-tagged
mCherry-fused IntS12* cDNAs. (B). Western blot analysis of cell lysates from panel A.
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Discussion
In this chapter we presented the biochemical characterization of IntS12 and investigated
the functional involvement of these features in snRNA 3’ end formation. The IntS12 PHD finger
was determined to bind histone H3 in vitro (Figure 5.1) and enhance Integrator protein
interaction in vivo (Figure 5.4). The former result is consistent with the prevailing findings that
PHD fingers have the ability to recognize a variety of histone modification markers
(Musselman and Kutateladze 2011; Sanchez and Zhou 2011). However, the latter result
indicates that IntS12 PHD may also contribute to protein-protein interactions, which is
supported by two recently reported findings demonstrating that the PHD finger from Pygo1/2
or MLL1 is able to recognize non-histone proteins (Hom et al. 2010; Miller et al. 2010). Our
data presented here support both non-exclusive models for IntS12 PHD action: act as a
histone reader to bring the Integrator complex to specific genomic loci or to work as a proteinprotein interacting domain for Integrator complex assembly. Further experiments need to be
conducted to better understand these potential working mechanisms. We also determined that
T76 is responsible for IntS12 phosphorylation, and our data suggest the phosphorylation is
likely a negative regulator for Integrator protein interaction. Nevertheless, snRNA-GFP reporter
combined with RNAi-rescue assay indicates that all of these biochemical features of IntS12
protein are dispensable for snRNA 3’ end processing, making the roles of these characterized
features unknown. It is very likely that these features we identified here contribute to a yet-tobe characterized cellular process.
Why has evolution selected for the central IntS12 PHD finger?
The central PHD finger region of IntS12 is one of the few domains found among the
Integrator subunits whose function can be readily inferred from sequence conservation aside
from the conserved MBL/β-CASP domains of IntS9/11. Members of the PHD finger family of
proteins are involved in a diverse range of biological functions; yet typically bind to specific
histone H3 posttranslational modifications (reviewed in (Bienz 2006; Musselman and
Kutateladze 2011)). IntS12 PHD finger forming a canonical PHD finger topology is supported
by NMR structure analysis of the mouse IntS12 PHD finger (pdbid:1WEV; He F, Muto Y, Inoue
M, Kigawa T, Shirouzu M, Terada T, Yokoyama S, unpublished). Here we have also
experimentally confirmed that recombinant Drosophila and Human IntS12 PHD finger proteins
bind histone H3 in vitro. While nascent transcription from an snRNA promoter is essential for
Integrator function, a central role for chromatin in 3’ end formation has not been established
(de Vegvar et al. 1986; Hernandez and Weiner 1986; Cazalla et al. 2011; Ezzeddine et al.
2011). Although the presence of a stable nucleosome located between the DSE and PSE in
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human cells has been reported by several groups (Stunkel et al. 1997; Boyd et al. 2000; Zhao
et al. 2001; Pavelitz et al. 2008), the preponderance of evidence argues for a general
deficiency of histones within snRNA genes, with the snRNA promoter establishing a perpetual
“open” transcription state (Pavelitz et al. 2008; Egloff et al. 2009). In Drosophila, the lack of a
DSE (Hernandez 2001) and our own observations that the Proximal Sequence Element A
(PSEA) from the snRNA gene promoter alone is sufficient to impart Integrator sensitivity to our
actin 5C promoter driven reporters (JC, EJW, unpublished), suggests there is not likely a
stable nucleosome present at fly snRNA promoters. These data together with our observations
that the PHD domain is dispensable for snRNA 3’ end processing argues against the IntS12
PHD finger coupling the Integrator complex to the snRNA promoter via histone binding.
We cannot exclude the possibility that, the IntS12 PHD finger is involved in recruiting the
Integrator complex to chromatin at non-snRNA genes, though there is presently no indication
that the Integrator complex functions elsewhere in the genome. Whether the endogenous
target of the IntS12 PHD finger is indeed histone H3 in vivo has also yet to be determined.
There are numerous examples of PHD fingers that associate with non-histone substrates
(Musselman and Kutateladze 2011) including the MLL1 methyltransferase PHD3 finger bound
to the RNA recognition motif (RRM) of nuclear cyclophilin Cyp33 (Fair et al. 2001). The IntS12
PHD finger may behave similarly and interact with a non-histone partner.
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OVERVIEW, SUMMARY AND FUTURE DIRECTIONS
As the functional snRNPs are well known for their role in removal of introns from premRNA, it is predictable that any event disturbing the snRNP biogenesis pathway is likely to
affect downstream mRNA maturation, which in turn may have a significant impact on the
biological outcomes. One such well-documented case is SMA, which is caused by reduced
expression of the SMN due to mutations in the gene (Burghes and Beattie 2009; Coady and
Lorson 2011; Workman et al. 2012). The SMN complex plays critical roles in snRNP
biogenesis in that it is responsible for loading the Sm core onto the snRNA Sm site and
facilitates subsequent snRNP nuclear import (Figure 1.3A). Though it is still unclear how
exactly a mutation in SMN causes motor neuron death, it has been well documented that
snRNP maturation and mRNA splicing are both significantly affected in SMA patients and
mouse models (Gabanella et al. 2007; Zhang et al. 2008). Currently, the most tantalizing
model for the cause of motor neuron dysfunction and death in SMA patients is that inadequate
expression of SMN protein leads to insufficient snRNP assembly, which in turn affects critical
pre-mRNA splicing events that are essential for motor neurons. The results from SMA
research vividly demonstrate the importance of the snRNP biogenesis pathway in human
health.
The biogenesis of RNAPII-transcribed snRNA encounters a sophisticated nuclear and
cytoplasmic life cycle where they begin as snRNA precursors through a transcription-coupled
3’ -end processing event. Therefore, the nuclear 3’ end cleavage of snRNAs is an integral part
for snRNP maturation, and this event is brought about by the poorly understood Integrator
complex (Baillat et al. 2005). Twelve different polypeptides were initially thought to be present
in the Integrator complex, which associates with the C-terminal domain of RNAPII largest
subunit Rpb1. Analogous to the SMN complex, the Integrator complex is also essential for
snRNP biogenesis, and disruption of the Integrator complex is expected to affect downstream
cellular processes and biological outcomes where a functional snRNP is required, such as the
pre-mRNA splicing. Indeed, analysis of the RNA-sequencing data from cells depleted of the
catalytic subunit of the Integrator complex (IntS11) revealed a global defect in pre-mRNA
splicing, manifested by prevalent exon skipping and intron retention (Wagner lab, unpublished
data). It was also reported in Zebrafish that disruption of Integrator subunit 5 leads to a specific
red blood cell differentiation defect that is caused by missplicing of genes essential for the
hematopoiesis signaling pathway (Tao et al. 2009). Moreover, studies from several different
groups also show a requirement for the Integrator complex in mouse and fly development,
where it is likely to function through regulation of the snRNP biogenesis (Rutkowski and
Warren 2009; Ezzeddine et al. 2011). While these data contribute to understanding of the
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significance of the Integrator Complex, the molecular details of the 3’ end processing of the
RNAPII transcribed snRNAs are far from understood.
The existing working model for transcription-coupled 3’ end processing of snRNA is
described in Figure 6.1. The key questions to be addressed are how the Integrator Complex is
recruited to snRNA genes and also how it recognizes nascent transcripts to cleave them at the
cleavage site. Studies of the other two RNAPII transcripts (polyadenylated mRNA and
nonpolyadenylated histone mRNA) have established the requirements of two different RNAbinding proteins/protein complexes through recognition of two conserved cis-regulatory
sequence elements present in each transcript. These binding events serve to recruit the
catalytic core to the cleavage site and position it for proper 3’ end processing (Figure 1.4).
Interestingly, two functionally important 3’ end elements, a conserved 3’ box element and a
less conserved 3’ stem loop element have been identified in snRNAs (Hernandez 1985;
Ezzeddine et al. 2011), however, the factors responsible for recognition of these elements are
not known yet. An added challenge to identify these factors is that no identifiable RNA-binding
domains are found in the known Integrator complex (Figure1.5). Moreover, analogous to 3’
end formation of polyadenylated mRNA, the snRNA 3’ end formation is a transcription-coupled
process. The RNAPII CTD serine 5 phosphatase Ssu72 has been reported to serve as an
adaptor to bridge the RNAPII CTD and the cleavage/polyadenylation factor Symplekin (Pta1 in
yeast), thus coupling the mRNA transcription and subsequent 3’ end cleavage and
polyadenylation (He et al. 2003). During the period of this work, another RNAPII CTD serine 5
phosphatase RNA Pol II-associated protein 2 (RPAP2) has been proposed to play an
analogous role of Ssu72 to bridge the RNAPII CTD to the Integrator complex by specific
recognition of the pSer7 marker on the RNAPII CTD. RPAP2 is then thought to be important
for the recruitment of Integrator complex to RNAPII CTD (Egloff et al. 2012). Confounding this
result, however, is the subsequent observation that the RPAP2 yeast homolog Rtr1, lacked a
phosphatase catalytic domain and was devoid of dephosphorylation activity toward RNAPII
CTD in vitro (Xiang et al. 2012). These results do not rule out a model where RPAP2 serves
as an adaptor between RNAPII CTD and the Integrator complex but reduce the possibility that
RPAP2 exhibits any catalytic activity. Finally, the identity of the Integrator subunit that would
behave analogously to the mammalian cleavage/polyadenylation factor Symplekin to couple
transcription and 3’ end formation is still not determined yet.
The studies described in this dissertation are aiming to probe these biologically important
questions. To address these questions, I first identified missing protein factors that are
functionally required for snRNA 3’ end processing through a functional RNAi screen in
Drosophila S2 cells in Chapter 3. This was followed by a detailed structural and functional
analysis of one Integrator subunit that has the potential to lay the foundation to address the
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Figure 6.1 Schematic model for transcription-coupled metazoan snRNA 3’ end processing through the Integrator complex.

(I) The process is initiated by recognition of the RNAPII CTD pSer7 marker by the RNA Pol II-associated protein 2 (RPAP2), which may

recruit the Integrator complex to the RNAPII at the snRNA gene promoter. The kinase responsible for Ser7 phosphorylation is not fully

characterized yet. (II) The phosphorylation of the Ser2 and dephosphorylation of the Ser5 kicks off the elongation process governing by the

newly formed elongation complex. (III) Once the RNAPII surpasses the 3’ box element, the Integrator proteins recognize the snRNA 3’ end

processing signals (3’ box and a potential 3’ stem-loop) and cleaves the nascent snRNA transcripts. (IV) The cleaved precursor snRNA is
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released and gets to the nuclear export pathway and the Integrator complex may also function in transcription termination.
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above-mentioned questions. Below, I reflect on the significance of these two efforts and
expand on what I believe to be their meaning and future implications.
Functional RNAi screen identifies protein factors required for snRNA 3’ end formation.
In Chapter 3, I described a genome-wide RNA interference (RNAi) screen in Drosophila S2
cells to identify important genes required for snRNA 3’ end formation by utilization of an
snRNA-GFP reporter. The U7-GFP is a sensor of the U7 snRNA 3’ end formation, and only
knockdown of a gene causing U7 snRNA 3’ end cleavage defect will result in expression of
GFP in cells. Using this reporter, the screen identified 21 genes that when depleted leads to
strong or moderate levels of GFP expression in cells. This screen determined that 10 out of
the 12 known Integrator proteins (not IntS3 or IntS10) are functionally required for snRNA 3’
end formation. Interestingly, 11 novel factors were identified in our screen as well. These
genes encoding protein factors are involved in a variety of cellular functions, including protein
ubiquitination, phosphorylation, transport, DNA replication and others. More importantly, I also
revealed that Asunder and CG4785 are two additional core Integrator proteins in the Integrator
complex as both are functionally required for snRNA 3’ end formation and biochemically
associate with the known Integrator complex. Moreover, the CycC/Cdk8 kinase was
determined to be required for proper snRNA 3’ end formation where the kinase activity of
CdK8 is involved but is likely working through a pathway independent of the Mediator complex.
At this stage, it is still unclear how exactly these four factors carry out their function in snRNA 3’
end formation.
The Asu/IntS13 was originally identified to be a regulator of mitotic cell cycle and
Drosophila development (Stebbings et al. 1998), and recently was found to regulate the
perinuclear dynein localization during Drosophila spermatogenesis (Anderson et al. 2009).
Asu/IntS13 was also identified as a regulator of small RNA biogenesis in a S2 cell RNAi
screen (Zhou et al. 2008). Here we reported a novel function for Asu/IntS13 in snRNA 3’ end
formation. Whether the reported different function of Asu/IntS13 could be ascribed to the same
pathway in cells is not clear, but it is possible that Asu/IntS13 may function in multiple
pathways as the reported Asu/IntS13 associated processes take place in different cellular
compartments consistent with its bimodal localization observed in our study (Chen et al. 2012).
The Asu/IntS13 is a conserved protein across metazoan species and belongs to the cell cycle
regulator Mat89Bb family that contains a well-conserved but functionally unknown DUF2151
domain (Figure 6.2). It would be interesting to determine the functional domain(s) mediating
the differential roles of Asu/IntS13, especially in snRNA 3’end processing by using the
powerful RNAi/rescue/snRNA-GFP reporter system described in Chapter 4. An effort to
characterize the potential direct Integrator binding partner of Asu by directed Y2H assay failed
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Figure 6.2 Schematic representation of protein domains of Asu/IntS13 and
IntS14/CG4785.
Protein domain search is conducted by using Pfam analysis, and protein domains are labeled
in black. The species used for conservation analysis are human, cow, chicken, Drosophila and
zebrafish. Abbreviations: DUF, domain of unknown function; VWA, von Willebrand factor type
A domain; IntS, Integrator subunit.
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to score any known Integrator protein, leaving the functioning details of Asu in snRNA 3’ end
formation an open question to be addressed.
IntS14/CG4785 is a protein with much less known and there is a weakly defined von
Willebrand factor type A (VWA) domain in its N-terminal (Figure 6.2). A previous RNAi screen
in S2 cells for protein factors involved in small RNA (miRNA/siRNA) pathways also scored
IntS14 as a positive regulator (Zhou et al. 2008), implying that IntS14 may function in sRNA
biogenesis in Drosophila.
The identification of CycC/Cdk8 kinase in our screen was unexpected as it is predominantly
present in the Mediator Complex of the RNAPII, which is likely separated from the Integrator
Complex (Baillat et al. 2005; Galbraith et al. 2010). In eukaryotic cells, Cdk8 is a cell-cycle
dependent protein kinase but has not been observed to oscillate throughout nor affect the cell
cycle. CycC/Cdk8 is most characterized as part of the kinase module that interacts with the
Mediator Complex and consists of CycC, Cdk8, Mediator 12 (Med12) and Med13. This
module plays an important role in transcriptional regulation of gene expression as a means of
cellular adaptation to different environmental cues. Our results (Figure 3.4D, Figure 6.3)
demonstrate that the CycC/Cdk8 but not other Cdks are specifically required for U7 reporter
snRNA 3’ end formation, and its kinase activity in particular is involved in this process. This is
the first report that implicates the function of CycC/Cdk8 in snRNA 3’ end formation, and the
underlying mechanism of this reaction is not known yet. Our results also rule out the possibility
that CycC/Cdk8 contributes to snRNA 3’ end processing through transcriptional control of
Integrator expression as depletion of CycC or Cdk8 in cells did not affect expression of the
Integrator subunit mRNA or protein (Figure 3.5). We believe that the function of these two
proteins may be analogous to their role in the RNAPII-associated Mediator Complex, where
the Mediator Cdk8 module can phosphorylate the Rpb1 CTD as well as a specific Mediator
subunit (Knuesel et al. 2009). In the case of the Integrator Complex, CycC/Cdk8 may
phosphorylate the Rpb1 CTD or Integrator subunit. Indeed, our results showed that
CycC/Cdk8 functions independent of the Mediator Cdk8 module as depletion of the other two
essential components of the Mediator Cdk8 module Med12 and Med13 did not affect the
snRNA 3’ end processing (Figure 3.7A/B). Furthermore, a small fraction of CycC/Cdk8 was
found to associate with Integrator subunits but neither Med12 nor Med13 was found to
associate with the Integrator Complex(Figure 3.7C/D). Taken together, all of the existing data
support the presence of an Integrator Cdk8 module where the CycC/Cdk8 phosphorylates
either the RNAPII CTD or the Integrator subunit to regulate the transcription-coupled snRNA 3’
end formation. Since phosphorylation of the Ser2 and Ser7 in the Rpb1 CTD has been
determined to be essential events for the Integrator complex recruitment as shown that
mutation in these two residues abolished integrator complex association with RNAPII in vitro
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A.

Figure 6.3 Specific involvement of Cdk8 and CycC in snRNA 3’ end formation.
(A). Fluorescence image of S2 cells treated with cyclin or Cdk dsRNA followed by transient
transfection with U7-GFP reporters measuring snRNA 3’ end formation. Two representative
images were shown for each dsRNA treatment. (B). Western blot analysis of cell lysates from
panel (A).
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as well as occupancy on snRNA gene in vivo, which in turn affected the snRNA 3’ end
formation (Egloff et al. 2007; Egloff et al. 2010), it would be tempting to test whether
CycC/Cdk8 can serve as a Ser7 kinase or a redundant Ser2 kinase besides Cdk9. Indeed,
previous study has shown that Drosophila Cdk8 is able to phosphorylate RNAPII CTD in vitro
(Leclerc et al. 1996), a more specific in vitro kinase assay using recombinant proteins or an in
vivo assay to determine the phosphorylation alternations using RNAPII CTD phosphorylationspecific antibodies in CycC/Cdk8 depleted cells will provide more details on CycC/Cdk8
function mechanism in snRNA 3’ end formation.
Finally, in addition to the “strong hits” analyzed above, our screen also identified 7
“medium hits”, including a WD40 repeat-containing uncharacterized protein CG9945 and a
zinc-finger containing protein CG11247. Recent study of the Gemin5, a component of the
SMN complex, determined that the WD repeat is a previously undescribed RNA-binding
domain that specifically binds snRNA sequence (Lau et al. 2009). Results from recent studies
of zinc-finger proteins also showed that they are able to bind single-stranded RNA as well
expanding the canonical roles in DNA recognition and protein-protein interaction (Burdach et
al. 2012). Therefore, to functionally validate these two proteins and to determine their potential
for snRNA recognition and Integrator association may lead to the discovery of the elusive RNA
binding proteins in the snRNA 3’ end processing machinery.
Structural and functional analysis of the PHD finger-containing Integrator subunit
IntS12
It has been well established that chromatin states control gene transcription, and emerging
evidence from recent studies suggest that chromatin states also play important roles in exon
definition as well as pre-mRNA alternative splicing (Luco et al. 2010; Shukla et al. 2011). In
both cases, the epigenetic effectors are critical readers that transmit the chromatin pattern to
biological outcomes. While no study has been reported to implicate the chromatin architecture
in the 3’ end processing of pre-RNA, it is possible that such chromatin reader mediated
recognition may be involved. The plant homeodomain (PHD) finger is a reader domain of the
chromatin that preferentially recognizes modified or unmodified histone lysine markers
(Reviewed in (Musselman and Kutateladze 2011; Sanchez and Zhou 2011)), and it was found
to be the most conserved domain with a well-defined function in the Integrator proteins
besides the MBL/β-CASP domain present in IntS9/11 (Figure 1.5). It is possible that the
Integrator complex is recruited through recognition of specific chromatin markers present at
the 5’ or 3’ end of snRNA genes via the PHD finger present in Integrator subunit 12 (IntS12).
This provides the basis for our structural/functional study of IntS12.
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Chapter 4 and 5 described our biochemical and functional characterization of IntS12 to
understand how this PHD finger-containing Integrator protein functions in snRNA 3’ end
formation. Since IntS12 contains a chromatin reader domain, we tested the chromatin
recruitment of Integrator complex model by determination of the interaction between the
IntS12 PHD finger and histones. As expected, GST-pulldown assay established a specific
interaction between IntS12 PHD finger and the histone H3 (Figure 5.1B/C). However,
subsequent functional analysis clearly demonstrates that neither the conserved IntS12 PHD
nor the characterized interaction with histone H3 is required for mediating the U7 or U4
reporter snRNA 3’ –end formation (Figure 4.4C/D, Figure 5.5). To our surprise, systemic
analysis of IntS12 functional domain identified an N-terminal 30 amino acid long microdomain
that resides in a conserved region that is predicted to form a helix-coil-helix fold (Figure
4.4C/D/E, Figure 4.5A, Figure 6.4). This IntS12 microdomain functions autonomously as
shown functionally the microdomain by itself is able to mediate both reporter and endogenous
snRNA 3’ end formation (Figure 4.6, 4.7A). Further, biochemically it is sufficient to stabilize the
largest Integrator subunit IntS1 through a potential direct binding (Figure 4.7, 4.8, 4.9). This
study provided the first detailed functional analysis of one of the Integrator subunits and
established a working model for IntS12 in snRNA 3’ end formation where the N-terminal region
of IntS12 binds IntS1 to stabilize the putative scaffold protein to facilitate further complex
assembly (Figure 6.5). IntS1 has been determined to play important roles in snRNA 3’ end
formation and animal development. Depletion of IntS1 in S2 cells causes accumulation of
significant amount of premature snRNAs (Figure 3.3A) and disruption of IntS1 in mouse
causes misprocessing of snRNAs and eventually leads to embryonic lethality (Hata and
Nakayama 2007). The expression of IntS1 was found to be dependent on the expression of
several other Integrator subunits as shown in our co-depletion assay (Figure 6.6), further
supporting a scaffolding role of IntS1 in the Integrator complex. The functional microdomain of
IntS12 is predicted to adopt a helix-coil-helix fold that has been shown to serve as a proteinprotein dimerization surface (Johnen and Kaufman 1997; Colledge et al. 2011). However, an
effort to determine the structure of the IntS12 microdomain by nuclear magnetic resonance
(NMR) spectroscopy revealed that solution structure of the recombinant microdomain is likely
to be intrinsically disordered (data not shown). One possible explanation for the disparity is
that the correct folding for IntS12 microdomain requires the presence of its binding partner
(potentially IntS1). It would be interesting to determine which region of IntS1 is recognized by
IntS12 microdomain that will further advance our understanding on the function of the IntS12
microdomain in snRNA 3’ end formation.
Our results from the study of the IntS12 functional domain disfavors our initial model for
chromatin recruitment of Integrator complex to snRNA genes through the conserved PHD
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IntS12 (1-60)

Mt3

Mt5

Figure 6.4 Secondary structure prediction of IntS12 microdomain by Jpred3 predicts a helix-coil-helix fold.

Drosophila IntS12 N-terminal 1-60 amino acid sequence was used for secondary structure prediction using the Jpred3 secondary structure

prediction server (http://www.compbio.dundee.ac.uk/www-jpred/). The QUERY is the IntS12 (1-60) sequence and UniRef90 items are

sequences predicted with closest secondary structure to QUERY sequence. The predicted α-Helix is shown with read stick, and the

prediction confidence is right below (0-9, the larger the number, the more confidence). The red shade box represents the identified
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functional microdomain, and the functional important residues within the microdomain are red-boxed.
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Figure 6.5 Schematic working model of IntS12-IntS1 interaction in Integrator complex
assembly.
When IntS12 interacts with putative scaffolding Integrator subunit IntS1, it stabilizes IntS1
protein in cells, which serves as a platform for other Integrator binding and the complex
assembly. If this interaction is disrupted by either sequestering IntS12 or promoting its
degradation, IntS1 in cells will be destabilized and subject to degradation. Loss of the putative
scaffolding protein eventually will disassemble the Integrator complex. IntS12 is schematically
shown to have three features: an N-terminal microdomain (crescent), a PHD finger (pentagon)
and a phosphorylation at the Thr 76 residue.
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Figure 6.6 The stability of IntS1 in cells is dependent upon the expression of many other
Integrator subunits.
S2 cells were treated with dsRNA targeting either control PTB mRNA or different Integrator
mRNA for three days, and cell lysates were prepared from these cells on the fifth day. Lysates
were then subjected to Western blot analysis using antibodies specific for IntS1, IntS9, IntS11
and IntS12. NT, cells not treated with any dsRNA; IntS, Integrator subunit; a cross-reacting
band with IntS1 antibodies was used as a loading control.
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finger containing protein IntS12 to mediate proper 3’ end formation. This then generates the
question of what is the function of the IntS12 PHD finger? While we did observe that the
IntS12 microdomain can function autonomously, it exhibited lower efficiency in interaction with
other Integrators (Figure 4.7A/D). So there is a possibility that IntS12 PHD may contribute to
full interaction between IntS12 and other Integrators. Our results from the co-IP support this
idea as the PHD finger retaining IntS12 N-terminal fragment exhibited significantly stronger
interaction with other Integrators to a level equivalent to the full-length IntS12 protein (Figure
5.4B, lane 10 v.s. 2, 4). These results await follow-up experiments to determine whether the
observed enhanced Integrator interaction contributes to endogenous snRNA 3’ end formation.
Though here we focus our research interest on the Integrator Complex in snRNA 3’ end
formation, there are also sporadic reports that suggest Integrator subunits function in
processes beyond snRNA 3’ end formation (Reviewed in (Chen and Wagner 2010)). Recently
genome-wide CHIP-Seq studies of the SNAP protein and endonuclease IntS11 suggest that
the Integrator complex is potentially recruited to the genomic loci distinct from snRNA genes
((Baillat et al. 2012); Baillat & Shiekhattar, unpublished data). More interestingly, a statistical
analysis of Drosophila Integrator proteins scored in the public screens also suggests that the
Integrator complex may function in a variety of cellular and biological pathways. These
pathways include: notch signaling (Mourikis et al. 2010), mitogen-activated protein kinase
(MAPK) signaling, protein aggregate formation (Zhang et al. 2010) and cell morphology control
(Kiger et al. 2003) (Table 6.1). Thus, we can envision that the conserved IntS12 PHD may
contribute to these yet-to-be identified/confirmed cellular and biological processes.
Finally, this thesis project provides a powerful tool for characterization of functional
domains present in other Integrator subunits that are required for snRNA 3’ end formation. The
unique Drosophila RNAi rescue system we presented here combined with our snRNA-GFP
reporters enables us to ultimately validate the candidate genes and dissect any functional
domains present in the validated factors. The Drosophila RNAi system uses ~500bp dsRNAs
to elicit depletion of endogenous proteins, which makes it difficult to generate an RNAiresistant cDNA. This, in turn, makes any RNAi-rescue structure/function analysis intrinsically
more challenging. Two common methods to do RNAi rescue in fly cells are: (1) design dsRNA
targeting the UTRs of the endogenous mRNA and rescue by the wild-type cDNA open reading
frame (ORF) of the targeted gene; (2) dsRNA targeting the coding sequence and rescue with
an ortholog cDNA (i.e. some other Drosophilids) of the targeted gene. The limitation for the
first method is that many of the Drosophila genes have short UTR regions that when targeted
elicit limited levels of reduction of endogenous proteins. Significant effort was wasted to
determine that this was the case for the IntS12 3’UTR (~70 nt) (Data not shown). The limitation
for the second method lies in that it rescues with a different protein, which may function
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Table 6.1 Integrator proteins as positive hits in public screens
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IntS5/Omd
IntS6/DICE1
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IntS8
IntS9
IntS10
IntS11
IntS12
IntS13/Asu
IntS14
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Cdk8
Total

S
12
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19
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S1. Modifiers of Notch Signaling; S2. S2R+ Morphology Screen; S3. Functional genomic analysis of the Wnt-Wingless Signaling Pathway; S4. MAPK Signaling Pathway Screen; S5. RTK

Specificity; S6. Identification and characterization of proteins required for MicroRNA and siRNA biogenesis and functioning; S7. Host factors important for uptake, survival and multiplication of

chlamydia caviae; S8. Modifiers of Intracellular aggregates derived from mis-folded proteins; S9. General Secretion Screen; S10. CRACM1 Is a Plasma Membrane Protein Essential for

Store-Operated Ca2+ Entry; S11. Hedghog secretion; S12. Interactions between Legionella pneumophila and its host; S13. Genes regulating lipid storage in Drosophila melanogaster; S14.

Comparison of GPCR Induced vs. Small G-Protein Induced Signalling to the Nucleus; S15. Identifying factors that regulate the recruitment and function of the dosage compensation complex

in Drosophila melanogaster.; S16. ERK Signaling Dynamics; S17. RNAI screen for genes required for processing of Cubitus interruptus (Ci); S18. Screen for novel regulators of G2/M
checkpoint; S19. BCL9 Screen

Table 6.1 Integrator proteins as positive hits in public screens. The data for this statistical analysis is derived from the Drosophila

RNAi Screening Center (DRSC). In total 78 genome-wide RNAi screen data were investigated and the screens that identified positive

Integrator (including CycC/Cdk8) hits are shown here. In each screen, the hits are scored by Stong (S), Medium (M) or Weak (W). Off-
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targets here means predicted number of off-targets for each dsRNA used to target Integrator component.
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different from the wild-type protein. Here we described another way to do the RNAi rescue in
fly cells by using dsRNA targeting the coding sequence while rescue is conducted with an
RNAi-resistant cDNA that encodes the same wild-type protein. This RNAi-resistant cDNA is
generated by chemical synthesis of a DNA sequence with all of the possible silent mutations
introduced to the cDNA region targeted by the dsRNA. This RNAi rescue method in fly cells
can circumvent the obstacles generated by using the other two methods, and theoretically it is
applicable to any gene in fly cells. With the development of synthetic biology, the cost using
this technique will continue to decrease.
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CONCLUDING REMARKS
This dissertation has contributed to the field of metazoan snRNA processing by providing
detailed functional analysis of the snRNA 3’ end processing machinery, the Integrator
Complex. Specifically, this work has redefined the Integrator complex to comprise of fourteen
core subunits and a regulatory kinase through a genome-wide functional RNAi screen.
Moreover, this work also provides the first detailed functional domain analysis of one Integrator
subunit IntS12, and reveals IntS12 mediates the function of Integrator complex in snRNA 3’
end formation through stabilization of the putative scaffold protein in the complex.
Finally, the work presented in dissertation provides the basis for further elucidating the
biochemical, cellular and biological function of the conserved IntS12 PHD finger, and for
identification of those elusive RNA-binding proteins in the Integrator complex for snRNA
sequence element recognition. The research into the Integrator Complex is only beginning
and this thesis has contributed to laying foundation for future work.

!

115

!
!
!
!
!
!
!

Appendix. IntS12 is Preferentially Recruited to Promoter Region of snRNA Genes.
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INTRODUCTION
Integrator Complex is the 3’ end processing machinery for RNAPII-transcribed snRNAs in
metazoan species that associates with the CTD of RNAPII, and IntS11 is the MBL/β-CASP
superfamily endonuclease that cleaves 3’ end of the nascent primary snRNA transcripts from
the elongating polymerase (Baillat et al. 2005). Subsequent functional analysis of the
Integrator complex has determined that all twelve subunits except IntS3 and IntS10, are
required for snRNA 3’ end formation in Drosophila cells (Ezzeddine et al. 2011). Several
Integrator subunits (IntS2, 9,10,11) have also been determined to recruit to U1 and U2 snRNA
genes but not the Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) encoding gene or
the histone H3 gene (Baillat et al. 2005), supporting a specific functional requirement for
Integrator Complex in snRNA biosynthesis. For the other two RNAPII transcripts, the poly(A)
mRNA and histone mRNA, the shared cleavage factor including CPSF73, CPSF100 and
Symplekin, is found to enrich at 3’ end of both types of genes in vivo (Sullivan et al. 2009),
supporting its cleavage role for both types of transcripts.
It has well documented that snRNA 3’ end formation is a transcription-coupled process that
requires transcription initiation from an snRNA promoter (de Vegvar et al. 1986; Hernandez
and Weiner 1986; Ezzeddine et al. 2011). This is analogous to the poly(A) mRNA 3’ end
cleavage/polyadenylation process but is distinct from the histone mRNA 3’ end formation. The
pre-mRNA 3’ end processing factors have been observed to be present at both 5’ and 3’ end
of coding genes (He et al. 2003; Glover-Cutter et al. 2008), supporting the model for
recruitment of processing factors to the promoter for coupling transcription and 3’ end
processing. Compared to mRNA encoding gene, the snRNA gene is very short with an
average size of ~ 200 bp, which makes it difficult to discriminate the occupancy of Integrator
proteins on the snRNA genomic loci by the Chromatin immunoprecipitations (CHIP) assay.
The original study showed that four Integrator subunits tested occupied both ends of U1 and
U2 snRNA genes in HEK293T cells (Baillat et al. 2005). However, the author described that
due to the low resolution of CHIP, it was difficult to conclude the exact occupying loci of the
Integrator proteins on snRNA genes.
Here I tried to develop a high-resolution CHIP assay for detection of Integrator proteins on
snRNA genes in Drosophila S2 cells. This assay could be used to determine the accurate
occupancy of Integrator proteins on snRNA genes (Promoter or 3’ region), and combined with
RNAi, it could be used to determine critical subunit for recruitment of Integrator complex to
snRNA promoter or 3’ end region, which will significantly advance our understanding for
Integrator Complex function in snRNA 3’ end formation. I started optimizing the CHIP
conditions by study of the IntS12 occupancy on snRNA genes (U7, U1, U2, U4). I determined
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the optimal chromatin fragmentation condition and screened good qPCR amplicons of various
regions of the snRNA genes in S2 cells. By using the developed CHIP assay, I have found that
IntS12 is preferentially recruited to the promoter region of U7 snRNA gene whereas the
RNAPII is enriched across the whole gene region. Then I also tested the requirement of the
conserved PHD and the T76 phosphorylation for IntS12 occupancy on promoter region of the
U7 snRNA gene.

!

118

RESULTS
Optimization of Chromatin Immunoprecipitation (CHIP) Conditions in S2 Cells
A high resolution CHIP profile is important for determining the in vivo genomic occupancy
of a protein under investigation, and several key factors are prerequisites to achieve that,
including the qualities of CHIP antibodies, chromatin fragments, qPCR amplicons. Figure A.1A
shows the standard procedure for CHIP assay, and the detailed procedure is described in the
Chapter 2 Materials and Methods section. Here I evaluated all the factors required for
development of a high resolution CHIP on snRNA genes. I purified the IntS12 polyclonal
antibodies by affinity purification using the recombinant GST-IntS12 (1-163 a.a.) antigenconjugated column, and showed that the antigen-purified IntS12 polyclonal antibodies can
specifically recognize endogenous IntS12 proteins in S2 cells (Figure A.1B). The size of the
fragmented chromatin is a critical determinant of the resolution of the CHIP assay. I tested
different sonication conditions and determined the optimal program to be 4 times of 30 sec
on/2.5 min off using the Ultrasonic Converter C5749. Under this condition, the major
population of the chromatin fragments was distributed ~ 300-400 bp (Figure A.1C). I also
tested qPCR primers for amplification of different regions upstream and downstream 1.6kb of
the U7 snRNA gene (Figure A.1D), and determined seven amplicons (~200 bp) that could be
specifically amplified across the U7 genomic loci (Figure A.1D). Collectively, I determined the
optimal CHIP conditions for test IntS12 occupancy on U7 snRNA genes in S2 cells by
controlling the quality of the antibodies, chromatin fragment size and amplicons.
IntS12 is preferentially occupying the U7 snRNA promoter region
Once optimized the CHIP condition in S2 cells, I tested the occupancy of IntS12 on U7
snRNA genomic loci. 1X108 S2 cells were used for the CHIP assay. DNA-proteins were
crosslinked, sonicated, immunoprecipitated, and precipitated DNA-protein were reverse
crosslinked and DNA was purified for qPCR analysis. Antibodies for RNAPII, IntS11 and
IntS12 were used for immunoprecipitation, and Guinea pig (GP) IgG were used as control for
pulldown. The RNAPII was observed to enrich in both the promoter and 3’ region of the U7
snRNA gene (Figure A.2d,e), and IntS12 was highly enriched in the U7 snRNA promoter
(Figure A.2d). In contrast, the endonuclease IntS11 was found to be present across the whole
region measured, with the highest occupancy in the 3’ end region of the U7 snRNA gene
(Figure A.2). This result indicates that there might be a sequential recruitment of different
Integrator subunit onto specific region of the U7 snRNA gene.
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Figure A.1 Optimization of CHIP conditions on Drosophila U7 snRNA gene.
(A). Schematic representation of the standard procedure for CHIP assay. (B). Western blot
analysis of S2 cell lysates using the antigen-purified IntS12 polyclonal antibodies. (C). Reverse
crosslinked total DNA was run on agarose gel and stained with Ethidium bromide. (D). top
panel, schematic representation of amplicon location relative to the U7 snRNA gene; bottom
panel, amplicons from qPCR were run on agarose gel and stained with Ethidium bromide.
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Figure A.2 CHIP profiles of IntS11, IntS12 and RNAPII on the U7 snRNA gene.
S2 cell CHIP DNA was prepared by following the optimized protocol described above, and
RNAPII, IntS11 and IntS12 antibodies were used for immunoprecipitations with GP IgG as
negative control. Purified DNA was used for qPCR analysis using primers described above.
Data were presented as percentage of input with the IgG background subtracted.
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DISSCUSSION
Chromatin Immunoprecipitation is a technique used to determine the occupancy of a
protein factor on specific genomic region in vivo. Information garnered from CHIP assay is an
important complementation for understanding the cellular function of nuclear acid associated
proteins. Integrator proteins were found to recruit to U1 and U2 snRNA genes and catalyze the
3’ end formation of RNAPII-transcribed snRNAs. However, it is still not clear whether it is
recruited to the promoter or the 3’ end region of snRNA. Both cases are possible as Integrator
complex are determined to couple the snRNA transcription and 3’ end formation as well as
cleave the nascent primary transcripts (de Vegvar et al. 1986; Hernandez and Weiner 1986;
Baillat et al. 2005). A high resolution CHIP assay will help answering these biologically
important questions. In this study, I developed a CHIP assay for detection of the occupancy of
IntS12 protein on U7 snRNA gene in vivo. The IntS12 proteins were found to preferentially
occupy the promoter region of the U7 snRNA gene.
In Chapter 4 and 5, we have comprehensively investigated the domain functions of IntS12
protein, and characterized an N-terminal microdomain that is essential for snRNA 3’ end
formation. We also determined the roles of the T76 phosphorylation and the conserved PHD
finger domain of IntS12 in Integrator interactions. It would be interesting to know whether
these characterized features are important for IntS12 occupancy on the U7 snRNA promoter
or not. To test that, we have generated S2 cell stable lines expressing FLAG-tagged PHD
deletion or point mutants, T76 point mutant or the N-terminal microdomain point mutants.
CHIP analysis using anti-FLAG antibodies in these stable cell lines gave ambiguous results
that are hard to interpret (data not shown). One potential caveat to do the CHIP analysis using
these stable lines is the uneven expression of tagged proteins in these cells, which makes the
CHIP signal hard to compare between different cell lines. To circumvent this problem, it will be
worth selecting the monoclonal S2 stable cell lines that give similar levels of expression for the
tagged proteins or to generate isogenic cells that harbor only a single copy of gene insertion at
a specific genomic site.
Nevertheless, using the CHIP assay we developed on snRNA genes combined with RNAimediated depletion of Integrator subunits, it will provide more details of Integrator function in
snRNA 3’ end formation, such as the promoter recruitment of Integrator complex and the 3’
end cleavage of snRNA, through study of the occupancy of all other Integrator subunits on
snRNA promoter and 3’ end region.
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